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O
6
-Alkylguanine-DNA alkyltransferases (AGT) are responsible for the removal of 
numerous mutagenic O
6
-alkyl 2’-deoxyguanosine (O6-alkyl dG) and O4-alkyl thymidine 
(O
4
-alkyl dT) adducts. The function of AGT in the recognition and removal of both 
mono-adducts and DNA interstrand cross-links (ICL) were undertaken. To achieve this, 
oligonucleotide probes containing alkylene linkers varying in length that tethered the O
4
 
atoms of thymidine (dT) or 2’-deoxyuridine (dU) and O6 atoms of 2’-deoxyguanosine 
(dG) were prepared. These ICL were generated using a combination of solution and solid 
phase synthesis. Various O
4
-alkyl dT and O
4
-alkyl dU mono-adducts were also prepared 
by similar methods and analyzed to further elucidate the limitation of AGT with respect 
to damage detection and repair. Three AGT homologues (human AGT/hAGT, and E. 





 modified oligonucleotides to note variations amongst species. Studies 
with the AGTs and modified DNA probes revealed: 1) hAGT is capable of repairing O
6
-
2’-deoxyguanosine-butylene-O6-2’-deoxyguanosine (O6dG-butylene-O6dG) and O6-2’-
deoxyguanosine-heptylene-O
6
-2’-deoxyguanosine (O6dG-heptylene-O6dG) ICLs in a 5’-
GNC sequence motif, designed to mimic the configuration of the ICL generated by 




























dT) ICL DNA shows promise since covalent 




dT cross-links; 4) Introducing 
the active site of OGT into the hAGT scaffold confers the chimera with enhanced repair 
capabilities of O
4
-alkyl dT adducts with respect to hAGT while maintaining ICL repair 
activity; 5) AGT mediated repair of O
4
-alkyl dT damage is hindered by the presence of 
the C5 methyl (up to 30-fold). This effect is most notable with hAGT and the chimera; 6) 
O
4
-2’-deoxyuridine-alkylene-O4-2’-deoxyuridine (O4dU-alkylene-O4dU) ICL DNAs are 
not repaired by AGT. This elusive property is attributed to the E conformation adopted 
by the linker about the C4-O
4
 bond of the modified dU, as demonstrated from NMR 
studies. There are no working models that provide a feasible hAGT based repair 
mechanism for ICL damage. ICL DNA:hAGT crystal structures are needed to shed light 
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DNA encodes the information required for biosynthesis of RNA and proteins, it is 
therefore essential for life. DNA is the source of information in the cell, it dictates the 
amino acid sequence of each protein. It is clear that the integrity of the genomic DNA 
should not be compromised or else the ramifications of these modifications in the DNA 
will be felt on multiple levels. The DNA that constitutes our genome is constantly under 
attack by endogenous and exogenous agents. The damage induced by these agents can 
have a harmful effect on the host due to their ability to induce mutations and/or 
modifications in the DNA. Mutation are more prone to occur when the agent damages the 
heterocyclic base of the DNA, while alkylation of the phosphotriester moiety, for 
example, are virtually silent on the nucleotide context. ICLs are very cytotoxic since 
complementary DNA strands are covalently bound together, inhibiting DNA replication, 
RNA transcription and ultimately gene expression.  
Cells have evolved repair mechanisms to deal with DNA damage that arise from 
exposure to modifying agents. The ultimate role of all DNA repair mechanisms are the 
same; revert the modified DNA back to its native state. Each DNA repair mechanism has 
its set of substrates, where some overlap amongst mechanisms is known. The repair 
mechanisms are not ubiquitous in all kingdoms of life. Different organisms have 
different/extra classes of repair systems with most of the repair pathways showing 
overlap amongst species. These vast arrays of repair mechanisms and variation amongst 




1.2 DNA alkylation 
1.2.1 Classes of DNA alkylating agents  
Most alkylating agents can be broken down into two general classes: mono-
functional and bi-functional. As the name infers, mono-functional alkylating agents cause 
one alkylation event in the DNA per molecule whereas the bi-functional alkylating agents 
can cause two alkylation events. 
Mono-functional alkylating agents can be harmful to the cell by impeding the 
ability of certain DNA polymerases to continue DNA replication and hence stop cell 
growth. The ability of an alkylation event to impede DNA polymerase function depends 
on the atom in question undergoing modification. Modification of the N3 atom of 2’-
deoxyadenosine (dA), the second most predominant point of alkylation, leads to 
replication inhibition.(1,2,3) Some sites have virtually no effect on polymerase activity, 
such as the N7 atom of dG, the most predominant point of alkylation.(1) 
Mono-functional alkylating agents can also induce mutations in both genomic and 
mitochondrial DNA. For example, alkylation at the O
6
 atom of dG is mutagenic since it 
participates in base-pairing, which will be elaborated upon later in the introduction.(4,5) 
Bi-functional alkylating agents have shown an increased ability to suppress tumor 
cells with reports dating back 60 years.(6) Bi-functional alkylating agents are more 
harmful to the cell than their mono-functional counterparts due their ability to introduce 
mono-adducts and cross-links in DNA duplexes.(7) The cross-links induced by this class 
of alkylating agents on DNA can either be intrastrand cross-links, where both alkylation 
events occur on the same DNA strand, or interstrand cross-links (ICL), where the two 
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alkylation events occur on complementary DNA strands. Their ability to cause ICL 
lesions in DNA is thought to be the reason for the cytotoxicity of these compounds.(8) 
The introduction of a covalent linkage between two complementary strands of DNA, 
inhibits DNA strand segregation.(7,9) Many cellular processes rely on this segregation 
for function with DNA replication and RNA transcription as examples. This entails that 
all processes downstream of these two vital events will also be inhibited, ultimately 
leading to cell arrest and apoptosis. 
1.2.2 Sites of DNA alkylation and their biological consequences 
Not all atoms of the DNA duplex are acted upon by alkylating agents. Alkylating 
agents perform their function due to their electrophilic properties with the exception of 
psoralens and other agents which act by intercalating between DNA bases prior to 
photoactivation.(7) There exist no alkylating agents capable of exclusive selectivity in 
targeting a defined nucleophilic centre.  
DNA alkylation occurs via a reaction of a nucleophilic center in the DNA on the 
electrophilic moiety of the alkylating agent and can be described to follow a mechanism 
that is either unimolecular (SN1) or bimolecular in nature (SN2).(10) In the SN1 type 
mechanism the rate of the reaction is governed solely by the nature of the electrophile 
(alkylating agent) making compounds that fall under this category less specific. In the 
SN2 type mechanism the rate of the reaction is not only governed by the electrophile but 
also by the nucleophile (nucleophilic centers of the DNA) making these agents more 
selective.  
The "softer", more charged delocalized alkylating agents undergo SN2 type 
mechanisms yielding predominantly N7-alkyl dG. The "harder", higher charge density 
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alkylating agents undergo SN1 type mechanisms yielding less of N7-alkyl dG and more 
of the exocyclic oxygen adducts, such as O
6
-alkyl dG and O
4
-alkyl dT.(1,10,11) Table 
1.1 shows how the nature of the alkylating agent can alter which atoms in the DNA 
undergo modification.  
Table 1.1: Percentage of total alkylation of each nucleophilic atom in DNA when treated 














In vitro In vivo In vitro In vivo 
Adenine N1 3.8   1.3   
  N3 10.4 8.7 9.0 4.2 
  N7 1.8 2.4 1.7 3.1 
Guanine N3 0.6 1.3 0.8 0.5 
  O
6
 0.3 0.3 6.3 5.1 
  N7 83.0 83.0 67.0 69.0 
Thymine O
2
 nd   0.11 5.1 
  N3 0.1   0.3   
  O
4
 nd   0.4   
Cytosine O
2
 nd   0.1   
  N3 <1 <1 0.6 0.4 
Diester   0.8   17.0 9.0 
The carcinogenicity of the various alkylating agents are not directly correlated with 
the magnitude of alkylating events but rather with the mutagenicity of the lesions. 
Despite the relatively low proportion of O
6
-alkyl dG formed with respect to the total 
DNA damage, this lesion along with O
4
-alkyl dT, are used as biomarkers to rank the 
mutagenic/carcinogenic factor of the different alkylating agents.  
O
6
-alkyl dG is mutagenic due to the tendency of DNA polymerases to incorporate 
an erroneous dT nucleotide opposite to the modification during DNA replication and 
6 
 
repair by the mismatch repair (MMR) machinery.(13) In human O
6
-alkylguanine-DNA 
alkyltransferase (hAGT) deficient tumor cells, one lethal event occurs for every 6 650 O
6
-
methyl-2’-deoxyguanosine (O6-MedG) produced in the genome.(14)  
Studies conducted with AGT deficient cells revealed that the MMR pathway was 
detrimental to the cell in the presence of O
6
-MedG.(15,16) The MMR machinery 
perceives an O
6
-MedG•dT pair as a substrate for repair as this base pairing does not 
constitute one of the two natural interactions found in DNA. In the case where the O
6
-
MedG is on the non-template strand the MMR machinery can repair the lesion correctly 
by removing the incorrectly incorporated modified nucleotide since it is on the newly 
synthesized strand. In the opposite case, where the lesion is present in the template 
strand, the MMR machinery cannot excise the modified nucleotide and thus it removes 
the dT erroneously incorporated opposite to the O
6
-MedG. This is followed by the 
misincorporation of dT opposite to O
6
-MedG. Multiple rounds of futile MMR eventually 
signal the cell to commit apoptosis in order to conserve genetic integrity.(17) This 
property has been exploited during chemotherapeutic regimens. Methylating agents 
capable of forming considerable amounts of O
6
-MedG, such as  temozolomide, are 
commonly used in the treatment of brain cancers where hAGT levels are at their 
lowest.(18) If the O
6
-alkyl dG•dT pair evades all repair mechanisms and remains in the 
genomic DNA a dG•dC to dA•dT transition is ultimately produced.(5,19)  
The thermal stability of various duplexes consisting of the self-complementary 
Dickerson dodecamers (CGXGAATTCYCG), where X is O
6
-MedG and Y is any of the 
four natural 2’-deoxynucleotides revealed that the thermal stability of the duplex 
decreased according to the following trend: dG•dC > dG•T > O6-MedG•dC > O6-
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MedG•dA > O6-MedG•dG > O6-MedG•T.(20) These results are counterintuitive 
considering that dT is generally incorporated opposite to O
6
-MedG by DNA 
polymerases.(21) If H-bonding properties governed the incorporation of the nucleotide 
opposite to O
6
-MedG then dT should be incorporated least. Rather, preferential 
incorporation of dT opposite to O
6
-MedG is governed by Watson-Crick geometry. NMR 
studies revealed that O
6






































-alkyl dT is highly mutagenic. O
4
-alkyl dT is mutagenic 
due to its ability to cause DNA polymerases to incorporate dG instead of dA opposite to 




-MedT) is a minor alkylation 
product with respect to its O
6





-MedT.(24) As with O
6
-MedG, misincorporation of dG at O
4
-
MedT sites is governed by the geometry of the base pair. NMR studies demonstrated that 
O
4



























Figure 1.2: Watson-Crick pairing of (A) dT•dA, (B) O4-MedT•dA and (C) O4-MedT•dG  
(A) (B) (C) 
(A) (B) (C) 
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In repair proficient cells transformed with single-stranded DNA (ssDNA) 
containing specific lesions, mutations rose 12% opposite to the O
4
-MedT while a < 2% 
mutation rate was observed opposite to O
6
-MedG.(27) A similar trend was observed for 
double-stranded DNA (dsDNA) in Escherichia coli (E. coli), where O
4
-MedT caused a 
45% mutation rate as opposed to 6% by O
6
-MedG.(28) In mammalian cells, O
4
-MedT is 
more toxic than O
6





-MedT is not affected by the expression or suppression of hAGT activity nor 
by MMR, explaining its added toxicity.(29,30) Nucleotide excision repair (NER) 
deficient cells exhibit added sensitivity to O
4
-MedT indicating that this lesion is 
eliminated via the NER pathway in mammalian cells.(31) E. coli has evolved two 
proteins from the direct repair pathway to process O
4
-MedT lesions; OGT and the c-
terminal of the adaptive response protein Ada-C.(4,32,33,34) As a result O
4
-MedT is less 
toxic in E. coli cells. 
ICL formation represents the most lethal event of all the possible reactions that can 
occur upon exposure to bi-functional alkylating agent (shown in Figure 1.3).(8) The 
presence of 40 ICL lesions in repair deficient mammalian cell is sufficient to cause cell 
death, while only one ICL is enough to kill repair deficient bacteria and yeast.(35,36) 
Due to their lethal properties ICL forming agents are employed in many instances during 
chemotherapy.(37,38,39) Some of the more commonly used and potent anti-cancer 
agents used today are cross-linking agents such as: nitrogen mustards, platinum drugs, 
alkyl methanesulfonates and mytomycin C.(9) In a study of 234 chemicals, which were 
tabulated in order of genotoxicity, bi-functional alkylating agents repeatedly appeared in 
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the most toxic chemicals.(40) Moreover, 12 out of the 15 most potent anti-cancer drugs 
were cross-linking agents.(41) 
 
Figure 1.3: Possible fates of bi-functional alkylating agents (42) 
In general, ICLs are challenging to eliminate causing their prolonged presence in 
the cell with respect to mono-alkylation.(9) This property allows ICL to target faster 
proliferating cells such as tumor and cancer cells.(8) As previously introduced, mono-
functional alkylating agents can react with multiple atoms on the nucleobases. Bi-
functional alkylating agents can react with those same atoms with an additional step of a 
second alkylation event increasing the number of different lesions induced by these 
agents. The various bi-functional alkylating agents display specific properties, which 
include which atoms are targeted and more importantly which nucleotide sequences are 
targeted for ICL formation.(42)  
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1.2.3 Sources of DNA alkylation 
The most prevalent endogenous DNA damage is the N7-methyl dG adduct. It is 
thought that on a daily basis 4000 N7-methyl dG adducts form per cell and its steady-
state level is around 3000 copies per cell.(43) S-adenosylmethionine, the major methyl 
donor in cells, is the main endogenous factor responsible for the formation of N7-methyl 
dG adducts.(44,45) S-adenosylmethionine is also responsible for the formation 600 N3-
MedA and 10-30 O
6
-MedG events, daily.(46) Other endogenous sources of DNA 
alkylation include: N-nitrosoglycocholic acid (N-nitroso bile acid conjugates) that form 
O
6
-carboxymethyl dG and O
6
-MedG;(47,48,49,50) and lipid peroxidation products, such 
as malondialdehyde that generate an array of adducts.(51,52,53)  
DNA modification by exogenous factors have been extensively analyzed. The 
adverse effects of tobacco have been actively investigated for decades. The metabolic 
activation of tobacco leads to the formation of the methyldiazonium ion, a known DNA 



























If alkylation damage to DNA is not repaired, this may have various negative 
outcomes in the cell. On the other hand, the introduction of lesions in DNA by the action 
of alkylating drugs can be beneficial overall; such is the case with chemotherapeutic 
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agents. In this scenario, the lesions induced exert their toxic influence to the foreign body 
(such as a cancer) to a greater extent than to the host, ultimately resulting in elimination 
of the foreign body without being lethal to the host. 
Despite its original purpose in chemical warfare during World War I, nitrogen 
mustard (mechlorethamine) was the first alkylating agent employed to combat cancer, 
dating back to 1946.(59) As shown in Scheme 1.1, the nitrogen mustards form DNA 
ICLs via reactions involving the displacement of the chlorine atom to form an 
aziridinium ion. This ion is involved in the first alkylation event on guanine and 












































Scheme 1.1: ICL formation by nitrogen mustards, where R=Me for mechlorethamine (7) 
The main ICL induced by nitrogen mustards tether the N7 atoms of dG in a 5'-GNC 
motif where the cross-link lies in the major groove of dsDNA.(60,61,62) Alkylation at 
the N7 atom of dG is unstable and for this reason the cross-links induced by nitrogen 




Chemotherapeutic alkylnitrosoureas produce ICLs in DNA by a different 
mechanism, depicted in Scheme 1.2. ICL formation is catalyzed by base to initially yield 
a chloroethyl diazonium compound, which is responsible for the alkylation of DNA. The 
first alkylation event involves chloroethylation of the O
6
 atom of dG. This is followed by 
cyclization to form an unstable five membered ring. To alleviate the formal positive 
charge, the cyclic structure is broken upon reaction with a nearby 2’-deoxycytidine (dC) 
at its N3 atom. Chloroethylating agents form ICLs between two complimentary 




















































Scheme 1.2: ICL formation by nitrosourea compounds (65) 
Alkyl sulfonates and their derivatives have also found use in the fight against 
cancer. The reactivity of alkyl sulfonates and their derivatives towards DNA nucleophilic 
centers stem from the stability of the leaving group as a result of the delocalization of the 
negative charge over three oxygen atoms. Interest in bi-functional alkyl sulfonates as 
chemotherapeutics originate from the discovery of busulfan (1,4-butanediol 
dimethanesulfonate) in the early 1950s.(66) Since its early stages busulfan was and is still 
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used to treat cases of leukemia, though its use is less common due to newer, less toxic 
agents.(67) Busulfan predominantly alkylates dG at the N7 atom. It is capable of forming 
cross-links in DNA though the nature of the cross-links are open for debate due to the 
length of the linker (6.0 Å) and the distance between the two nearest N7 atoms of dG on 
complementary strands (8.0 Å).(68,69,70) The general consensus is that busulfan 
predominantly generates intrastrand cross-links at 5'-GA-3' sites. To date, three 







































Figure 1.4: Structures of alkyl sulfonates and derivatives 
Of the later generation alkyl sulfonates and derivatives generated, hepsulfam 
received the most attention due to its increased activity against cancers in vitro.(72,73,74) 
Hepsulfam alkylates DNA mostly at the N7 atom of dG to form mono-alkylation adducts 
involving the displacement of a sulfamate moiety by water. Moreover, ICL lesions were 
characterized, where the linker joined two N7 atoms of dG in a 5'-GNC motif (see 
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Scheme 1.3: ICL formation by hepsulfam 
1.3 DNA repair 
The various sources of DNA damaging agents generally lead to a vast diversity of 
lesions, which require a range of repair mechanisms, each with their specific lesion 
detection and repair library. It is estimated that on a daily basis the average adult human 
requires 10
16–1018 repair events per day. The repair mechanisms are broken down into 6 
general classes: base excision repair (BER), nucleotide excision repair (NER), mismatch 
repair (MMR), homologous recombination (HR), nonhomologous end joining (NHEJ) 
and direct repair (DR).(76,77)  
1.3.1 Base excision repair 
BER recognized and removes modification on the heterocyclic bases of DNA. 
Lesions include: O
6
-MedG, thymine glycols, N3-MedA, 8-oxo-2’-deoxyguanosine, N7-
alkyl dG derived formamidopyrimidines, deamination products and base 
mismatches.(78,79) BER requires multiple enzymes, as shown in Figure 1.5. The repair 
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mechanism is initiated by removal of the damaged base by a DNA glycosylase, which 
cleaves the glycosidic bond.(80) Various DNA glycosylases are present in the cell, each 
with specific substrate(s) they can repair. The glycosylase recruits an endonuclease to the 
DNA, where the endonuclease cleaves the damaged strand 5' of the newly formed 
apurinic/apyrimidinic (AP) site. Polymerase-β is subsequently recruited where it removes 
the 5'-deoxyribosephosphate with its AP lyase activity and incorporates the proper 
nucleoside where the damaged heterocycle was previously located. The repair cycle is 
concluded by the closing of the 5' nick by DNA ligase I. 
 
Figure 1.5: General short patch BER repair pathway (81) 
1.3.2 Nucleotide excision repair 
NER is responsible for the repair of most exogenous DNA adducts such as adducts 
produced when DNA is treated with cisplatin and UV light.(82,83,84) This repair 
pathway is versatile in its capability to eliminate a wide variety of damage ranging from 





-alkyl dT and N
6










distortions including: base mispairing, helix unwinding, helix bending and transcription 
blockage.(86,87) 
As shown in Figure 1.6, the basic NER pathway begins with the recognition of the 
lesions. Incisions are then created on the damaged strand a few nucleotides 5' and 3' of 
the lesion where the incised DNA is excised out of the duplex. The generated gap is filled 
with new nucleotides by a DNA polymerase and the 3' nick is then sealed by a DNA 
ligase. The illustrated mechanism shows how NER can repair a wide array of lesions due 
to the incisions being far from the actual lesion. Indeed, very bulky lesions can easily be 
removed without inhibiting the repair process. 
1) DNA Lesion




Van Houten, B., & McCullough, A. (1994). Nucleotide excision repair in E. coli. Annals of 
the New York Academy of Sciences, 726, 236-251.
 
Figure 1.6: Overview of NER mechanism (adapted from 88) 
1.3.3 Mismatch repair 
The main substrates for the MMR pathway are DNA base pair mismatches, which 
can arise from improper incorporation of nucleotides by polymerases, spontaneous 
mutations or by mutations brought about by alkylating agents.(89) Interestingly, the E. 
coli MMR machinery can repair any kind of base pair mismatch except for the dC•dC 
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mismatch.(90,91) E. coli DNA is methylated at the N
6
 atom of dA in 5'-GATC sequences 
except for newly synthesized daughter DNA. Methylation of these 5'-GATC sequences 
allows MMR to distinguish between the template and the newly synthesized DNA. MMR 
requires three proteins specific for this pathway which are: MutS, MutL and MutH. Aside 
from these proteins, the pathway also requires a DNA helicase, an exonuclease, a single-
stranded DNA binding protein, a polymerase and a ligase.(92) The repair process is 
initiated by a MutS homodimer, which recognizes the lesion as illustrated in Figure 1.7. 
This is followed by the recruitment of a MutL homodimer, which aids in the mismatch 
detection and is responsible for the subsequent binding of MutH to the complex. MutH, 
which recognized unmethylated DNA, is activated by MutS and MutL as a result of ATP 
hydrolysis. MutH cleaves the unmethylated strand at the 5’ of the 5'-GATC sequence. A 
helicase subsequently unwinds the DNA and allows the exonuclease to cleave the newly 
nicked strand slightly past the mismatch at which point the single-stranded DNA binding 
protein caps the single strand to inhibit further DNA digestion. The newly generated gap 




Figure 1.7: MMR pathway in E. coli (adapted from 89)  
1.3.4 Nonhomologous end joining 
Ionizing radiation from X-rays or γ-rays, DNA damage from alkylating agents, 
replication errors and recombinational events are all sources of double strand breaks 
(DSBs).(93) These DSBs are repaired by the NHEJ repair pathway.(94) In mammalian 
cells, after formation of a DSB a Ku heterodimer, composed of Ku70 and Ku80 binds the 
ends of the dsDNA created. The Ku complex translocates away from the DNA ends 
which allows recruitment of DNA-PKcs, a serine/threonine protein kinase. This new 
complex, termed DNA-PK, promotes the formation of the ‘synapsis’, which occurs when 
the two DNA fragments are brought back together. This is followed by DNA processing 
by various enzymes to remove overhangs or DNA damage ensued in the DSB formation 
process. DNA ligase IV is recruited to the site of lesion and the DNA-PK complex 







1.3.5 Homologous recombination 
HR repairs DSB in an error-free manner but unlike NHEJ requires a second copy of 
the genomic DNA entailing that the cell must be in the G2 or S phases where the sister 
chromatid is present (see Figure 1.8).(97) Primary response to the DSB is initiated by 
activation of Ataxia-telangiectasia-mutated protein kinase (ATM) which phosphorylates 
Nijmegen breakage syndrome 1 (NBS1). Phosphorylated NBS1 in complex with RAD50 
and MRE11 is thought to process the DSB using its 5'-3' exonuclease activity whereby 3' 
overhangs are created at the original DSB site.(98) RAD51 proteins polymerize as the 
site of the 3' overhang with the help of replication protein A (RPA) and RAD52, forming 
nucleoprotein filaments. The nucleoprotein filaments recruit the homologous sister DNA, 
which is used as a template by the polymerase. The nicks are later sealed by a ligase and 




Figure 1.8: Homologous recombination pathway (100) 
1.3.6 Direct repair 
The direct repair pathway is unique since the original nucleotide remains after the 
repair event. Two direct repair pathway exist in mammals: oxidative 
demethylases/dioxygenases (ABH2 and ABH3) and AGT, which will be discussed later.  
ABH2 and ABH3 repair methylation and ethylation at the N1 atom of dA and 
methylation at the N3 atom of dC, which are known to be cytotoxic due to DNA 
replication inhibition.(101,102) ABH proteins require O2, Fe(II) and 2-oxoglutarate to 
perform their functions. In the process, 2-oxoglutarate is decarboxylated to form 






hydroxylated alkyl group is spontaneously released as formaldehyde or acetaldehyde, 




Organisms have evolved AGT proteins to repair the highly mutagenic alkyl lesions 
at the O
6
 atom of dG and O
4
 atom of dT by a single step reaction without the need for 
cofactors or other proteins. The single step reaction irreversibly alkylates the protein 
making each protein able to accept only one alkyl group per active site.(103) Once 
alkylated, the protein is degraded by the ubiquitin pathway.(104) The importance of AGT 
for maintaining genomic integrity is evident considering its presence in Eubacteria, 
Archea and Eukaryotes.(105) Interestingly, the various AGT homologues display diverse 
substrate specificities.  
All AGT have the totally conserved -PCHR- active site motif, an asparagine hinge 
and a DNA recognition helix, as shown in Figure 1.9. The alkyl group is transferred from 
the point of lesion located on an exocyclic oxygen to the central Cys residue of the active 
site motif by an SN2 type reaction. The conserved asparagine hinge is responsible for 
protein degradation due to a rotation about this hinge that highly destabilizes the 
alkylated form of the protein. AGTs bind the minor groove of DNA rather than the major 




Figure 1.9: Sequence alignment of active site, asparagine hinge and recognition helix of 
AGT homologues (106) 
1.4.1 AGT homologues 
hAGT    1   --MDKDCEMKRTTLDSPLGKLELSGCEQGLHEIKLLGKGTSAADAVEVPAPAAVLGGPEP 
Ada     181 RHGGENLAVRYALADCELGRCLVAESERGICAILLGDDDAT-----LISELQQMFPAAD- 
OGT     1   -----MLRLLEEKIATPLGPLWVICDEQFRLRAVEWEEYSE-----RMVQLLDIHYRKEG 
                                                                
hAGT    59  L----MQCTAWLNAYFHQPEAIEEFPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISY 
Ada     235 ----NAPADLMFQQHVREVIASLNQRDTPLTLPLDIRGTAFQQQVWQALRTIPCGETVSY 
OGT     51  YERISATNPGGLSDKLREYFAGNLS--IIDTLPTATGGTPFQREVWKTLRTIPCGQVMHY 
                                                      
hAGT    115 QQLAALAGNPKAARAVGGAMRGNPVPILIPCHRVVCSSGAVGNYSGGLAVKEWLLAHEGH 
Ada     291 QQLANAIGKPKAVRAVASACAANKLAIVIPCHRVVRGDGSLSGYRWGVSRKAQLLRREAE 
OGT     109 GQLAEQLGRPGAARAVGAANGSNPISIVVPCHRVIGRNGTMTGYAGGVQRKEWLLRHEGY 
              
hAGT    175 RLGKPGLGGSSGLAGAWLKGAGATSGSPPAGRN 
Ada     351 NEER----------------------------- 
OGT     169 LLL------------------------------ 
 
Figure 1.10: hAGT, Ada and OGT sequence alignments 
The first AGT protein discovered was isolated from E. coli cells and given the 
name Ada, short for "Adaptive Response to Alkylating Damage".(107) Its discovery 
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stemmed from E. coli's ability to withstand greater levels of N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG) levels when the cells were pretreated with a lower dose of the 
drug.(108,109) This resistance was later attributed to Ada's ability to repair O
6
-








-ethyl dT and the 
Sp diastereomer of the methylphosphotriester.(33,34,112,113,114) 
This 354 amino acid protein has three discrete functions. The N-terminal domain of 
the protein, Ada-N, is responsible for two of these activities. This 20 kDa domain is 
responsible for the regulation of the adaptive response pathway and for the repair of the 
Sp diastereomer of the methylphosphotriester adduct.(115,116)  









-ethyl dT, is attributed to the C-terminal domain. This protein 
whose substrate range is limited, shows faster repair of O
6
-MedG than it does O
4
-
MedT.(117) Moreover, the repair of O
6
-ethyl dG is 1000 times slower than O
6
-MedG but 
is still more than 10 times faster than the repair of O
4
-MedT.(34) Clearly, DNA damage 
repair by Ada-C is not only affected by the nature of the alkylated atom but is also very 
sensitive to steric effects. 
The crystal structure of Ada-C has been solved and resembles the true nature of 
AGT proteins with the telltale -PCHR- motif in its active site, unlike its N-terminal 
domain.(118) Ada Cys 321 (or Cys 146 for Ada-C domain) is the alkyl acceptor group. 
Normally, the pKa of a Cys side chain is ~8.4 such that at physiological pH the thiolate 
anion should not be predominant. The pKa of Cys 146 is reduced due to a nearby 
hydrogen bond network involving the His residue from the -PCHR- motif, a Glu and 
water molecule. Rough experimental data places the pKa of Cys 146 at ~5.1.(119)  
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DNA damage recognition by Ada-C has been attributed, through cross-linking 
experiments, to weakened hydrogen bonding between complimentary nucleotides.(120) 
This mode of recognition is efficient since the lesions detected by Ada-C disrupt normal 
Watson-Crick base pairing between either T:A in the case of O
4
-alkyl dT or G:C in the 
case of O
6
-alkyl dG.  
E. coli possess a second copy of an AGT protein called OGT.(32) The necessity for 
a second AGT arises from the low basal level of Ada prior to its adaptive response. 
Before the adaptive response Ada is present at a level of 1-2 molecules per cells. After 
the adaptive response, Ada is present at approximately 3000 molecules per cell. OGT is 
present at roughly 30 molecules per cell and is constitutively expressed.(121,122) OGT is 
therefore required for E. coli cells to survive mild initial alkylating damage. 
OGT has shown the greatest activity at eliminating O
4
-MedT from DNA. Its ability 
to repair this lesion is virtually identical to that of O
6
-MedG.(117) Unfortunately, OGT 
has not been crystallized and hence its increased rate of repair of O
4
-MedT cannot be 
concretely explained. The current belief is that the shape of the active site of OGT differs 
from most other AGT proteins, which would explain this increased activity.(123) To 















-heptyl-7-ol dG, a dG nucleoside linked through its O
6
 
atom to an oligonucleotide through the O
6




Like Ada-C, substrate repair by OGT is hindered by increasing the size of the 





-ethyl dG. For instance, OGT and Ada-C have virtually identical 
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repair rates for O
6




hAGT is the most studied AGT. Like OGT, hAGT is constitutively expressed, 
though its levels vary depending on the tissue. The liver displays the highest levels and 
the brain the lowest.(65) Its known substrate range is more vast than the other AGTs due 
to the increased interest in this system. hAGT has the ability to repair large lesions at the 
O
6
 atom of dG, which has not been observed in other homologues. Its known substrates 
are depicted in Figure 1.11.(126,127,128,129) Its inability to repair O
4
-MedT efficiently 




Figure 1.11: Known hAGT substrates (adapted from 132) 
In vivo, hAGT can recognize and bind O
4
-MedT lesions but cannot remove them 
efficiently.(133) In effect, hAGT physically shields the lesion from the NER machinery 
rendering it counterproductive.(123) hAGT variants with increased repair capabilities of 
O
4
-MedT have been investigated. The Loeb group employed a random sequence 
mutagenesis approach to generate multiple variants followed by a functional 
complementation assay to obtain a variant with 8 alterations (C150Y, S152R, A154S, 
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V155G, N157T, V164M, E166Q, and A170T). This variant displayed a rate of repair of 
O
4
-MedT that was roughly 11.5 times that of native hAGT.(134,135) The Pegg group 
used a method that resembles a mix of rational design (based on information from PDB 
1T38) and sexual PCR (horizontal gene transfer from OGT to hAGT) to generate various 
hAGT-OGT chimeras.(123) Their most promising construct harboured 8 alterations 
(V149I, C150G, S151R, S152N, A154T, V155M, G156T and N157G) and displayed a 





-benzylguanine (as a free base), a purely synthetic molecule, has shown great 
variation in repair rates between homologues. Ada-C has shown no repair of this 
substrate whether as a free base or in an oligonucleotide due to steric congestion in the 
active site. Site-directed mutagenesis studies revealed that the W336A and A316P double 







-benzylguanine was repaired more rapidly by this variant in the 
presence of spectator DNA, indicating a conformational change upon DNA binding helps 
the Ada-C perform its repair function.  
OGT showed great repair activity of O
6
-BndG in an oligonucleotide while the 





-BndG in an oligonucleotide. hAGT repaired O
6
-BndG in DNA 
with similar ease as OGT but was 400 times more efficient at repairing O
6
-benzylguanine 
than OGT.(137) Interestingly, competition experiments revealed that hAGT repairs O
6
-
BndG more efficiently than O
6
-MedG in short oligonucleotides.(127) Alternatively, O
4
-





-benzylguanine so readily that this molecule has undergone 
clinical trials for use during chemotherapeutic regimens. Indeed, increased levels of 
hAGT have been shown to cause cellular resistance to certain chemotherapeutic agents 
including the chloroethylating agents and nitrogen mustards.(139,140,141) Two hAGT 





bromothenyl)guanine, see Figure 1.12 for structures.(142,143) The later molecule has 
shown an increased hAGT inhibitory effect over O
6
-benzylguanine, where its I50 is 0.003 


















Figure 1.12: Structures of (A) O
6
-benzylguanine and (B) O
6
-(4-bromothenyl)guanine 
AGT homologues also show dramatic differences in the processing of ICL lesions. 
AGT repair studies conducted with ICL DNA, where the cross-link tethered two O
6
-
atoms of dG in a directly opposed motif (1,1 orientation) by a 7 or 4 methylene chain, 
were investigated.(145,146) hAGT repaired both ICL DNAs, while Ada-C and OGT 
were unable to do so. It was proposed that the increased size of the hAGT active site with 
respect to the other homologues was responsible for this unique property. This hypothesis 
was further supported by the observed lack of repair with the smaller active site 




1.4.2 hAGT structure 
 
Figure 1.13: Crystal structure of hAGT (PDB 1T38)  
hAGT is a 21 kDa monomeric protein.(147) It consists of two distinct domains, as 
depicted in Figure 1.13, that when expressed separately show no activity.(105) The N-
terminal domain (residues 1-85) provides structural stability to the protein. This domain 
is responsible for the binding of Zn
2+
, a known cofactor for higher eukaryote AGT. The 
binding of Zn
2+
 is believed to increase structural stability by causing better packing 
between the N- and C-domains due to the interaction of Helix 3 and the 3 β-strands of the 
N-terminal domain via the ion, as exemplified in Figure 1.14. Zn
2+
 is coordinated by the 
protein by Cys 5, Cys 24, His 29 and His 85 residues more than 20 Å away from the 
active site.(148) Zn
2+
 bound hAGT has shown an increase in repair of ~60-fold for both 
O
6
-benzylguanine and methylated DNA. This increase in activity correlates with the 







binding by hAGT stabilizes the protein, as assessed by urea denaturation 






Figure 1.14: N-terminal domain of Zn
2
+ bound hAGT (PDB 1EH6) 
The C-terminal domain (residues 92-176), shown in Figure 1.15, contains the 
alkyltransferase activity and all the residues that make up the binding pocket as well as 
those conferring DNA-binding capabilities. This domain is absolutely conserved in all 


















92 ESFTRQVLWKLLKVVKFGEVISYQQLAALAGNPKAARAVGGAMRGNPVPI  
 
143  LIPCHRVVCSSGAVGNYSGGLAVKEWLLAHEGHRL 
Figure 1.15: C-terminal domain of hAGT (PDB 1QNT). (A) Cartoon representation and 
(B) secondary structure representation 
AGT binds DNA through the use of a helix-turn-helix motif (HTH). HTH motifs 
are usually reserved for major groove binders, whereas this motif in hAGT binds to the 
minor groove. The hAGT HTH motif is composed of Helix 5, a loop and Helix 6, 
underlined in Figure 1.15B.(150) Helix 6, also known as the "recognition helix", is 










responsible for interacting with DNA. It partially interacts via its small hydrophobic 
residues that pack well into the minor groove. Also, Ala 127 and Ala 129 help widen the 
minor groove by clashing with the sugars on opposite strands. Finally, Arg 128, also 
called the "arginine finger", plays the critical role of flipping out the damaged nucleotide 
and maintaining the DNA conformation.(151) These 3 properties of Helix 6 allows for 
the minor groove to expand by 3 Å relative to B-form DNA making it ~15 Å wide while 
bending the duplex by 15°. Once the modified nucleotide is flipped out of the duplex an 
orphan dC is formed and is stabilized by a hydrogen bond by Arg 128.  
Downstream of the HTH motif is the asparagine hinge. The Asn hinge is comprised 
of two tight turns which contains Asn 137. Asn 137 makes hydrogen bonds with the main 
chains of Val 139 and Ile 143 and the thiol group of Cys 145. The Asn hinge also 
interacts with the N-terminal domain and is responsible for roughly 40% of the surface 
buried area between the domains.(150) Upon alkylation of the protein a steric clash is 
produced between the Cys 145 thiol and Asn 137 causing the hydrogen bond network 
that make up the Asn hings to be disrupted.(148) This causes the hinge to open and 
expose hydrophobic areas of the protein. This conformational change in turn leads to 
ubiquitination of the protein and ultimatly degradation of alkylated protein by the 
proteosome.(104)  
Opening of the Asn hinge exposes the 98-VLWKLLKVV-106 sequence and allows 
hAGT to bind to the estrogen receptor. This inhibits the binding of the estrogen receptor's 
natural partner, steroid receptor coactivator-1. The steric blocking of the estrogen 
receptor thus causes a reduction in cell proliferation rates.(152)  
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Lys 125, Ala 126, Ala 127 and Arg 128 (KAAR) make up a nuclear localization 
signal allowing hAGT to be targeted to the nucleus where RNA transcription 
occurs.(153) This motif is similar to that of histone H1 (KAAK). RNA polymerase does 
not stall at O
6
-MedG sites and introduces mutations in the RNA. It is therefore essential 
that the DNA damage be repaired prior to transcription. As a result, hAGT must be 
concentrated in the area of transcription to remove the lesions as rapidly as possible.(154) 
The current hypothesis stipulates that hAGT binds vacated areas of DNA where histone 
H1 is absent such as the areas of DNA that undergo transcription. This partly explains 
how hAGT can detect lesions in the 3 billion bp human genome while having only a 
modest binding preference (~3-fold) for O
6
-MedG over dG. 
The highly conserved -PCHR- active site motif is present on Helix 7, a 310 helix. 
Cys 145 of the -PCHR- motif, known to be the catalytic residue, resides in a ridge 
measuring 7 x 9 x 14 Å which corresponds to the binding pocket where the alkylated 
nucleotide is inserted for repair.(106) Tyr 114, Gly 131, Met 134, Asn 137, Pro 140, Ile 
143, Pro 144, Cys 145, His 146, Arg 147, V148, Val 149, Val 155, Gly 156, Asn 157, 
Tyr 158, Ser 159 and Gly 160 make up the binding pocket.(148)  
The benzylated form of hAGT has been crystallized. The structure shows how the 
adduct stacks in the active site between the side chain of Pro 140, the Cβ of Ser 159 and 





Figure 1.16: Interaction of benzyl group in hAGT binding pocket (PDB 1EH8) 
hAGT recognizes dG and O
6
-MedG over the other natural nucleotides due to steric 
factors and specific hydrogen bonds. O
6
-alkyl dG fits specifically in the active site due to 
steric factors imposed by Met 134, Val 155, Gly 156, Asn 157, Tyr 158, Ser 159 and Gly 
160 residues that form the proper hydrophobic ridge. The exocyclic amine of the 
nucleotide hydrogen bonds with the carbonyl groups of Cys 145 and Val 148. The 
hydroxyl group of Tyr 114 donates a hydrogen bond to the N3 atom of guanine while the 
amide nitrogen of Ser 159 donates a hydrogen bond to the O
6
 atom. In summary, the 
steric factors allow a better fit for purine bases while the hydrogen bond network, as 










Figure 1.17: Hydrogen bonding network between hAGT and O
6
-MedG (PDB 1T38) 
The interaction of O
4
-MedT and hAGT has not been studied as thoroughly as that 
of O
6
-MedG resulting in a poor understanding of how hAGT can repair this adduct. The 
co-crystallization of hAGT with a modified oligonucleotide containing N
4
-p-
xylylenediamine-2’-deoxycytidine has given some insight as to how hAGT interacts with 
pyrimidine nucleotides. The only interaction observed with this probe was that of Tyr 114 
donating a hydrogen bond to the O
2
 atom of the modified dC as seen in Figure 1.18. It 
should be noted that Ser 159 was not built into the final structure indicating that 
flexibility of the sheet on which this residue resides was observed supporting the lack of a 
hydrogen bond between Ser 159 and the probe.(151) The O
2
 atom of dC is also present in 











Figure 1.18: Hydrogen bonding network of hAGT and N
4
-p-xylylenediamine-2’-
deoxycytidine (PDB 1YFH). Hydrogen bonds shown with black dashes represent those 
that are present with O
6









-MedT (generated from N
4
-p-xylylenediamine-2’-deoxycytidine from PDB 
1YFH). The first apparent difference between both structures is the distance between the 
thiol receiving group from Cys 145 and the α-carbon of the alkyl group. For O6-MedG, 
this distance is 2.68 Å while for O
4
-MedT this distance is 4.00 Å. This marked difference 
explains why hAGT repairs O
6
-MedG more rapidly than O
4
-MedT. Upon substituting N
4
-
p-xylylenediamine-2’-deoxycytidine with O4-MedT in PDB 1YFH it can be observed that 
the Ser 159 amide nitrogen can hydrogen bond with the O
4
 atom with some movement of 







N3 atom of dG or O
2
 atom of dT with similar distances due to the virtually identical 
location of these atoms in the active site.  
 
Figure 1.19: Overlay of O
4
-MedT (generated from PDB 1YFH) and O
6
-MedG (PDB 
1T38) in hAGT active site. Interaction of O
6
-MedG and hAGT shown in blue and O
4
-
MedT and hAGT shown in green. 
1.4.3 hAGT repair mechanism 
Prior to repair, the alkylated nucleotide must be flipped out of the DNA scaffold 
and placed into the active site of the AGT, where the catalytic triad composed of Glu-
His-Cys can transfer the alkyl group to the Cys residue. This task is achieved partly by 
the binding of the AGT protein where an observed bend of 15° (for hAGT) is introduced 
into the dsDNA, widening the minor groove. The nucleotide is flipped out of the duplex 
by Tyr 114, due to steric and electrostatic interactions, as well as by Arg 128, which 
helps stabilize the irregular dsDNA structure as eluded to earlier.(155, 156) 





The Cys responsible for AGT activity is made highly nucleophilic as a result of the 
formation of its thiolate anion which is promoted by a Cys-His-Glu catalytic triad.(148) 
The flipped out alkylated nucleotide is oriented by the hydrophobic ridge of the AGT 
active site, thus promoting repair. In hAGT, Glu 172 activates His 146 via a hydrogen 
bond. His 146 abstracts a proton from a near by water molecule, which in turn abstracts a 
proton from Cys 145 to form the thiolate anion. The thiolate anion performs a 
nucleophilic attack on the α-carbon of the alkyl group through an SN2 type mechanism, 
generating the alkylated protein and deprotonated form of the restored nucleotide.(106) 
Tyr 114 donates a proton to the nucleotide forming the fully repaired DNA and abstracts 
a proton from Lys 145, shown in Scheme 1.4.(157) The repaired DNA strand is then 



















































Scheme 1.4: hAGT mediated repair mechanism of O
6
-alkyl dG 
According to quantum-mechanical/molecular-mechanical studies, hAGT mediated 
repair of O
6
-MedG follows a distinctly different mechanism than the one usually 
accepted, noted above.(158) Unlike previously accepted, the proposed repair mechanism 
occurs in two distinct steps rather than one. The suggested model stipulates that the first 
step, being rate limiting, is the formation of the methyl carbocation, which is then 
followed by nucleophilic attack by the active site Cys residue. 
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1.4.4 DNA damage detection model 
The mode by which AGT proteins are capable of locating damage in such a vast 
number of nucleotides as the genome is still a mystery. Three mechanisms have been 
proposed by Dr. He, which all assume that AGT binds the DNA at random sites prior to 
movement.(1) 1) AGT actively flips out every nucleotide into its active site as it migrates 
along the DNA until damage is detected. 2) The protein migrates along the DNA and 
flips out nucleotides that participate in weakened base pairs, which are intrahelical. 3) 
The protein migrates along the DNA and only captures transiently flipped out nucleotides 
(extrahelical) that arise from improper base pairing. 
Cross-linking experiments were conducted with hAGT using a modified dC 
containing a disulfide moiety capable of forming a cross-link with the reactive Cys 
residue of the protein were undertaken to probe the proposed models.(159) hAGT could 
capture both damage that was transiently flipped out (hypothesis 3) and damage that was 
still intrahelical (hypothesis 2). Later experiments revealed that hAGT selectively flips 
out O
6
-alkyl dG from the duplex, supporting the 2
nd
 hypothesis.(160)  
Findings inferred from the cross-linking experiments are in accordance with the 
structural data.(151,155) hAGT is documented by both crystallographic groups as 
imposing a bend in the DNA duplex upon binding. Such a stress on the DNA scaffold 
could hold a fine balance where only weakened base pairs will be disrupted, while the 
normal Watson-Crick base pairs remain unaffected. Such a "pinching" mechanism has 
been put forth for other DNA damage repair proteins, such as DNA glycosylases.(161)  
The position of the modified nucleotide in the DNA sequence plays a role on how 







-BndG at varying positions in short oligonucleotides revealed hAGTs poor 
capability to remove lesions that are 4 nucleotides or less from the 3' end in ssDNA. This 
effect is virtually eliminated when the damaged nucleotide is introduced into dsDNA, 
where the modified nucleotide must be 2 or more nucleotides from the 3' end for efficient 
repair. This positional effect is non-existent when the lesion is at the 5' end of the DNA 
(dsDNA or ssDNA).(162) hAGT binds the DNA in the same orientation when the lesion 
is found in ssDNA; while adding the complement strand allows hAGT to access lesions 
further down the 3' end, perhaps by interacting with the complement strand. 
1.4.5 DNA binding by hAGT 
Many binding experiments have been conducted with hAGT and DNA where 
dissociation constants (Kd) ranging from 300 nM to 3 μM are reported.(163,164,165) 
hAGT interacts with ssDNA and dsDNA with a similar affinities, yet hAGT repairs 
damage in dsDNA more efficiently than it does in ssDNA.(162,166,167)  
The binding affinity of hAGT to unmodified DNA, whether in duplex or single 
stranded form, is length dependant.(166,167) Experimental evidence indicated that hAGT 
binds DNA with higher affinity when the nucleotide length is a multiple of 4 and when 
the DNA is longer than 11 nucleotides. A model was established by Dr. Fried to explain 
the DNA length dependence observed by hAGT, depicted in Figure 1.20.  
The model proposes that hAGT occludes 4 nucleotides but spans 8. It also suggests 
that a strong contact exists between the n and n+3 protein on the DNA. Indeed, the model 
implies that few contacts are made between the n and n+1 or n+2 neighbours. This 
hypothesis was later validated with modelling, cross-linking and site directed 
mutagenesis experiments.(168,169) From the model, one can see that a DNA length >11 
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nucleotides would allow at least 4 proteins to bind to the DNA and thus allowing the n 
and n+3 contact to form. Lastly, hAGTs ability to occlude 4 nucleotides supports the 
notion that DNA length that are multiples of 4 nucleotides would promote tighter binding 
since all the DNA is occupied by the proteins favouring inter-protein contacts.  
 
Figure 1.20: Model of hAGT binding to unmodified DNA. The proteins are depicted as 
filled ovals and DNA as a black rod. Left, side view of the complex, where the n and n+3 
proteins are similarly coloured and in close contact. The model proposes a three-protein 
repeating motif where the n and n+3 proteins are on the same face of the DNA. 
Sequential proteins are rotated 138° with respect to their neighbours about the plane of 
the DNA. Right, cross-section of the DNA showing the protein arrangment about the axis 
of the duplex.(167) 
The computational model produced by Dr. Fried, though rudimentary in nature, 
reveals other important properties of both hAGT-DNA and hAGT-hAGT interactions. 
According to the computational results, hAGT makes 3 ionic contacts with the phosphate 
backbone of dsDNA (Lys 125, Arg 128 and Arg 135) but only makes 2 with ssDNA (Arg 
128 and Arg 135).(168) More importantly, the in silico data reveals a large protein-
protein interface between the n and n+3 proteins, which is responsible for the high level 
of cooperativity observed upon binding of unmodified DNA by hAGT.(163,166,167) 
This interface spans ~1100 Å
2
, which represents 70% of the protein-DNA interface 
(~1600 Å
2
). The protein-protein interface is peppered with ionizable residues, which 
point to potential ionic interactions amongst proteins. Such ionic interactions would 
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promote the adoption of a head-to-tail pattern by hAGT monomers upon multimerization 
along the DNA scaffold.  
Residues 1-7 and 163-169 of hAGT are important for the protein-protein 
interaction. Altering these two regions not only reduces the cooperativity of DNA 
binding but also reduces the binding affinity, highlighting the impact of cooperativity on 
binding affinity for this system.(169) 
hAGT interacts with modified dsDNA differently than it does with unmodified 
DNA. The binding of hAGT to either a 24-mer or 26-mer harbouring a single O
6
-MedG 
displays a binding stoichiometry of 2:1 hAGT:DNA.(170) This value is substantially less 
than those reported for unmodified 24-mer and 26-mer DNA (~6:1).(167) Binding 
experiments conducted with O
6
-MedG containing DNA revealed the presence of 1:1 
hAGT:DNA complex, which formed at lower hAGT concentration than the 2:1 complex. 
This lead to the finding that hAGT binds the O
6
-MedG in the duplex first, directly or 
through migration from distal portions of the DNA. This is followed by a second hAGT 
molecule binding the DNA to form the cooperative protein-protein complex. This 
preliminary localization of hAGT to O
6
-MedG prior to recruitment of another hAGT 
molecule was not observed with ssDNA, validating that modified dsDNA and ssDNA are 
processed differently by the protein. 
Binding cooperativity takes on a new role when hAGT interacts with larger 
unmodified DNA fragments (1000 bp). Larger DNA substrates are not saturated with 
hAGT, unlike shorter oligonucleotides, but rather clusters of proteins are formed with up 
to 11 proteins per cluster.(171) The finite size of the hAGT clusters is believed to be a 
result of the deformation of the DNA upon hAGT binding. Every hAGT added to the 
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cluster adds a stress to the DNA structure until this stress outweighs the protein-protein 
interaction energy causing the cluster size to cease increasing. This hypothesis also 
supports hAGTs preference for DNA ends. 
The observed cooperativity of binding by hAGT to DNA is not conserved amongst 
AGTs since Ada-C has been reported to lack this property.(172) Further dissimilarities 
exist amongst these AGTs. Two Ada-C proteins bind to dsDNA while only one binds to 
ssDNA, irrespective of DNA length. But like hAGT, Ada-C binds both ssDNA and 
dsDNA with similar affinities (Kd ~ 2 μM at 100 mM NaCl) and spans 7 ± 1 nucleotides, 
showing some parallels with regards to substrate binding.(172,173)  
1.5 Objectives and arrangement of thesis 
1.5.1 Objectives 
The purpose of this research is to shed light on the role of AGT on ICL damage 
recognition and repair. The occurrence of ICL damage has been known for years but the 
exact mechanisms of repair are not fully elucidated and appear to be different depending 
on the nature of the ICL lesion. If AGT does play a role in ICL detection and repair, its 
inhibition may be beneficial during chemotherapeutic regimens. Indeed, increased levels 
of hAGT are correlated with resistance to certain chemotherapeutic agents such as the 
chloroethylating agent carmustine and the nitrogen mustards chlorambucil, 
mechlorethamine and cyclophosphamide, suggesting that hAGT may play a role in ICL 
damage processing.(139,140,141) 
To achieve this goal, various AGT proteins were used in binding and repair assays 
with diverse ICL damage. These ICL containing either 4 or 7 methylene groups as cross-
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links were designed to mimic the effects of busulfan or hepsulfam treated DNA, 
respectively. Based on the known AGT substrates, ICL involving the O
6
 atom of dG and 
O
4
 atom of dT were originally investigated, as these were the only potential ICL that 









dT ICLs.  
The next aim was then to determine the cause for this elusive behavior and to 




dT ICLs. The first means 





containing ICL was to generate AGT-ICL DNA covalent complexes to aid in 
crystallization studies, since there are no crystal or NMR structures reported for AGT in 
complex with O
4
-alkyl dT.  





dT ICLs by modelling O
4
-MedT into the hAGT active site. The 
modelling results spearheaded research that focussed on the design of a chimera and O
4
-


















dG ICLs to establish structural causes for the selective repair by 
hAGT. 
1.5.2 Arrangement of thesis 
CHAPTER I  
This chapter highlights the importance of DNA damage and repair in the cells. A 
brief overview of different classes of alkylating agents and the DNA damage they 
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produce is provided with a focus on the cytotoxic nature of ICL lesions. The mechanisms 
of ICL formation by nitrogen mustards, nitrosoureas and alkyl sulfonates and their 
derivatives are elaborated upon. The general mechanisms and substrate ranges of BER, 
NER, MMR, NHEJ, HR and direct repair are covered. The properties and roles of AGT 
homologues are discussed in great detail. An extra emphasis is placed on hAGT mediated 
DNA damage repair and binding.  
CHAPTER II-CHAPTER VII Overview 
CHAPTER II-CHAPTER V constitute published work, while CHAPTER VI and 





-2’-deoxyguanosine interstrand cross-link in a 5'-GNC motif and repair by 
human O
6
-alkylguanine-DNA alkyltransferase") and CHAPTER III ("O
4
-alkyl thymidine 
cross-linked DNA to probe recognition and repair by O
6
-alkylguanine DNA 
alkyltransferases") are published work in Organic & Biomolecular Chemistry (Royal 
Society of Chemistry), CHAPTER IV ("Preparation of Covalently Linked Complexes 
Between DNA and O
6
-Alkylguanine-DNA Alkyltransferase Using Interstrand Cross-
linked DNA") is published in Bioconjugate Chemistry (American Chemical Society) and 
CHAPTER V ("Engineering of a O
6
-Alkylguanine-DNA alkyltransferase Chimera and 
Repair of O
4
-Alkyl Thymidine Adducts and O
6
-Alkylene-2’-Deoxyguanosine Cross-
Linked DNA") is published material in Toxicology Research (Royal Society of 
Chemistry). CHAPTER VI ("Effect of the C5 Methyl on O
6
-Alkylguanine-DNA 
Alkyltransferase Mediated Repair of O
4
-alkyl Thymidine Adducts") and CHAPTER VII 





-2’-deoxyguanosine and not O4-2’-Deoxyuridine-heptylene-O4-2’-
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deoxyuridine Interstrand Cross-Linked Containing DNA") are to be submitted for 
publication in the near future.  
The relationships between chapters will be made evident in this section rather than 
between chapters for clarity and brevity. This section provides a quick glance into each 
chapter; the major goals, including their experimental rational. Finally, the most note 
worthy results and drawn conclusions, which were used as a stepping stone for the 
subsequent chapter, are given. 
CHAPTER II 
This chapter presents the synthesis of cross-linked amidites linking the O
6
 atoms of 
dG by a butylene and heptylene linkage and their incorporation into oligonucleotides in a 
1,3 orientation for hAGT based studies. These ICL DNAs were prepared to supplement 
previously published data involving similar ICL DNAs where the cross-links were 
introduced in a directly opposed manner (1,1 motif). This 1,3 motif was employed to 
generate a more accurate mimic of the cross-links formed by hepsulfam (see Scheme 
1.3). hAGT was capable of repairing both 1,3 ICL DNAs and did so at similar rates as 
was previously reported for the 1,1 motif. The orientation of the cross-link does not play 
a substantial role on how it is processed by hAGT.  
CHAPTER III 
Despite what its name infers, AGTs are capable of repairing O
4
-alkyl dT adducts in 
addition to O
6
-alkyl dG damage. This chapter presents the synthesis of cross-linked 
amidites linking the O
4
 atoms of dT by butylene and heptylene tethers and their 
incorporation into oligonucleotides in a directly opposed motif to gain an understanding 
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of the AGT ICL substrate range. These ICL DNAs were prepared to compliment results 





dT ICL DNAs evaded repair by hAGT, OGT and Ada-C. The 
respective mono-adducts, O
4
-butyl-4-ol dT and O
4
-Heptyl-7-ol dT were synthesized and 
used as probes to note the limitations of AGT with respect to O
4
-alkyl dT repair. These 
mono-adducts were repaired solely by OGT. The cause for the poor repair of O
4
-alkyl dT 
mono-adducts and cross-links is not understood considering AGTs have never been 
crystallized with O
4
-alkyl dT containing DNA. 
CHAPTER IV 




dT containing ICL DNAs containing butylene 
and heptylene linkages and their use as substrates for AGT are reported in this chapter. 
Since hAGT is capable of repairing cross-links involving the O
6
 atom of dG (CHAPTER 
II) but not those involving the O
4
 atom of dT (CHAPTER III) the repair of such cross-
links should, in theory, lead to the formation of a covalent complex composed of hAGT 
linked to the O
4
 atom of the modified dT. Such covalent complexes could show use for 
crystallographic studies, which would shed light into hAGT mediated repair of O
4
-alkyl 
dT damage. For this reason cross-links of different length were tested to obtain an idea of 









dT one. The 




dT containing ICL 





dT containing ICL DNAs for the formation of covalent complexes to be used 
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ICL DNA generated considerable levels of hAGT-DNA cross-links. 
CHAPTER V 




dT ICL repair 
is presented in this chapter. The engineered chimera protein was generated by replacing a 
portion of the active site of hAGT with the respective amino acids in OGT, with the 
omission of one amino acid for solubility purposes. The chimera was prepared in hopes 
that it would harbour properties of hAGT (capable of repairing ICL DNA, CHAPTER II 
and CHAPTER IV) and OGT (capable of repairing O
4
-alkyl dT damage, CHAPTER III), 





The chimera displayed augmented repair of O
4
-alkyl dT mono-adducts, with respect to 














links. According to the modelling data, the chimera showed increased repair of O
4
-alkyl 
dT mono-adducts due to the increased flexibility of its active site. The modelling results 
exposed a potential clash between the protein`s active site and the C5 methyl of O
4
-alkyl 
dT, supporting why O
4
-alkyl dT mono-adducts are not processed as readily by the 
chimera when compared to OGT. 
CHAPTER VI 
This chapter provides the synthesis O
4
-alkyl dU mono-adduct containing DNA and 
their use as AGT substrates. These probes were generated to verify the adverse effect of 
the C5 methyl of dT on O
4
-alkyl damage repair by AGT, as hypothesized from modelling 
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studies performed in CHAPTER V. Indeed, removal of the C5 methyl, as observed with 
the dU derivatives, leads to increased repair by AGTs when compared to similar adducts 
on the on the O
4
 atom of dT (CHAPTER III). According to the modelling, removing the 
C5 methyl allows the modified nucleotides to penetrate further into the hAGT active site, 
placing the alkyl group closer to the reactive Cys residue. 
CHAPTER VII 





ICL DNAs and their use as AGT substrates. These probes were generated to verify the 
adverse effect of the C5 methyl of dT on ICL repair by AGT, as inferred from 
experimental and modelling results obtained in CHAPTER VI. Removal of the C5 
methyl from the cross-linked nucleotides did not grant any AGT the ability to remove the 









dG containing DNA revealed no dramatic differences in global structure 
between both ICL DNAs. On a more local level, the heptylene cross-link adopted the E-
configuration about the C4-O
4
 for the dU containing ICL DNA, whereas the Z-
configuration about the C6-O
6
 bond was adopted by the cross-link for the modified dG 
containing ICL DNA. Based on the co-crystal structures of hAGT, the protein orients the 
lesion in the Z-configuration about the C6-O
6
 of dG (Figure 1.17) or C6-N
6
 of 
pyrimidines (Figure 1.18) prior to repair, suggesting that the configuration may play a 




This chapter provides conclusions that summarize the results from CHAPTER II-












cross-link in a 5'-GNC motif and repair by human O
6
-
alkylguanine-DNA alkyltransferase  
  
Graphical Abstract: Representation of the ICL lesion in a 1,3 motif 
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dG ICL with a four and seven methylene linkage in a 5’-GNC- motif 
have been synthesized and their repair by hAGT investigated. Duplexes containing 11 
base-pairs with the ICL in the center were prepared by automated DNA solid-phase 
synthesis using a cross-linked dG dimer phosphoramidite, prepared via a seven step 
synthesis which employed the Mitsunobu reaction to introduce the alkyl lesion at the O
6
 
atom of dG. Introduction of the four and seven carbon ICL resulted in no change in 
duplex stability based on UV thermal denaturation experiments compared to a non-cross-
linked control. Circular dichroism (CD) spectra of these ICL duplexes exhibited features 
of a B-form duplex, similar to the control, suggesting that these lesions induce little 
overall change in structure. The efficiency of repair by hAGT was examined and it was 
shown that hAGT repairs both ICL containing duplexes, with the heptylene ICL repaired 
more efficiently relative to the butylene cross-link. These results were reproducible with 
various hAGT mutants including one that contains a novel V148L mutation. The ICL 
duplexes displayed similar binding affinities to a C145S hAGT variant compared to the 
unmodified control duplex. Experiments with Chinese hamster ovary (CHO) cells to 
investigate the sensitivity of these cells to busulfan and hepsulfam demonstrate that 









ICLs that are formed in DNA as a consequence of the action of bifunctional 
alkylating agents represent some of the most toxic lesions encountered by cells due to the 
obstruction of unwinding of the two strands, critical to the processes of DNA replication, 
transcription and recombination.(8) Interference with these key cellular processes by the 
presence of ICL is the basis of the mechanism of action of bifunctional alkylating agents, 
such as mechlorethamine, that are used as cancer therapeutics.(42) However, the potency 
of these agents is reduced by the ability of cancer cells to repair the lesions resulting in an 
overall resistance to therapy.  
In eukaryotic cells the repair of ICL is a complex process with numerous repair 
pathways including nucleotide excision repair, homologous recombination and non-
homologous end joining implicated in the removal of the damage.(7) Understanding the 
molecular basis of how ICL repair occurs will play an important role towards the 
development of new chemotherapeutic agents that may evade this process, thus 
increasing the efficacy of these drugs.  
One approach employed in elucidating the roles various DNA repair pathways 
contribute in removing DNA ICL involves the use of chemically synthesized 
oligonucleotides that contain representative lesions formed by bifunctional alkylating 
chemotherapeutics.(174,175,176) These oligonucleotides are designed to contain lesions 
linking specific atoms in DNA in well defined orientations and can be incorporated into 
plasmids for DNA repair experiments. This approach uses solid-phase synthesis which 
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generates sufficient amounts of ICL DNA to enable structural studies and repair 
assays.(177,178,179,180,181) 
Some of these ICL are challenging to prepare synthetically. For example, the 
bifunctional alkylating agent hepsulfam which has been investigated clinically (182), has 
been shown to form a cross-link between the N7 atoms of dG in 5’-GNC sequences 
(Figure 2.1) as demonstrated through the use of mass spectrometry and identification of 
1,7-bis(guanyl)heptane.(75) N7-alkyl dG are chemically unstable, for example the 
presence of N7-methyl dG can result in an apurinic site in DNA or undergo ring opening 

































































Figure 2.1: Structures of the (A) N7dG-heptylene-N7dG cross-link induced by 




dG cross-link (where n = 3 or 6) and oligomers (C) 
XLGG4 and XLGG7 
In order to prepare oligonucleotides containing a cross-link that models the 
orientation of the lesion formed by hepsulfam, our group has explored methodologies to 
prepare ICL DNA that links the O
6
 atoms of dG.(184) The O
6
 atom of dG is a known site 
of alkylation by chemotherapeutic drugs such as the methylating agent temozolomide and 
the chloroethylating agent carmustine which proceeds to form a dG-dC ICL.(185)  
Different chemical groups at the O
6
 position of dG have been incorporated by 
organic synthesis for numerous purposes including protection during oligonucleotide 
(A) (B) (C) 
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synthesis and as substrates for DNA repair studies.(186,187) Examples of synthetic 
methods that have been employed to introduce these groups include the post-synthetic 
modification of oligonucleotides containing the 2′-deoxyribonucleoside of 2-amino-6-
methylsulfonylpurine and the Mitsunobu reaction.(187,188)  
Using a combination of solution and solid-phase synthesis, a 5’-GNC ICL has been 




dG phosphoramidite that 
contains various protecting groups to permit orthogonal removal, enabling a unit of 
asymmetry to be engineered in the final ICL DNA duplex to allow for a clinically 
relevant staggered 1,3 orientation. The synthetic scheme to produce this amidite involved 
the Mitsunobu reaction which was selected due to its mild conditions, compatibility with 
all protecting groups employed and direct route to introduce alkyl linkers of various 
lengths. This method allows for the production of ICL duplexes to explore the influence 
of linker length in substrates of defined structure and for the systematic investigation of 
susceptibility to DNA repair mechanisms.  
The ability of wild hAGT and some mutants to repair these ICLs was also 
investigated. AGT are a class of repair proteins that are found in numerous organisms 
whose role is to repair alkylation at the O
6
 position of the dG and thus they play an 
important role in maintaining genomic integrity.(189) Alkylation at the O
6
 position of dG 
can be mutagenic, disrupting normal Watson-Crick base pairing leading to point 
mutations which may be fatal. The mechanism by which hAGT repairs alkylated DNA 
involves flipping the alkylated nucleoside out of the duplex and into the active site of the 
protein where transfer of the alkyl group from the O
6
 position of dG to a C145 residue 
occurs.(155) The protein can only act once due to the irreversible alkylation of C145, 
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whereupon the protein is degraded by the ubiquitin pathway.(104) hAGT has been shown 
not only to repair small adducts at the O
6
 position of dG such as a methyl group but also 
larger groups such as benzyl and 4-(3-pyridyl)-4-oxobutyl.(129) The study of these novel 
ICL substrates to undergo repair by hAGT will contribute to the range of DNA substrates 




2’-deoxyribonucleoside-5’-O-(β-cyanoethyl-N,N’-diisopropyl) phosphoramidites and 
N,N-diisopropylamino cyanoethyl phosphonamidic chloride were purchased from 
ChemGenes Inc. (Wilmington, MA). 5’-O-Dimethoxytrityl-2’-deoxyribonucleoside-3’-
O-(β-cyanoethyl-N,N’-diisopropyl)phosphoramidites and protected 2’-
deoxyribonucleoside-polystyrene supports were purchased from Glen Research (Sterling, 
Virginia). All other chemicals and solvents were purchased from the Aldrich Chemical 
Company (Milwaukee, WI) or EMD Chemicals Inc. (Gibbstown, NJ). Flash column 
chromatography was performed using silica gel 60 (230–400 mesh) obtained from 
Silicycle (Quebec City, QC). Thin layer chromatography (TLC) was performed using 
precoated TLC plates (Merck, Kieselgel 60 F254, 0.25 mm) purchased from EMD 
Chemicals Inc. (Gibbstown, NJ). NMR spectra were recorded on a Varian INOVA 300 
MHz NMR spectrometer at room temperature. 
1
H NMR spectra were recorded at a 
frequency of 300.0 MHz and chemical shifts were reported in parts per million downfield 
from tetramethylsilane. 
31
P NMR spectra (
1
H decoupled) were recorded at a frequency of 
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121.5 MHz with H3PO4 used as an external standard. ESI mass spectra for 
oligonucleotides were obtained at the Concordia University Centre for Biological 
Applications of Mass Spectrometry (CBAMS) using a Micromass Qtof2 mass 
spectrometer (Waters) equipped with a nanospray ion source. The mass spectrometer was 
operated in full scan, negative ion detection mode. ESI mass spectra for small molecules 
were recorded at the McGill University Department of Chemistry Mass Spectrometry 
Facility with a Finnigan LCQ DUO mass spectrometer in methanol or acetone. 
Ampicillin, isopropyl β-D-thiogalactopyranoside (IPTG), and most other biochemical 
reagents as well as polyacrylamide gel materials were purchased from Bioshop Canada 
Inc (Burlington, ON). Ni-NTA Superflow Resin was purchased from Qiagen 
(Mississauga, ON). Complete, Mini, ethylenediaminetetraacetic acid-free (EDTA-free) 
Protease Inhibitor Cocktail Tablets were obtained from Roche (Laval, QC) Nitrocellulose 
filters (0.20 μm) were obtained from Millipore. XL-10 Gold E. coli cells were obtained 
from Stratagene (Cedar Creek, TX). DpnI, T4 PNK, Unstained Protein Molecular Weight 
Marker and restriction enzymes EcoRI and KpnI were obtained from Fermentas 
(Burlington, ON). [γ-32P]ATP was purchased from Amersham Canada Ltd. (Oakville, 
ON).  
2.2.2 Solution synthesis of small molecules 




















































diisopropyl)phosphoramidite]}-heptane (7b) were performed as previously 
described.(190) 
2.2.3 Oligonucleotide synthesis and purification 
The cross-linked duplexes XLGG4 and XLGG7, whose sequences are shown in 
Figure 2.1, were assembled using an Applied Biosystems Model 3400 synthesizer on a 1 
µmole scale employing standard β-cyanoethylphosphoramidite cycles supplied by the 
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manufacturer with slight modifications to coupling times described below. The 
nucleoside phosphoramidites containing standard protecting groups were prepared in 
anhydrous acetonitrile (ACN) at a concentration of 0.1 M for the 3’-O-2’-
deoxyphosphoramidites, 0.15 M for the cross-linked 3’-O-2’-deoxyphosphoramidites (7a 
and 7b) and 0.2 M for the 5’-O-2’-deoxyphosphoramidites. Assembly of sequences first 
involved detritylation (3% trichloroacetic acid (TCA) in DCM), followed by nucleoside 
phosphoramidite coupling with commercial 3’-O-2’-deoxyphosphoramidites (2 min), 5’-
O-2’-deoxyphosphoramidites (3 min) or cross-linked phosphoramidites 7a or 7b (10 
min); Subsequent capping with phenoxyacetic anhydride/pyridine/tetrahydrofuran (1:1:8, 
v/v/v; solution A, and 1-methyl-1 H-imidazole/tetrahydrofuran 16:84 w/v; solution B) 
and oxidation (0.02 M iodine in tetrahydrofuran/water/pyridine 2.5:2:1) followed every 
coupling. To complete assembly of the cross-linked duplexes, the cyanoethyl groups 
were removed from the polystyrene-linked oligomers by treating the support with 1 mL 
of anhydrous triethylamine (TEA) for at least 12 h. The support was then washed with 30 
mL of anhydrous ACN followed by anhydrous THF. The t-butyldimethylsilyl (TBS) 
group was removed from the partial duplex by treating the support with 2 x 1 mL 
triethylamine trihydrofluoride (TEA•3HF) for a total of 1 h. The support was then 
washed with 30 mL each of anhydrous THF and ACN followed by drying via high 
vacuum (20 min). The final extension of the cross-linked duplex was then achieved using 
5’-O-2’-deoxyphosphoramidites with a total detritylation exposure of 130 seconds and 
removal of the 3’-terminal trityl group by the synthesizer to yield duplexes XLGG4 and 
XLGG7 on the solid support.  
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The oligomer-derivatized polystyrene beads were transferred from the reaction 
column to screw cap microfuge tubes fitted with teflon lined caps and the oligomer 
released from the support and protecting groups removed by treatment with a mixture of 
concentrated ammonium hydroxide/ethanol (0.3 mL:0.1 mL) for 4 h at 55 ºC. The cross-
linked final products were separated from pre-terminated products by strong anion 
exchange (SAX) HPLC using a Dionex DNAPAC PA-100 column (0.4 cm x 25 cm) 
purchased from Dionex Corp, (Sunnyvale, CA) with a linear gradient of 0–50% buffer B 
over 30 min (buffer A: 100 mM Tris HCl, pH 7.5, 10% ACN and buffer B: 100 mM Tris 
HCl, pH 7.5, 10% ACN, 1 M NaCl) at 40 °C. The columns were monitored at 260 nm for 
analytical runs or 280 nm for preparative runs. The purified oligomers were desalted 
using C-18 SEP PAK cartridges (Waters Inc.) as previously described.(175)  
2.2.4 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
The cross-linked oligomers (0.1 A260 units) were characterized by enzymatic 
digestion (snake venom phosphodiesterase: 0.28 units and calf intestinal alkaline 
phosphatase: 5 units, in 10 mM Tris, pH 8.1 and 2 mM magnesium chloride) for a 
minimum of 36 h at 37 °C as previously described.(175) The resulting mixture of 
nucleosides was analyzed by reversed phase HPLC carried out using a Symmetry® C-18 
5μm column (0.46 x 15 cm) purchased from Waters Inc, Milford, MA. The C-18 column 
was eluted with a linear gradient of 0-60% buffer B over 30 min (buffer A, 50 mM 
sodium phosphate, pH 5.8, 2% ACN and buffer B, 50 mM sodium phosphate, pH 5.8, 
50% ACN). The resulting peaks were identified by co-injection with the corresponding 
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standards and eluted at the following times: dC (4.6 min), dG (7.9 min), dT (8.5 min), dA 
(9.6 min), cross-link dimers (18.1 for the four carbon and 26.2 min for the seven carbon 
cross-link), and the ratio of nucleosides was determined. The molecular weights of the 
cross-linked oligomers were determined by ESI-MS and these were in agreement with the 
calculated values. 
2.2.5 UV thermal denaturation studies  
Molar extinction coefficients for the oligonucleotides and cross-linked duplexes 





). Non-cross-linked duplexes were prepared 
by mixing equimolar amounts of the interacting strands and lyophilizing the mixture to 
dryness. The resulting pellet was then re-dissolved in 90 mM sodium chloride, 10 mM 
sodium phosphate, 1 mM EDTA buffer (pH 7.0) to give a final concentration of 2.8 μM 
duplex. The cross-linked duplexes were dissolved in the same buffer to give a final 
concentration of 2.8 μM. The solutions were then heated to 90 °C for 10 min, cooled 
slowly to room temperature, and stored at 4 °C overnight before measurements. Prior to 
the thermal run, samples were degassed by placing them in a speed-vac concentrator for 2 
min. Denaturation curves were acquired at 260 nm at a rate of heating of 0.5 °C/min, 
using a Varian CARY Model 3E spectrophotometer fitted with a 6-sample thermostated 
cell block and a temperature controller. The data were analyzed in accordance with the 
convention of Puglisi and Tinoco (191) and transferred to Microsoft Excel™. 
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2.2.6 CD spectroscopy  
CD spectra were obtained on a Jasco J-815 spectropolarimeter equipped with a 
Julaba F25 circulating bath. Samples were allowed to equilibrate for 5-10 min at 10 °C in 
90 mM sodium chloride, 10 mM sodium phosphate, 1 mM EDTA (pH 7.0), at a final 
concentration of 2.8 μM for the cross-linked duplexes and 2.8 μM for control duplex. 
Each spectrum was an average of 5 scans. Spectra were collected at a rate of 100 nm/min, 
with a bandwidth of 1 nm and sampling wavelength of 0.2 nm using fused quartz cells. 
The CD spectra were recorded from 350 to 200 nm at 10 °C. The molar ellipticity was 
calculated from the equation [] = ε/Cl, where ε is the relative ellipticity (mdeg), C is the 
molar concentration of oligonucleotides (moles/L), and l is the path length of the cell 
(cm).  
2.2.7 Molecular modelling of ICL duplexes  
The DNA duplex (5’-dCGATGTCATCG)/(5’-CGATGACATCG) and cross-linked 
duplexes XLGG4 and XLGG7 were built using HyperChem™ molecular modelling 
software. All duplexes were geometry optimized using the AMBER forcefield.  
2.2.8 Protein expression and purification  
Site directed mutagenesis as well as transformation into XL-10 E. coli cells were 
performed as directed by the Stratagene manual. Cells containing either a plasmid coding 
for wild-type or mutant hAGT were grown in a 1 L cultures of LB (Luria broth) + 100 
μg/mL ampicillin until an OD600 = 0.6 was reached. The cells were induced with 0.3 mM 
IPTG, incubated at 37
 
°C for 4 h with shaking at 225 rpm and harvested by centrifugation 
at 6000 x g at 4
 
°C for 30 min. Pellets were weighed and resuspended in 5 mL of 
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resuspension buffer (20 mM Tris HCl (pH 8.0), 250 mM NaCl, 20 mM β-
mercaptoethanol supplemented with Complete, Mini, EDTA-free Protease Inhibitor 
Cocktail Tablets) for each gram of pellet. The cells were homogenized by using 
approximately 20 strokes in a dounce homogenizer, lysed using two rounds of French 
press, centrifuged at 17000 x g for 45 min at 4
 
°C. The lysate was applied to a pre-
equilibrated Ni-NTA Superflow column containing 3.5 mL of resin. The column was 
washed with 200 mL resuspension buffer and 20 mM imidazole, until the OD280 of the 
eluant was constant. The protein eluted with 50 mL resuspension buffer supplemented 
with 200 mM imidazole. 1 mL fractions were collected and fractions that displayed 
protein content (generally fractions 4-11) were pooled followed by dialysis versus 4 L of 
dialysis buffer (50 mM Tris HCl (pH 7.6), 250 mM NaCl, 20 mM β-mercaptoethanol and 
0.1 mM EDTA) using 8000 Da cutoff dialysis tubing. Typically a yield of 8-10 mg of 
purified protein was obtained per L of culture inoculated. 
2.2.9 Protein characterization  
All proteins were analyzed by ESI-MS and were prepared by precipitation using 
one volume of TCA for every four volumes of protein. Samples were incubated for 10 
min on ice, centrifuged at 4
 
°C for 5 min at 14 krpm on a table-top centrifuge, the 
supernatant removed, the pellet washed with 200 μL of cold acetone and washing 
repeated. The protein pellet was dried at 95
 
°C for 5 min, resuspended in a 50% ACN and 
1% formic acid solution in water at a protein concentration of 10 μM. The samples were 




Far-UV CD spectra were obtained on a JASCO 815 spectropolarimeter using a 2 
mm path length cell. The scans were performed at 20
 
°C, by averaging 5 wavelength 
scans from 260 to 200 nm (1 nm bandwidth) in 0.2 nm steps at a rate of 20 nm/min, and 1 
sec response at a protein concentration of 5 μM in CD buffer (50 mM potassium 
phosphate (pH 7.5), 75 mM NaCl and 2 mM dithiothreitol (DTT)). 
Thermal denaturation curves were obtained by monitoring the change in mdeg at 
222 nm (corresponding to the α-helical content of the protein). The heating rate was set at 
15 °C/h using a Peltier-type temperature controller, which ranged from 40-70
 
°C. The Tm 
was obtained by noting the temperature at which the 1
st
 derivative of the denaturation plot 
was the highest.  
Fluorescence spectra were obtained using a Varian Cary Eclipse Fluorescence 
Spectrophotometer in a 10 mm quartz cuvette with 3.5 μM protein in CD buffer at room 
temperature. Excitation and emission slits were set at 5 nm with a detector voltage of 650 
and the spectra were the average of 10 accumulations. Tyrosine and tryptophan 
fluorescence were obtained using an excitation wavelength of 280 nm and recording the 
emission spectrum between 300 and 400 nm. To monitor the tryptophan fluorescence 
solely an excitation wavelength of 295 nm was used and the emission spectrum was 
monitored between 300 and 400 nm. 
2.2.10 Cross-link repair assay 
The cross-linked oligonucleotides XLGG4 and XLGG7 as well as the control 
DNA (non-cross-linked duplex) were labeled at the 5’-end using [γ-32P]ATP. 10 μL 
reaction volumes were used for the labeling of the DNA. The reaction mixture was 
comprised of 1x T4 PNK buffer (Fermentas), 21 μM oligonucleotide, 10 μM cold-ATP, 1 
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μL [γ-32P]ATP (10 μCi/μL) and 5 units of T4 PNK. The reaction mixture was incubated 
at 37
 
°C for 1 h and terminated by placing the reaction in boiling water for 10 min. 60 
pmol of wild-type and mutant hAGT protein was incubated with 2 pmol of labeled DNA 
in a total reaction volume of 15 μL comprised of hAGT buffer (80 mM Tris HCl (pH 
7.6), 0.1 mM EDTA and 5 mM DTT). The reactions were incubated at 37
 
°C for 14 to 16 
h with similar results indicating that the reaction was complete by 14 h. Denaturing 
PAGE in 7 M urea was used to analyze the products. The reaction was terminated by 
adding 18.2 μL of stop reaction buffer (81 mM Tris HCl, 81 mM boric acid, 1.8 mM 
EDTA and 1% sodium dodecyl sulphate (SDS) (pH 8.0) in 80% formamide) to the 
reaction tube and placed in boiling water for 10 min. The samples were loaded onto 14 
cm x 16 cm, 17% polyacrylamide gels (19:1) in the presence of 7 M urea. The gels were 
run using 1 X TBE (89 mM Tris HCl, 89 mM boric acid, 2 mM EDTA (pH 8.0)) for 1.5 h 
at 700 V, which heated the gels to 40
 
°C. After electrophoresis, the gels were covered in 
Saran wrap and exposed to a storage phosphor screen. The image was captured using a 
Typhoon 9400 (GE Healthcare, Piscataway, NJ) and the counts of the radiolabelled 
products quantified using ImageQuant™ (Amersham Biosciences). A control lane was 
used as a standard in order to quantitate the other bands on the gel. For the repair time 
course assay of the ICL a 150 μL master mix composed of 600 pmol of wild-type hAGT 
and 20 pmol of DNA substrate in hAGT buffer was prepared. The sample was placed at 
37
 
°C. At every time point 7.5 μL (1 pmol of DNA) was removed from the master mix 
and placed in a tube with 9.1 μL of stop reaction buffer and terminated as above. 
66 
 
2.2.11 Binding studies of C145S hAGT  
Reaction tubes consisting of 5 nM DNA and increasing C145S hAGT 
concentrations (ranging from 1 to 35.69 μM) were prepared in a total solution volume of 
20 μl of binding buffer (10 mM Tris HCl (pH 7.6), 5 mM DTT and 0.1 mM EDTA). The 
samples were allowed to equilibrate on ice for 30 min. Triplicate samples were incubated 
for longer (45 min and 2 h) and yielded similar results indicating that equilibrium had 
been attained. Each sample (0.1 pmol) was loaded on 14 cm x 16 cm, 4
 
°C, 
preequilibrated native 6% polyacrylamide (75:1) gels. The gels were electrophoresed in 
10 mM Tris acetate (pH 7.6) and 0.25 mM EDTA buffer at 125 V for 1 h. On completion, 
the gels were covered and processed as described above.  
Estimates of the monomeric dissociation constant (Kd) and the cooperativity factor 
(n) were obtained from the electro mobility shift assay (EMSA) as explained 
previously.(164) The binding of n moles of hAGT protein [P] to 1 mole of cross-linked 
DNA [D] follows the equation: nP + D ↔ PnD. Isolating the variables and taking the 












Plotting log [PnD]/[P] as a function of log [P] gives a slope equal to n. At half-
saturation: log [PnD]/[P] = 0 and observed Kd can be obtained from the relation observed 
Kd = -n ln [P]. The monomeric Kd can be obtained by taking the n
th




2.2.12 Colony forming assay in CHO cells treated with busulfan 
and hepsulfam. 
CHO cells transfected with either the empty pCMV vector or pCMV-hAGT were 
grown in -MEM media (Gibco-Invitrogen, Carlsbad, CA) containing 26 mM NaHCO3, 
10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, CA), 100 U/ml penicillin 
and 100 g/ml streptomycin. The cells were maintained by seeding at 1x105 cells/25 cm2 





 flask and 24 h later were treated with different concentrations of busulfan 
(Sigma, St Louis, MO) or hepsulfam (NCI, Frederick, MD) for 4 h. The cells were 
washed with phosphate buffered saline (PBS) twice, and then the medium was replaced 
with fresh medium and the cells allowed to grow for another 16-18 h. They were then 
replated at densities of 250-1000 cells per 25 cm
2
 flask and grown for 6-8 days until 
discrete colonies had formed. The colonies were washed with 0.9% saline solution, 
stained with 0.5% crystal violet and counted. 
2.3 Results and discussion 
2.3.1 Syntheses and characterization of the ICL duplexes  
ICL DNA repair studies require access to substrates of well defined structure. The 
bifunctional alkylating agent hepsulfam has been shown to alkylate specifically at the N7 
atom of dG in sequences containing a 5’-GNC motif placing a heptylene linkage between 
the two dG.(75) Because they are synthetically challenging to prepare, we have focused 
on the synthesis of a cross-link that joins the O
6
 atoms in this particular sequence motif. It 
should be emphasized that this specific cross-link has not been identified as a product of 
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alkylation by hepsulfam. The methodology to produce this ICL was used to prepare 
duplexes containing alkyl linkages of various lengths to investigate the affect of linker 
length on ICL stability, structure and repair by hAGT. The chemotherapeutic agent 
busulfan is another example of a bifunctional alkylating agent that has been used for the 
treatment of chronic myelogenous leukemia.(192) This agent introduces a butylene 
linkage between the nucleobases with the demonstration that this agent reacts with dG to 
form 1,4-di(7-guanosinyl)butane.(193) Mass spectrometry of the reaction products of 
busulfan with oligonucleotides suggested that this agent forms intrastrand cross-links 
with 5′-GA-3′ sequences.(68) 




dG cross-link and the sequences containing 
the butylene and heptylene cross-links (XLGG4 and XLGG7) are shown in Figure 2.1. 
The synthesis of the cross-linked amidites 7a and 7b were performed according to the 





-2’-deoxyguanosine the free 3’-alcohol was 
protected as an allyloxycarbonyl ester 1 using allyl 1-benzotriazoyl carbonate.(194) The 
adducts 2a and 2b were prepared by introduction of 1-t-butyldiphenylsilyloxy-butan-4-ol 
or 1-t-butyldiphenylsilyloxy-heptan-7-ol at the O
6
 position of 1 via the Mitsunobu 
reaction.(186,188) Removal of the t-butyldiphenylsilyl protecting group on compounds 
2a and 2b was accomplished with TBAF at room temperature for 30 min to yield the 
adducts 3a and 3b. The formation of dimers 5a or 5b were achieved via a second 
Mitsunobu reaction using 5’-O-dimethoxytrityl-N2-phenoxyacetyl-3’-O-t-butyldimethyl-
silyl-2’-deoxyguanosine (4) in yields of 63 and 71 %, respectively. Amidite precursors 6a 
and 6b required the removal of the 3’-O-alloxycarbonyl group from 5a or 5b with 
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palladium (0) tetrakistriphenylphosphine in THF at room temperature. These were then 
converted to phosphoramidites 7a and 7b using a slight excess of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride and isolated by hexane precipitation. The isolated 
phosphoramidites 7a and 7b were analyzed by mass spectrometry and were found to have 
the expected molecular masses. 
31
P NMR analysis of these phosphoramidites revealed the 
presence of two signals for 7a (143.92 and 144.14 ppm) and 7b (143.91 and 144.11 ppm) 
in the region diagnostic for a phosphoramidite.  
The synthesis of the 1,3-GNC engineered ICL using phosphoramidite dimers 7a or 
7b required three different protecting groups around the cross-linked site enabling an 
orthogonal approach for their removal. This would allow for the synthesis of three 
different branches in terms of sequences around the site of the ICL. The Mitsunobu 
reaction was chosen for its specificity at the O
6
 position of a protected dG (186,188)
 
and 
the versatility of this method which allows for the synthesis of cross-links of various 
lengths, depending on the diol linker used. This reaction was employed twice in the 
synthetic pathway outlined in Scheme 2.1, first for the synthesis of the monomers 2a and 
2b containing the four and seven carbon linkers at the O
6
 atom and later in the scheme for 
dimers 5a and 5b. The dimerization reaction to give dimer 5b proceeded in a slightly 
higher yield relative to 5a (71 versus 63 %), presumably due to the reduced steric 











































































Reagents and conditions: (i) Alloc-OBt, DCM/pyridine (9:1), 12 h; (ii) 4-(t-
butyldiphenylsiloxy) butan-1-ol or 7-(t-butyldiphenylsiloxy) heptan-1-ol (1.1 eqv.), PPh3 
(1.25 eqv.), DIAD (1.2 eqv.) (iii) TBAF (1 M in THF), 30 min; (iv) 4 (1.01 eqv.), PPh3 
(1.25 eqv.), DIAD (1.2 eqv.), 1 h; (v) Pd(PPh3)4 (5mol%), PPh3 (0.25 eqv.), n-
butylamine/formic acid (1:1, 2.5 eqv.), THF, 20 min; (vi) N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride, DIPEA, THF, 30 min. 
Solid phase synthesis of XLGG4 and XLGG7 was performed on a 1 µmol scale 
using phosphoramidites 7a or 7b according to Figure 2.2. The first arm of the duplex 
was synthesized on a polystyrene support using commercially available 3’-O-2’-
deoxyphosphoramidites. Coupling of the cross-linked phosphoramidites 7a or 7b 
introduced the ICL at the 5’-ends to the linear oligomers. The dimethoxytrityl groups of 
the dimer moiety were removed by brief treatment with 3% TCA in DCM to expose the 
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5’-OH groups from which the second and third arms of the duplex were then synthesized 
with a noted increase in the trityl conductivity reading on the synthesizer. Repetitive 
coupling with protected 3’-O-2’-deoxyphosphoramidites gave, after detritylation and 
capping (phenoxyacetic anhydride), the branched oligomer Y-TBS (Figure 2.2). The 3’-
O-TBS group was then removed from Y-TBS by treating the support with anhydrous 
TEA for 16 h followed by TEA•3HF twice for 30 min at room temperature. C-18 
Reversed-phase HPLC analysis of the deprotected intermediate Y-OH revealed complete 
removal of the silyl group with the shift of the major peak from 11.2 to 8.2 min in the 
case of the butylene containing cross-link (data not shown). Continued synthesis with 
repetitive coupling of 5’-O-2’-deoxyphosphoramidites at the 3’-end of intermediate Y-























































































































Figure 2.2: Methodology to construct the cross-linked duplexes XLGG4 and XLGG7 
via solid phase synthesis.  
(i) Coupling of amidite 7a or 7b; (ii) extension with 3’-O-2’-deoxyphosphoramidites 
followed by capping with phenoxyacetic anhydride; (iii) removal of the 3’-O-t-
butyldimethylsilyl group with TEA∙3HF; (iv) extension with 5’-O-2’-
deoxyphosphoramidites and (v) cleavage from the solid support. 
The solid-phase synthesis of the ICL containing oligonucleotides XLGG4 and 
XLGG7 required some changes from the standard synthesis cycle and reagents employed 
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during solid-phase oligonucleotide synthesis. First, synthesis was performed using a 
polystyrene rather than controlled-pore glass (CPG) solid-support due to the 
incompatibility of TEA•3HF with the latter.(175) As an added precaution, the cyanoethyl 
protecting groups were removed using TEA as it has been observed that prolonged 
fluoride treatment using TBAF could lead to chain cleavage.(195) Phenoxyacetic 
anhydride rather than acetic anhydride was used as capping reagent due to a undesirable 
N-acetylation reaction that has been observed with ‘fast-deprotecting’ amidites.(196) 
Additionally, the protection of the exocyclic amine functionalities of the cross-linked 
guanine bases with the phenoxyacetyl group would allow for milder deprotection 
conditions and ease of its removal at the final stage.  
Chain assembly in the 3’ to 5’ direction proceeded smoothly using 3’-O-2’-
deoxyphosphoramidites and the cross-linked dimers 7a and 7b with essentially 
quantitative coupling observed by conductivity measurements to assess the trityl values. 
A higher concentration (0.15 M) and longer coupling time (10 min) was used for 
phosphoramidites 7a and 7b to ensure a high coupling efficiency due to their larger size 
compared to the standard 3’-O-2’-deoxyphosphoramidites. At this point, capping with 
phenoxyacetyl anhydride gave intermediate Y-TBS (Figure 2.2) which was desilylated 
to give the free 3’OH functionality. The efficiency of this step was readily monitored by 
C-18 reversed phase HPLC (data not shown). A small amount (approximately 1 mg) of 
the solid support was deprotected using NH4OH/ethanol (3:1), milder conditions that 
have been developed for the deprotection of RNA to ensure that the TBS groups are not 
removed.(197) The removal of the TBS group decreases the hydrophobicity of the 
oligomer and a change in the retention time for the oligomer from 11 to 8 min on the C-
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18 reverse phase HPLC indicates removal to give the more hydrophilic Y-OH 
intermediate (Figure 2.2). The final step in the assembly of XLGG4 and XLGG7 is 
continued chain extension with 5’-O-2’-deoxyphosphoramidites. Cleavage and 
deprotection of XLGG4 and XLGG7 were performed with concentrated ammonium 
hydroxide/ethanol (3:1) at 55 °C for 4 h to yield 141.8 and 108.6 OD of material, 
respectively (Table 2.1). Analysis by SAX HPLC revealed that the major product was 
the desired ICL whose retention times are shown in Table 2.1. The combination of mild 
deprotection conditions and bulky nature of the adduct that the ICL represents at the O
6
 
position may account for the stability under these deprotection conditions. Purification by 
SAX HPLC, followed by desalting gave XLGG4 and XLGG7 in approximately 26 and 
36% overall isolated yields.  
Table 2.1: Amounts, retention times, nucleoside ratios and mass spectral data for cross-







Nucleoside     Ratios 
exp         obs 
       Mass 
exp          obs 
XLGG4 141.8 (36.9) 23.7 dC 6.0 6.1 6727.5 6726.8 
   dG 4.0 4.2   
   dT 5.0 5.0   
   dA 5.0 5.1   
   dG-dG 1.0 1.1   
XLGG7 108.6 (39.1) 25.5 dC 6.0 5.8 6769.6 6769.0 
   dG 4.0 4.1   
   dT 5.0 5.0   
   dA 5.0 5.1   
   dG-dG 1.0 1.1   
 
a
 Amount of crude ICL duplex purified by SAX HPLC. The numbers in parentheses 
indicate the amount of pure duplex obtained.  
b
 Retention times (min) of ICL duplexes on SAX HPLC using a 0.0-0.5 M linear gradient 
of sodium chloride. 
These ICL duplexes were digested to the constituent nucleosides with a 
combination of snake venom phosphodiesterase and calf intestinal alkaline phosphatase 
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and analyzed by C-18 reversed phase HPLC. In addition to the four standard 2’-
deoxynucleosides, one additional peak was observed with a retention time of 18.1 min for 
XLGG4 and 25.5 min for XLGG7. As shown in Table 2.1, the ratios of the component 
2’-deoxynucleosides and cross-linked nucleosides were consistent with the theoretical 
composition of ICL duplexes XLGG4 and XLGG7. The ICL oligomers XLGG4 and 
XLGG7 required additional time for digestion compared to single stranded 
oligonucleotides (48 h as opposed to 30 min). ESI mass spectrometry of the duplexes 
XLGG4 and XLGG7 had masses of 6726.8 and 6769.0 Da, consistent with the 
theoretical values for the cross-linked duplexes. 
2.3.2 UV thermal denaturation and CD of ICL duplexes  
UV denaturation experiments were carried out to assess the effect of the alkyl 
linkers on duplex stability. The UV thermal denaturation (Tm) curves for the ICL 
duplexes XLGG4, XLGG7, and the corresponding non-cross-linked control duplex all 
exhibited a sigmoidal denaturation profile with similar hyperchromicities for the 
transition curves (see Appendix II). The melting temperature for XLGG4, XLGG7 and 
the non-cross-linked control were all similar with a value of ~ 48 °C. 





in an 11-bp duplex, an increase in Tm of 23
 
°C over the control duplex was 
observed.(184)
 
UV thermal denaturation experiments with oligonucleotides containing an 
O
6
-MedG / dC base pair have shown that a single O
6
-methyl substitution reduced duplex 
stability by at least 18 °C per substitution in 1 M NaCl buffer and DNA duplexes 
containing two of these alkylated lesions were found to have a Tm 40 °C lower than that 





-alkyl lesions are counterbalanced by the preorganization of the covalently linked 
strands of the duplex resulting in a stability comparable to the non-cross-linked 
control.(175,184) 
The CD spectra of cross-linked duplexes XLGG4, XLGG7 and the non-cross-
linked control were recorded at 10 °C (spectra are shown in Appendix II). In all cases, the 
CD spectra of the duplexes exhibited signatures characteristic of B-form DNA with a 
positive maximum peak centered around 275 nm, a negative peak at approximately 250 
nm and a cross over around 260 nm.(200,201) The CD spectra of non-cross-linked 
controls revealed some minor differences, particularly a reduction of the signal at 275 
nm. 
These results suggests that the cross-links had minimal effect on the global B-form 
structure. NMR studies performed with dodecanucleotides containing a O
6
-MedG •C 
base pair implicate the formation of a wobble base pair, with the methylated dG sliding 
towards the major groove and the dC oriented towards the minor groove. This base pair is 
stacked in the duplex between the flanking base pairs inducing only a small 
conformational change from the wild-type duplex.(23) In a standard B-form duplex, the 




 atoms in a 5’-GNC sequence is approximately 6.4 Å. The O-
O distance in the fully extended 1,4-butanediol and 1,7-heptanediol are 6.2 and 9.9 Å, 
respectively, which is sufficient to span the distance linking the two O
6
 atoms in a 5’-
GNC sequence motif without inducing a significant structural change. Molecular models 
for the oligomers XLGG4, XLGG7 and the non-cross-linked control duplex that were 
geometry optimized using the AMBER forcefield suggest that the alkylene linkers are 
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oriented towards the major groove and do not greatly distort the duplex, consistent with 
our findings (see Appendix II). 
2.3.3 Cross-link repair 
Repair assays were performed on the ICL containing oligomers XLGG4 and 
XLGG7 with wild-type hAGT and the variants C145S, P140A and V148L. The C145S 
variant was selected as a negative control due to its lack of alkyltransferase activity and 




dG ICLs.(163) The 
P140A mutation has been investigated for the influence of reduced size of the active site 
pocket on hAGT activity.(202,203) In addition, some AGTs such as the E.coli Ada-C, 
have alanine in place of proline in the equivalent position of hAGT. The V148L variant 
was prepared to probe the effect of the side chain of Val 148 on the repairing ability of 
the protein. This variant was selected since little is known about this amino acid other 
than the carbonyl group of Val 148 has been shown in wild-type hAGT to accept a H-
bond from the N
2
 atom of a bound dG.(148,155) We suspected that substituting Val to a 
larger amino acid would reduce the size of the active site pocket yielding a protein with 
the same properties as P140A. 
All protein (wild-type hAGT, C145S, P140A and V148L) masses were verified by 
ESI-MS and were in agreement with the calculated values (see Appendix II). The 
secondary structure of the proteins by far UV CD was examined to ensure that the 
alterations did not compromise the structure. CD scans of the P140A and V148L hAGT 
variants revealed similar secondary structures to the wild-type hAGT due the highly 
conservative nature of these alterations (see Appendix II). The C145S mutation had a 
greater impact on the global secondary structure of the protein. Although the size of the 
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cysteine and serine side groups are relatively similar, the H-bonding capabilities of these 
two amino acids differ. 
The stability of the proteins (wild-type hAGT, C145S, P140A and V148L) were 
assessed via thermal denaturation studies to ensure that the proteins were properly folded 
at the assay temperature (37 °C) by monitoring the α-helical content of the protein at 222 
nm as a function of increasing temperature. The thermal denaturation studies 
demonstrated that all hAGT proteins were still properly folded at 37 °C due to their Tm’s 
being well above this temperature. Thermal denaturation studies of the wild-type hAGT 
correlated with values reported of complete inactivation of the protein at 60 °C.(204) All 
mutations destabilized the protein based on CD spectra where the stability of the 
secondary structure of the protein was compromised (see Appendix II).  
The intrinsic fluorescence of the hAGT proteins were investigated by monitoring 
the local environments containing both tryptophan and tyrosine residues using an 
excitation wavelength of 280 nm while in the case of tryptophan alone the excitation 
wavelength of 295 nm was used. It is clear from the emission wavelengths and intensities 
that the mutations had no dramatic affect on the tertiary structure of the protein with 
V148L having a slight impact on tertiary structure of the protein relative to the other 
mutants (see Appendix II).  
The 5’-32P labeled ICL DNA duplexes XLGG4 and XLGG7 (2 pmol) were 
incubated with 60 pmol of either the wild-type hAGT or the variants (C145S, P140A and 
V148L) overnight at 37 °C to determine repair. Trials for either 14 or 16 h were 
performed with virtually identical results obtained, indicating that the reaction was 
complete as monitored by denaturing PAGE (Figure 2.3). Lanes 1 and 2 contain 2 pmol 
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of ssDNA corresponding to the sequence of one of the repaired strands with the only 
difference being the presence of hAGT in lane 2. Lanes 3 and 8 contain 2 pmol of 
XLGG4 and XLGG7, respectively, representing the unrepaired ICL duplexes with a 
reduced mobility relative to that of completely repaired substrate. Lanes 4 and 9 contain 
60 pmol of hAGT with 2 pmol of either XLGG4 (lane 4) or XLGG7 (lane 9). In both 
cases two additional bands are seen, one that migrates more quickly corresponding to the 
completely repaired single stranded product and the other at the top of the gel with 
significantly reduced mobility which is likely a single hAGT-bound covalently to a DNA 
species, a median repair product. For both XLGG4 and XLGG7, no repair products are 
observed with 60 pmol of the variants C145S (lanes 5 and 10), while P140A (lanes 6 and 
11) or V148L (lanes 7 and 12) show very minimal repair of XLGG7 and no repair of 
XLGG4. The repair assays demonstrate that both XLGG4 and XLGG7 are repaired by 
hAGT with XLGG7 undergoing a greater amount of repair (with 57.0% of ICL repaired) 
over XLGG4 (31.4% of ICL repaired) based on quantitation of ICL remaining as 
measured by the relative counts of the labelled products present on the gel by 




Figure 2.3: Repair of XLGG4 and XLGG7 by wild-type hAGT, C145S, P140A and 
V148L.  
(A) Denaturing PAGE of repair reactions as described in the experimental section: Lane 
1, 2 pmol Control; lane 2, 2 pmol Control + 60 pmol hAGT; lane 3, 2 pmol XLGG4; lane 
4, 2 pmol XLGG4 + 60 pmol hAGT; lane 5, 2 pmol XLGG4 + 60 pmol C145S; lane 6, 2 
pmol XLGG4 + 60 pmol P140A; lane 7, 2 pmol XLGG4 + 60 pmol V148L; lane 8, 2 
pmol XLGG7; lane 9, 2 pmol XLGG7 + 60 pmol hAGT; lane 10, 2 pmol XLGG7 + 60 
pmol C145S; lane 11, 2 pmol XLGG7 + 60 pmol P140A; lane 12, 2 pmol XLGG7 + 60 
pmol V148L. 
For the repair assays involving XLGG4 and XLGG7, the samples were denatured 
in stop reaction buffer before being loaded on a 7 M urea denaturing gel to prevent self-
complexation of the repaired DNA strands which could complicate determination of 
ratios of the repaired intermediate and fully repaired product versus intact (unrepaired) 
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Scheme 2.2: Proposed repair pathway of cross-link species by wild-type hAGT, P140A 
and V148L (MP - median product; FP- final product). 
The inactive C145S variant was unable to repair both ICL duplexes as expected due 
to the lack of the active site Cys residue which is known to be the alkyl group acceptor. 
The other P140A and V148L variants showed no repair of XLGG4 and very poor repair 
for XLGG7 (4.5% and 3.0%, respectively). The diminished capacity for repair by the 
P140A variant has been observed as it is much less active than wild-type hAGT in 
dealkylating O
6
-benzylguanine, which has been explained by the reduced size of the 
binding pocket.(205) 
Time course assays were performed using 60 pmol wild-type hAGT and 2 pmol of 
the XLGG4 and XLGG7 substrates by quantitating the amount of unrepaired, partially 
and fully repaired species (see Appendix II). XLGG4 was repaired at a much slower rate 
with 25% repair of the ICL occurring in 8.5 h whereas the same level of repair for 
XLGG7 required approximately 1 h. 
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The results obtained from the time course experiments for the 5’-GNC-3’ ICL for 





dG ICL in a mismatch duplex.(146) It was shown that 50% final 





ICL, also observed in the repair of XLGG7. These results are surprising, as the ICL 





dG mismatch ICL. The mechanism by which hAGT 
repairs DNA alkylation involves rotation of the alkylated nucleoside from the DNA 
duplex from the minor groove into the active site allowing for transfer of the alkyl group 
to the residue C145.(189) The improved repair of XLGG7 versus XLGG4 can be 
rationalized by the difference in distances of the cross-link. For the four carbon linker of 
XLGG4, the O-O distance of the fully extended linker is just sufficient (6.2 Å) to span 
the distance necessary to link the O
6
 atoms in a 5’-GNC sequence (6.4 Å). In a geometry 
optimized model of XLGG4, the O-O distance was found to be 4.5 Å with some tilting of 
the guanine bases towards each other (see Appendix II). The model of XLGG7 has an O-
O distance of 7.1 Å with the longer alkylene chain protruding into the major groove. This 
would suggest that rotation of one of the alkylated dG of XLGG7 into the active site of 
hAGT would be less difficult relative to the more strained XLGG4 ICL. These findings 
demonstrate that there could have been some distortion in the cross-linked duplexes 
inherent in the nature of the substrates prior to the repair process and that XLGG4 is too 
short to fit optimally in the active site relative to the XLGG7 counterpart. 
The formation of the final product occurs at a faster rate than the formation of the 
median product for both XLGG4 and XLGG7, as the % final product observed is always 
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greater than the % median product. Final and median product formation occur at different 
rates, suggesting that hAGT preferentially repairs the median product over the initial 
substrate as indicated by the lack of accumulation of median product at any time. If 
hAGT preferentially repaired the median product over the initial substrate the median 
product should not increase with time as the median product would be consumed as it 
would be formed.  
One possible explanation as to why this reaction does not go to completion is that 
the reacted hAGT binds to another lesion containing ICL or oligonucleotide in our assay. 
It is known that alkylated hAGT can also bind to DNA.(163) In vivo, dissocation is most 
likely reinforced by ubiquitination resulting in degradation of the alkylated hAGT.(206) 
In addition, it is possible that the cross-link may be oriented in an alternate, less reactive 
conformation, as has been postulated for O
6
-(2-hydroxyethyl) dG and O
6
-[4-oxo-4-(3-
pyridyl)but-1-yl] dG containing oligonucleotides.(129) 
2.3.4 Binding studies of C145S hAGT  
Binding cooperativity (Hill factor) and monomeric Kd values were determined for 
the non-cross-linked control duplex, XLGG4 and XLGG7 with the C145S hAGT mutant 
(see Table 2.2 and Appendix II). Similar cooperativity values were obtained for the 
control duplex (1.41 ± 0.06) and XLGG7 (1.32 ± 0.06) whereas this value was found to 
be slightly higher for XLGG4 (1.75 ± 0.13). All three DNA duplexes showed a similar 
monomeric dissociation constant ranging from 8.36 for the control duplex to 9.87 μM for 
XLGG4 (see Appendix II). 
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Table 2.2: Hill factor and monomeric Kd values of C145S hAGT-DNA complexes 
DNA  Cooperativity Factor Kd (μM) 
Control 1.41 ± 0.06 8.36±1.11 
XLGG4 1.75 ± 0.13 9.87±1.22 
XLGG7 1.32 ± 0.06 9.67±1.12 
Experiments to measure cooperativity and dissociation constants for XLGG4 and 
XLGG7 showed only two bands by EMSA corresponding to the free and bound ICL 
DNA. The absence of an intermediate band on the native gel indicates that there is 
cooperativity in the binding of hAGT for the ICL DNA. XLGG7 and the control duplex 
showed similar cooperativity and dissociation constants indicating that the presence of 
the 7-methylene cross-link had little influence on hAGT interaction with the DNA. 
XLGG4 had a slightly higher cooperativity of interaction with hAGT, however, all the 
measured Hill factors for ICL duplexes XLGG4 and XLGG7 were between 1 and 2 in 
accordance with previous work which showed that 1 hAGT protein binds every 4 
nucleotides.(164) A Hill factor of 2 indicates perfect cooperativity, as previously shown 
in the case of hAGT for many unmodified oligonucleotide sequences under different 
assay conditions whereas a value of 1 indicates no cooperativity.(164)
 
 
In the absence of NMR or X-ray structural data for XLGG4 or XLGG7, it can only 
be speculated that the butylene cross-link induces a structural change in the DNA that has 
an influence on the interaction of the ICL with hAGT contributing to the slight increase 
in cooperativity that is observed. It is known that binding of hAGT to DNA causes 
structural changes in the DNA, which may play a role in aiding the rotation of the 
damage base from the DNA double helix and subsequently promote hAGT cooperative 
binding.(151,155) However, the shorter alkylene linker of XLGG4 versus XLGG7 may 
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hinder rotation of the alkylated dG into the active site contributing to a reduction in repair 
by hAGT. 
2.3.5 Colony forming assay in CHO cells treated with busulfan 






CHO cells that do not express AGT were sensitive to killing by hepsulfam (Figure 
2.4). Expression of hAGT provided a significant but not complete protection from this 





accounts for at least part of the cytotoxicity of this agent and that the efficient repair of 
this 7 carbon adduct by hAGT prevents this killing. There was no protection from 
busulfan, which is in accord with the poor repair of the 4 carbon adduct produced by this 
agent.  
Extensive study of the hAGT reaction has shown that DNA repair by this protein is 
specific for adducts on the O
6
 position with a minor capability to repair adducts on the O
4
 
position of dT. The results shown here using in vitro assays show that a DNA interstrand 
cross-link containing 7 carbon atoms linking two O
6 
atoms of dG residues is efficiently 
repaired by hAGT. Such a cross-link would be expected to be formed in treated cells by 
hepsulfam and, although it has not yet been characterized, the finding that hAGT reduces 
the cytotoxicity of hepsulfam is strong evidence that it does occur. Unrepaired DNA 
interstrand cross-links are very toxic and only a small number of such cross-links may be 
formed. The results also suggest that a high level of hAGT expression would render 





Figure 2.4: The effect of the expression of hAGT on exposure of CHO cells to busulfan 
and hepsulfam.  
Cell survival was measured with a colony forming assay as described in the experimental 
section. * p<0.05, Compared to cells expressing hAGT; ** p<0.01, Compared to cells 
expressing hAGT. 
2.4 Conclusions 





that enables the construction of a 1,3-staggered 5’-GNC motif by solid-phase synthesis 
using phosphoramidite chemistry and an orthogonal approach to removing protecting 
groups is described. These ICL were obtained in high yield and purity that is required for 
DNA repair studies. ICL duplexes containing a four and seven methylene linkage were 
found to have similar thermal stability and structure relative to a non-cross-linked 
control. Both were repaired by hAGT, where hAGT displayed a higher efficiency for the 
ICL containing the seven methylene linkage. Binding studies suggested similar affinity of 
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hAGT for both ICL. Studies with cells treated with hepsulfam demonstrate that hAGT 
reduces the cytotoxicity that this bifunctional alkylating agent induces and serves as 




dG cross-link may account for at least part of the 
cytotoxicity of this agent. 
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dT interstrand cross-link 
have been prepared by the synthesis of cross-linked nucleoside dimers which were 
converted to phosphoramidites to produce site specific ICL. ICL duplexes containing 
alkyl chains of four and seven methylene groups were prepared and characterized by 
mass spectrometry and nuclease digests. Thermal denaturation experiments revealed four 
and seven methylene containing ICL increased the Tm of the duplex with respect to the 
non cross-linked control with an observed decrease in enthalpy based on thermodynamic 
analysis of the denaturation curves. CD experiments on the ICL duplexes indicated 
minimal difference from the standard B-form DNA structure. These ICL were used for 
DNA repair studies with hAGT, Ada-C and OGT, whose purpose is to remove O
6
-alkyl 
dG and in some cases O
4









dT ICL prepared in this study 
were found to evade repair by hAGT, OGT and Ada-C. EMSA results indicated that the 
absence of any repair by hAGT was not a result of binding. OGT was the only AGT to 





-heptyl-7-ol dT. Binding experiments conducted with hAGT demonstrated that 
the protein bound O
4
-alkyl dT lesions with similar affinities as O
6
-MedG, which hAGT 
repairs efficiently, suggesting the lack of O
4





Interference by ICLs of critical cell events involving DNA unwinding is exploited 
in cancer chemotherapy regimens employing bis-alkylating agents.(35,36,42) The 
potency of these agents may be diminished by the ability of cancer cells to repair the very 
lesions they induce. Numerous DNA repair pathways including DR, BER, NER, HR, 
NHEJ and MMR remove various DNA lesions.(8,9,78,207) Some pathways, such as 
NER, are complex with broad substrate specificities whereas direct repair by AGT, which 
involves one protein, has a narrow range of damage that it repairs. ICL damage is 
challenging to repair as information on both DNA strands is affected. Removal of the 
ICL on one strand of DNA leaves behind damage on the opposing strand, complicating 
error-free repair from a template strand. Repair pathways such as NER, HR and 
translesion DNA synthesis (TLS) have all been implicated in ICL repair in mammalian 
cells, however, there is an increasing realization that ICL processing may depend on the 
nature of the lesion making it challenging to generalize how specific ICLs are 
repaired.(7,208,209) 
An approach pursued by a number of groups to enhance our understanding of these 
processes involves the preparation of ICL DNA substrates by solution and solid-phase 
synthesis for repair studies.(62) A number of elegant examples have been reported 
including the preparation of numerous phosphoramidites of nucleosides and other 
molecules to introduce site-specific lesions in DNA for various 
experiments.(176,180,210,211,212) Repair and binding experiments can be conducted by 
incorporating the oligonucleotides containing lesions into specific plasmids.(213) 
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Due to the instability of certain ICL formed in DNA as a consequence of DNA 
treatment with bifunctional alkylating agents it is at times necessary to modify the 
structure of the ICL by producing a mimic similar in structure but exhibiting improved 
stability to enable biophysical and repair studies. For example, the alkyl sulfamate 
hepsulfam and the nitrogen mustard mechlorethamine both form similar ICL between 
two N7 atoms of dG in DNA containing a 5'-GNC.(60,61,75) Alkylation at the N7 atom 
of dG destabilizes the nucleoside. For example, the half-life of the mechlorethamine 
induced ICL is on the order of hours which can limit experiments that may be 





dG ICL via a versatile synthetic strategy that enables introduction of an alkyl 





dG ICL with AGT proteins were conducted. AGT proteins, which are found in all 
kingdoms of life, are responsible predominantly for the repair of O
6
-MedG lesions which 
are renowned to cause point mutations by disrupting normal Watson–Crick base pairing 
proving that this protein is integral in maintaining genomic integrity.(189) hAGT, the 
most thoroughly characterized AGT protein, repairs alkylated DNA by flipping the 
damaged nucleotide out of the helix and into its active site where the alkyl group is 
transferred from the point of lesion to the active site Cys 145 residue.(155) Once 
alkylated, this protein is degraded by the ubiquitin pathway.(104) 




dG ICL in mismatched 
(146) and 5’-GNC sequence motif DNA, the latter designed to mimic the lesion formed 
by hepsulfam.(214) We reported that hAGT reduces hepsulfam cytotoxicity in 







ICL given that hAGT repairs only O
6
-alkyl dG. Interestingly, neither AGT homologues 
from E. coli (Ada-C or OGT) were capable of repairing these ICL. 
DNA mismatches can arise from heteroduplexes formed during homologous 
recombination, errors in DNA replication, deamination and base damage by alkylating 
agents.(215,216,217,218) The exocyclic atoms of mispaired nucleobases are more 
susceptible to alkylation as a result of altered hydrogen bonding patterns that expose 
these atoms to the external environment, as observed by the enhanced reactivity of 
mispaired dT residues to osmium tetroxide.(219) Moreover, formation of mutagenic 
alkylated nucleobases, such as O
4
-MedT, can cause mispairs when encountered by DNA 
polymerases to form, for example, an O
4
-MedT:dG mismatch.(4) 
Formation of pyrimidine-pyrimidine ICL introduced by bifunctional alkylating 
agents have been reported. DNA containing mispaired dC residues treated with 
mechlorethamine have been shown to form ICL linking N3 atoms.(220) This recent 
discovery of ICL formation involving two mispaired pyrimidines is unique and 
unprecedented. Not much is known about the properties of these ICL because of their 
recent appearance and is an area of research that requires further investigation. 










dT ICL in a directly opposed motif as well as their respective mono-
adducts (Figure 3.1) by adapting methods described by Swann's group requiring the 
preparation of convertible nucleosides.(221) These ICL were prepared by solid-phase 
oligonucleotide synthesis and the influence of various alkyl linker lengths on duplex 
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dT interstrand cross-link, (B) duplex 
where T-T is the ICL, (C) O
4
-alkyl dT monoadducts and (D) DNA sequence where X 
contains the monoadduct. 
The formation of O
4
-MedT in DNA is highly mutagenic due to the preferential 
incorporation of dG opposite this alkylated nucleotide during replication by DNA 
polymerases, as indicated previously.(4) O
4
-MedT is a minor alkylation product with 
respect to its mutagenic O
6





-MedT.(24) Though found in relatively low abundance this 
lesion is important as it has been observed in the DNA of smokers and is partly 
responsible for the adverse effects of tobacco.(54) 
In mammalian cells, O
4
-MedT is more toxic than O
6
-MedG both in normal and 




-MedT is not affected by the 
expression or suppression of hAGT activity nor by MMR explaining its added toxicity. 
NER deficient cells exhibit increased sensitivity to O
4
-MedT indicating that this lesion is 
possibly repaired via the NER pathway in mammalian cells.(31) E. coli has evolved two 
proteins from the direct repair pathway to eliminate O
4
-MedT lesions, OGT and the C-




terminal of the adaptive response protein Ada, highlighting the importance of repairing 
this lesion in vivo, underscoring an interesting difference in substrate preference between 




O-(β-cyanoethyl-N,N’-diisopropyl) phosphoramidites and N,N-
diisopropylaminocyanoethylphosphonamidic chloride were purchased from ChemGenes 
Inc. (Wilmington, MA). 5’-O-Dimethoxytrityl-2’-deoxyribonucleoside-3’-O-(β-
cyanoethyl-N,N’-diisopropyl)phosphoramidites and protected 2’-deoxyribonucleoside-
CPG supports were purchased from Glen Research (Sterling, Virginia). All other 
chemicals and solvents were purchased from the Aldrich Chemical Company 
(Milwaukee, WI) or EMD Chemicals Inc. (Gibbstown, NJ). Flash column 
chromatography was performed using silica gel 60 (230–400 mesh) obtained from 
Silicycle (Quebec City, QC). TLC was performed using precoated TLC plates (Merck, 
Kieselgel 60 F254, 0.25 mm) purchased from EMD Chemicals Inc. (Gibbstown, NJ). 
NMR spectra were recorded on a Varian 500 MHz NMR spectrometer at room 
temperature. 
1
H NMR spectra were recorded at a frequency of 500 MHz and chemical 





H decoupled) were recorded at a frequency of 125.7 MHz with 
tetramethylsilane as a reference. 
31
P NMR spectra (
1
H decoupled) were recorded at a 
frequency of 202.3 MHz with H3PO4 used as an external standard. High resolution mass 
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spectrometry of modified nucleosides were obtained using a LTQ OrbitrapVelos - ETD 
(Thermo Scientific) at the Concordia University Centre for Biological Applications of 
Mass Spectrometry. The mass spectrometer was operated in full scan, positive ion 
detection mode. Ampicillin, IPTG, and most other biochemical reagents as well as 
polyacrylamide gel materials were purchased from Bioshop Canada Inc (Burlington, 
ON). Ni-NTA Superflow Resin was purchased from Qiagen (Mississauga, ON). 
Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets were obtained from 
Roche (Laval, QC) XL-10 Gold and BL21(DE3) E. coli cells were obtained from 
Stratagene (Cedar Creek, TX). DpnI, T4 PNK, Unstained Protein Molecular Weight 
Marker and restriction enzymes EcoRI and KpnI were obtained from Fermentas 
(Burlington, ON). [γ-32P]ATP was purchased from Amersham Canada Ltd. (Oakville, 
ON). Phusion Polymerase was obtained from New England Biolabs (Ipswich, MA). DNA 
primers for site directed mutagenesis and cloning were purchased from Biocorp 
(Montreal, QC). Oligonucleotides containing O
4
-MedT required for repair studies were a 
kind gift from TriLink Biotechnologies (San Diego, CA). 
3.2.2 Solution synthesis of small molecules 
3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-O4-(hydroxybutyl)-thymidine 
(1a) 
1,4-butanediol (1.60 g, 17.8 mmol) was dissolved in THF (15 mL). Sodium metal 
(2.35 g, 102 mmol) was added. After 5 h, the salt was extracted to be immediately used in 
the subsequent reaction. 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-
(1,2,4-triazol-1-yl)-thymidine (preperad as described in 221) (2.5 g, 3.52 mmol) was 
dissolved in dioxane (10 mL). Sodium 4-hydroxybutan-1-olate was added dropwise. 
95 
 
After 15 h, the solvent was evaporated in vacuo, the crude product was taken up in DCM 
(50 mL) and the solution was washed with two portions of sodium bicarbonate (2 x 50 
mL). The organic layer was dried over sodium sulphate and concentrated to produce a 
yellow gum. The crude product was purified by flash column chromatography using a 
hexanes : ethyl acetate solvent system (2 : 3) to afford 2.05 g (79.8 %) of product as a 
colorless foam.  
Rf (SiO2 TLC): 0.24 hexanes : ethyl acetate (2 : 3). λmax(ACN) = 282 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 7.98 (s, 1H, H6), 7.30-7.45 (m, 10H, Ar), 6.85-6.88 (m, 3H, 
Ar), 6.36 (dd, 1H, H1’, J = 6.0 Hz), 4.53 (m, 1H, H3’), 4.47 (m, 2H, ArOCH2), 4.02 (m, 
1H, H4’), 3.85 (s, 6H, OCH3), 3.75 (t, 2H, CH2), 3.56 (dd, 1H, H5’), 3.31 (dd, 1H, H5’’), 
2.56 (m, 1H, H2’), 2.27 (m, 1H, H2’’), 1.90 (m, 2H, CH2), 1.74 (m, 2H, CH2), 1.64 (s, 
1H, OH), 1.57 (s, 3H, ArCH3), 0.87 (s, 9H, SiC(CH3)3), 0.08 (s, 6H, Si(CH3)2). 
13
C NMR 
(125.7 MHz, CDCl3, ppm): 170.4, 158.7, 156.0 144.4, 139.5, 135.53, 135.51, 130.11, 
130.10, 128.2, 127.9, 127.1, 113.24, 113.21, 104.6, 86.7, 86.5, 86.3, 71.0, 67.1, 62.4, 
62.2, 42.2, 29.1, 25.7, 25.1, 17.9, 11.7, -4.62, -4.94. IR (thin film); νmax (cm
−1
) = 3414, 
3061, 2953, 1669, 1509, 1252, 1178, 1109, 1035,835, 782. HRMS (ESI-MS) m/z 
calculated for C41H54N2O8SiNa
+





1,7-heptanediol (1.7 g, 11.35 mmol) was dissolved in THF (10 mL). Sodium metal 
(1.7 g, 65.2 mmol) was added. After 5 h, the salt was extracted to be immediately used in 
the subsequent reaction. 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-
(1,2,4-triazol-1-yl)-thymidine (1.7 g, 1.13 mmol) was dissolved in dioxane (5 mL).(221) 
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Sodium 7-hydroxyheptan-1-olate was added dropwise. After 15 h, the crude product was 
taken up in ethyl acetate (50 mL) and the solution was washed with two portions of 
sodium bicarbonate (2 x 50 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a hexanes : ethyl acetate solvent system (6 : 4). Further 
purification of the product was achieved by flash column chromatography using a ACN : 
DCM (1 : 9 → 3 : 25) solvent system to afford 0.594 g (42.1 %) of product as a colorless 
foam.  
Rf (SiO2 TLC): 0.43 hexanes : ethyl acetate (2 : 3). λmax(ACN) = 282 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 7.96 (s, 1H, H6), 7.29-7.34 (m, 10H, Ar), 6.86-6.88 (m, 3H, 
Ar), 6.37 (dd, 1H, H1’, J = 5.7 Hz), 4.53 (dd, 1H, H3’), 4.24 (t, 2H, ArOCH2), 4.02 (m, 
1H, H4’), 3.85 (s, 6H, OCH3), 3.69 (m, 2H, CH2OH), 3.56 (dd, 1H, H5’), 3.30 (dd, 1H, 
H5’’), 2.55 (m, 1H, H2’), 2.25 (m, 1H, H2’’), 1.80 (m, 2H, CH2), 1.63 (m, 2H, CH2), 
1.57 (s, 3H, CH3Ar), 1.47 (m, 6H, (CH2)3), 0.89 (s, 9H, SiC(CH3)3), 0.08 (s, 6H, 
Si(CH3)2). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.5, 158.7, 156.0 144.4, 139.4, 
135.56, 135.55, 130.12, 130.10, 128.2, 127.9, 127.1, 113.24, 113.21, 104.6, 86.7, 86.5, 
86.3, 71.1, 67.3, 62.9, 62.4, 55.3, 42.2, 32.7, 29.8, 29.0, 28.4, 25.8, 25.7, 25.6, 17.9, 11.8, 
-4.62, -4.94. IR (thin film); νmax (cm
−1
) = 3420, 3060, 2930, 1668, 1509, 1252, 1177, 












1a (0.154 g, 0.205mmol) and 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-
dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-thymidine (0.117 g, 0.164 mmol) was dissolved 
in pyridine (3 mL). 1,8-Diazabicycloundec-7-ene (DBU) (0.062 g, 0.410 mmol) was 
added dropwise. After 3 days, the crude product was taken up in ethyl acetate (100 mL) 
and the solution was washed with four portions of sodium bicarbonate (4 x 50 mL). The 
organic layer was dried over sodium sulphate and concentrated to produce a yellow gum. 
The crude product was purified by flash column chromatography using a hexanes : ethyl 
acetate (1 : 1 →2 : 3) solvent system to afford 0.151 g (67.7 %) of product as a colorless 
foam.  
Rf (SiO2 TLC): 0.22 hexanes : ethyl acetate (2 : 3). λmax(ACN) = 282 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 7.96 (s, 2H, H6), 7.30-7.46 (m, 20H, Ar), 6.86-6.88 (m, 6H, 
Ar), 6.37 (dd, 1H, H1’, J = 5.7 Hz), 4.53 (m, 2H, H3’), 4.47 (m, 4H, CH2), 4.01 (m, 2H, 
H4’), 3.84 (s, 12H, OCH3), 3.57 (dd, 2H, H5’), 3.31 (dd, 2H, H5’’), 2.55 (m, 2H, H2’), 
2.26 (m, 2H, H2’’), 1.93 (m, 4H, CH2), 1.57 (s, 6H, ArCH3), 0.87 (s, 18H, SiC(CH3)3), 
0.07 (s, 12H, Si(CH3)2). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.4, 158.7, 155.9 144.4, 
139.6, 135.51, 135.50, 130.11, 130.10, 128.2, 127.9, 127.1, 113.24, 113.21, 104.5, 86.7, 
86.5, 86.3, 71.1, 66.6, 62.4, 55.2, 42.2, 25.7, 25.3, 17.9, 11.7, -4.62, -4.94. IR (thin film); 
νmax (cm
−1
) = 3057, 2954, 1671, 1608, 1509, 1463, 1329, 1252, 1178, 1035, 835, 736. 
HRMS (ESI-MS) m/z calculated for C79H98N4O14Si2Na
+










1b (0.500 g, 0.647 mmol) and 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-
dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-thymidine (0.368 g, 0.518 mmol) was dissolved 
in pyridine (10 mL). DBU (0.197 g, 1.29 mmol) was added dropwise. After 4.5 days, the 
crude product was taken up in ethyl acetate (150 mL) and the solution was washed with 
four portions of sodium bicarbonate (4 x 50 mL). The organic layer was dried over 
sodium sulphate and concentrated to produce a yellow gum. The crude product was 
purified by flash column chromatography using a ACN : DCM (1 : 9 → 3 : 25) solvent 
system to afford 0.358 g (39.5 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.49 hexanes : ethyl acetate (2 : 3). λmax(ACN) = 282 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 7.99 (s, 2H, H6), 7.33-7.49 (m, 20H, Ar), 6.89-6.91 (m, 6H, 
Ar), 6.40 (dd, 2H, H1’, J = 12.0 Hz), 4.54 (dd, 2H, H3’), 4.44 (t, 4H, ArOCH2), 4.03 (m, 
2H, H4’), 3.86 (s, 12H, OCH3), 3.58 (dd, 2H, H5’), 3.34 (dd, 2H, H5’’), 2.58 (m, 2H, 
H2’), 2.26 (m, 2H, H2’’), 1.81 (m, 4H, CH2), 1.59 (s, 6H, CH3Ar), 1.48 (m, 6H, (CH2)3), 
0.88 (s, 18H, SiC(CH3)3), 0.07 (s, 12H, Si(CH3)2). 
13
C NMR (125.7 MHz, CDCl3, ppm): 
170.5, 158.7, 156.0 144.4, 139.4, 135.5, 130.13, 130.11, 128.2, 127.9, 127.1, 113.24, 
113.21, 104.6, 86.7, 86.5, 86.3, 71.1, 67.3, 62.4, 55.3, 42.2, 29.0, 28.5, 25.9, 25.7, 17.9, 
11.8, -4.61, -4.94. IR (thin film); νmax (cm
−1
) = 3058, 2952, 1671, 1533, 1508, 1327, 
1252, 1177, 1035, 834. HRMS (ESI-MS) m/z calculated for C81H104N4O14Si2Na
+
 









2a (0.658 g, 0.485 mmol) was dissolved in THF (4.8 mL). TBAF (1M in THF) 
(1.97 mL, 1.97 mmol) was added dropwise. After 30 min, the crude product was taken up 
in ethyl acetate (50 mL) and the solution was washed with two portions of sodium 
bicarbonate (2 x 50 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a methanol : hexanes : ethyl acetate (1 : 5 : 4 → 1 : 4 : 5) solvent 
system to afford 0.514 g (93.0 %) of product as a colorless foam.  
Rf (SiO2 TLC) : 0.21 methanol : hexanes : ethyl acetate (1 : 5 : 4). λmax(ACN) = 282 
nm. 
1
H NMR (500 MHz, CDCl3, ppm): 7.78 (s, 2H, H6), 7.23-7.37 (m, 20H, Ar), 6.78-
6.81 (m, 6H, Ar), 6.34 (dd, 2H, H1’, J = 6.0 Hz), 4.52 (m, 2H, H3’), 4.40 (m, 4H, CH2), 
4.05 (m, 2H, H4’), 3.77 (s, 12H, OCH3), 3.46 (dd, 2H, H5’), 3.35 (dd, 2H, H5’’), 2.58 
(m, 2H, H2’), 2.25 (m, 2H, H2’’), 2.11 (s, 2H, OH),1.85 (m, 4H, CH2), 1.56 (s, 6H, 
ArCH3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.4, 158.7, 158.6, 144.5,139.8, 135.6, 
135.5, 130.1, 130.1, 128.1, 128.0, 127.0, 113.3, 105.0, 86.8, 86.5, 86.3, 66.8, 63.5, 60.4, 
55.2 42.2, 25.2, 21.1, 14.2, 11.7. IR (thin film); νmax (cm
−1
) = 3353, 3057, 2953, 1661, 
1509, 1431, 1329, 1251, 1177, 1095, 1035, 829, 735. HRMS (ESI-MS) m/z calculated for 
C66H70N4O14Na
+







2b (0.357 g, 0.263 mmol) was dissolved in THF (2 mL). TBAF (1M in THF) (0.63 
mL, 0.63 mmol) was added dropwise. After 25 min, the crude product was taken up in 
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ethyl acetate (50 mL) and the solution was washed with three portions of sodium 
bicarbonate (3 x 50 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a methanol : hexanes : ethyl acetate (1 : 5 : 4 → 1 : 4 : 5) solvent 
system to afford 0.256 g (82.0 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.22 methanol : hexanes : ethyl acetate (1:11:8). λmax(ACN) = 282 nm. 
1
H NMR (500 MHz, CDCl3, ppm): 7.77 (s, 2H, H6), 7.18-7.37 (m, 20H, Ar), 6.79-6.80 
(m, 6H, Ar), 6.34 (dd, 2H, H1’, J = 12.5 Hz), 4.50 (m, 2H, H3’), 4.29-4.39 (m, 4H, CH2), 
4.05 (m, 2H, H4’), 3.78 (s, 12H, OCH3), 3.46 (dd, 2H, H5’), 3.36 (dd, 2H, H5’’), 2.58 
(m, 2H, H2’), 2.25 (m, 2H, H2’’), 1.70-1.74 (m, 4H, CH2), 1.56 (s, 6H, ArCH3), 1.39-
1.41 (m, 6H, CH2). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.6, 158.7, 156.2, 144.5, 
139.5, 135.6, 135.5, 130.1, 128.1, 128.0, 127.1, 113.3, 105.0, 86.8, 86.4, 86.1, 71.9, 67.4, 
63.4, 55.3, 42.1, 28.5, 25.8, 11.8. IR (thin film); νmax (cm
−1
) = 3350, 3058, 2932, 1654, 
1532, 1508, 1458, 1328, 1251, 1177, 1035, 829, 735. HRMS (ESI-MS) m/z calculated for 
C69H76N4O14Na
+










3a (0.200 g, 0.175 mmol) and DIPEA (0.068 g, 0.525 mmol) were dissolved in 
THF (2 mL), followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride 
(0.104 g, 0.438 mmol) and the reaction was allowed to stir at room temperature for 30 
min. Upon completion, the reaction was quenched by the addition of ethyl acetate (50 
mL), and the solution was washed with sodium bicarbonate (3%, 2 x 25 mL) and brine 
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(25 mL). The organic layer was dried over sodium sulphate, decanted, and evaporated. 
The product, a colorless powder, was precipitated from hexanes (0.152 g, 56.2 %).  
Rf (SiO2 TLC): 0.12, 0.18, 0.27 ethyl acetate. λmax(ACN) = 282 nm. 
1
H NMR (500 
MHz, d6-acetone, ppm): 7.83-7.91 (s, 2H, H6), 7.47-7.50 (m, 4H, Ar), 7.21-7.39 (m, 14H, 
Ar), 6.87-6.91 (m, 8H, Ar), 6.29-6.34 (m, 2H, H1’), 4.70-4.74 (m, 2H, H3’), 4.37 (m, 4H, 
CH2), 4.17-4.24 (m, 2H, H4’), 3.57-3.89 (m, 20H, CH2OP, OCH3), 3.34-3.51 (m, 4H, 
H5’, H5’’), 2.74 (t, 2H. CH2CN), 2.52-2.63 (m, 4H, H2’,CH2CN), 2.34-2.41 (m, 2H, 
H2’’), 1.89-1.91 (m, 4H, (CH2)2), 1.57-1.60 (m, 6H, ArCH3) 1.15-1.20 (m, 18H, CH3), 
1.07-1.08 (m, 6H, CH3). 
31
P NMR (202.3 MHz, d6-acetone, ppm): 148.28, 148.07. 
13
C 
NMR (125.7 MHz, d6-acetone, ppm): 170.0, 158.9, 158.8, 154.7, 144.97, 145.95, 140.03, 
139.97, 135.7, 135.63, 135.60, 135.56, 130.17, 130.15, 128.2, 128.1, 127.87, 127.86, 
126.91, 126.88, 118.1, 117.9, 113.1, 103.5, 103.4, 86.64, 86.61, 85.99, 85.9, 85.5, 85.3, 
85.2, 73.6, 73.5, 73.1, 73.0, 66.2, 63.2, 63.0, 58.70, 58.69, 54.70, 54.68, 43.1, 43.0, 40.4, 
40.3, 29.4, 25.1, 24.05, 24.03, 23.99, 23.93, 19.9, 19.8, 11.18, 11.17. IR (thin film); νmax 
(cm
−1
) = 3031, 2966, 1672, 1534, 1509, 1462, 1329, 1251, 1179, 1035. HRMS (ESI-MS) 
m/z calculated for C84H104N8O16P2Na
+









3b (0.170 g, 0.143 mmol) and DIPEA (0.056 g, 0.430 mmol) were dissolved in 
THF (2 mL), followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride 
(0.085 g, 0.359 mmol) and the reaction was allowed to stir at room temperature for 30 
min. Upon completion, the reaction was quenched by the addition of ethyl acetate (50 
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mL), and the solution was washed with sodium bicarbonate (3%, 2 x 25 mL) and brine 
(25 mL). The organic layer was dried over sodium sulphate, decanted, and evaporated. 
The product, a colorless powder, was precipitated from hexanes (0.146 g, 64.3 %).  
Rf (SiO2 TLC): 0.31, 0.46, 0.62 ethyl acetate. λmax(ACN) = 282 nm.
 1
H NMR (500 
MHz, d6-acetone, ppm): 7.88-7.92 (s, 2H, H6), 7.48-7.51 (m, 4H, Ar), 7.23-7.40 (m, 14H, 
Ar), 6.87-6.93 (m, 8H, Ar), 6.30-6.35 (m, 2H, H1’), 4.70-4.76 (m, 2H, H3’), 4.30-4.32 
(m, 4H, CH2), 4.18-4.24 (m, 2H, H4’), 3.60-3.91 (m, 20H, CH2OP, OCH3), 3.39-3.52 (m, 
4H, H5’, H5’’), 2.77 (t, 2H, CH2CN), 2.53-2.64 (m, 4H, H2’,CH2CN), 2.37-2.42 (m, 2H, 
H2’’), 1.74-1.78 (m, 4H, (CH2)2), 1.58-1.61 (m, 6H, ArCH3) 1.44-1.49 (m, 6H, (CH2)3), 
1.18-1.21 (m, 18H, CH3), 1.09-1.11 (m, 6H, CH3). 
31
P NMR (202.3 MHz, d6-acetone, 
ppm): 148.28, 148.07.
 13
C NMR (125.7 MHz, d6-acetone, ppm): 170.09, 170.08 158.88, 
158.86, 154.7, 145.0, 140.0, 139.9, 135.7, 135.63, 135.61, 135.57, 130.2, 130.1, 128.2, 
128.1, 127.9, 127.8, 126.89, 126.86, 118.1, 117.9, 113.1, 103.5, 103.4, 86.62, 86.59, 86.0, 
85.9, 85.5, 85.3, 85.2, 73.6, 73.5, 73.1, 73.0, 66.6, 63.2, 63.0, 58.7, 58.5, 54.68, 54.66, 
43.1, 43.0, 40.4, 40.3, 29.4, 25.7, 24.04, 24.02, 23.97, 23.96, 23.9, 19.94, 19.89, 19.83, 
19.77, 13.6, 11.17, 11.16. IR (thin film); νmax (cm
−1
) = 3057, 2966, 1672, 1510, 1463, 
1329, 1252, 1179, 1036. HRMS (ESI-MS) m/z calculated for C87H110N8O16P2Na
+
 





1a (0.300 g, 0.410 mmol) was dissolved in THF (1.2 mL). Triethylamine (0.145 g, 
1.43 mmol) followed by phenoxyacetyl chloride (0.122 g, 0.715 mmol) was added 
dropwise. The reaction was set in an ice bath for 25 min. After 1.5 h, the crude product 
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was taken up in ethyl acetate (50 mL) and the solution was washed with three portions of 
sodium bicarbonate (3 x 50 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a hexanes : ethyl acetate (3 : 7) solvent system to afford 0.266 g 
(75.1 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.39 hexanes : ethyl acetate (1 : 1). λmax(ACN) = 276 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 7.98 (s, 1H, H6), 7.26-7.50 (m, 13H, Ar), 6.85-7.09 (m, 5H, 
Ar), 6.37 (dd, 1H, H1’, J = 6.0 Hz), 4.69 (s, 2H, PhOCH2CO), 4.53 (m, 1H, H3’), 4.42 
(m, 2H, ArOCH2), 4.30 (t, 2H, COCH2),4.01 (m, 1H, H4’), 3.84 (s, 6H, OCH3), 3.58 (dd, 
1H, H5’), 3.31 (dd, 1H, H5’’), 2.55 (m, 1H, H2’), 2.26 (m, 1H, H2’’), 1.84 (m, 4H, CH2), 
1.57 (s, 3H, ArCH3), 0.87 (s, 9H, SiC(CH3)3), 0.08 (s, 6H, Si(CH3)2). 
13
C NMR (125.7 
MHz, CDCl3, ppm): 170.3, 169.0, 158.7, 157.8, 155.6, 144.4, 139.7, 135.52, 135.50, 
130.11, 130.09, 129.6, 128.2, 127.9, 127.1, 121.8, 114.6, 113.24, 113.21, 104.4, 86.7, 
86.5, 86.3, 71.1, 66.5, 65.3, 64.8, 62.4, 55.2, 42.2, 25.7, 25.3, 25.1, 17.9, 11.7, -4.62, -
4.94. IR (thin film); νmax (cm
−1
) = 3061, 2954, 1760, 1672, 1532, 1509, 1497, 1252, 1178, 
835, 783. HRMS (ESI-MS) m/z calculated for C49H60N2O10SiNa
+





1b (0.527 g, 0.682 mmol) was dissolved in THF (0.5 mL). Triethylamine (0.110 g, 
1.09 mmol) was added followed by cooling of the reaction in an ice bath for 10 min. 
Phenoxyacetyl chloride (0.175 g, 1.02 mmol) was added dropwise. After 1.5 h, the 
solvent was evaporated in vacuo, the crude product was taken up in DCM (50 mL) and 
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the solution was washed with two portions of sodium bicarbonate (2 x 50 mL). The 
organic layer was dried over sodium sulphate and concentrated to produce a yellow gum. 
The crude product was purified by flash column chromatography using a hexanes : ethyl 
acetate (4 : 1 → 2 : 3) solvent system to afford 0.491 g (79.4 %) of product as a colorless 
foam.  
Rf (SiO2 TLC): 0.49 hexanes : ethyl acetate (1 : 1). λmax(ACN) = 276 nm. 
1
H NMR 
(500 MHz, CDCl3, ppm): 8.00 (s, 1H, H6), 7.45 (dd, 2H, Ar), 7.25-7.34 (m, 9H, Ar), 
6.85-7.04 (m, 7H, Ar), 6.37 (dd, 1H, H1’, J = 6.0 Hz), 4.68 (s, 2H, PhOCH2CO), 4.53 
(dd, 1H, H3’), 4.41 (t, 2H, ArOCH2), 4.25 (t, 2H, CH2OCO), 4.02 (m, 1H, H4’), 3.84 (s, 
6H, OCH3), 3.58 (dd, 1H, H5’), 3.30 (dd, 1H, H5’’), 2.55 (m, 1H, H2’), 2.26 (m, 1H, 
H2’’), 1.77 (quintet, 2H, CH2), 1.71 (quintet, 2H, CH2), 1.58 (s, 3H, CH3Ar), 1.37-1.46 
(m, 6H, (CH2)3), 0.88 (s, 9H, SiC(CH3)3), 0.07 (s, 6H, Si(CH3)2.
 13
C NMR (125.7 MHz, 
CDCl3, ppm): 170.5, 169.1, 158.7, 157.8, 156.0, 144.4, 139.4, 135.5, 130.11, 130.09, 
129.5, 128.2, 127.9, 127.1, 121.7, 114.6, 113.23, 113.21, 104.5, 86.7, 86.5, 86.3, 71.1, 
67.2, 65.4, 65.3, 62.4, 55.2, 42.2, 28.8, 28.5, 28.4, 25.8, 25.71, 25.69, 17.9, 11.8, -4.62, -
4.95. IR (thin film); νmax (cm
−1
) = 3062, 2928, 1760, 1675, 1510, 1464, 154, 1065, 832, 
734. HRMS (ESI-MS) m/z calculated for C52H66N2O10SiNa
+ 





5a (0.200 g, 0.231 mmol) was dissolved in THF (2.4 mL). TBAF (1M in THF) 
(0.277 mL, 0.277 mmol) was added dropwise. After 15 min, the crude product was taken 
up in ethyl acetate (50 mL) and the solution was washed with two portions of sodium 
bicarbonate (2 x 50 mL). The organic layer was dried over sodium sulphate and 
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concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a methanol : hexanes : ethyl acetate (2 : 11 : 7) solvent system to 
afford 0.164 g (94.1 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.29 methanol : hexane : ethyl acetate (2 : 11 : 7). λmax(ACN) = 276 
nm. 
1
H NMR (500 MHz, CDCl3, ppm): 7.79 (s, 1H, H6), 7.18-7.37 (m, 13H, Ar), 6.79-
6.96 (m, 5H, Ar), 6.34 (dd, 1H, H1’, J = 6.5 Hz), 4.61 (s, 2H, PhOCH2CO), 4.50 (m, 1H, 
H3’), 4.36 (m, 2H, ArOCH2), 4.23 (t, 2H, COCH2),4.05 (m, 1H, H4’), 3.77 (s, 6H, 
OCH3), 3.47 (dd, 1H, H5’), 3.36 (dd, 1H, H5’’), 2.58 (m, 1H, H2’), 2.23 (m, 1H, H2’’), 
1.75-1.78 (m, 4H, CH2), 2.04 (s, 1H, OH), 1.55 (s, 3H, ArCH3). 
13
C NMR (125.7 MHz, 
CDCl3, ppm): 170.4, 169.0, 158.7, 158.6, 157.8, 156.1, 144.5, 139.9, 135.6, 135.5, 
130.08, 130.07, 129.6, 128.1, 128.0, 127.0, 121.8, 114.6, 113.3, 104.9, 86.8, 86.5, 86.4, 
72.0, 66.7, 65.3, 64.8, 63.5, 55.2, 42.2, 25.3, 25.1, 11.7. IR (thin film); νmax (cm
−1
) = 
3342, 3061, 2956, 1758, 1663, 1533, 1509, 1251, 1177, 1090, 755. HRMS (ESI-MS) m/z 
calculated for C43H46N2O10Na
+




5b (0.491 g, 0.541 mmol) was dissolved in THF (4.5 mL). TBAF (1M in THF) 
(0.65 mL, 0.65 mmol) was added dropwise. After 25 min, the solvent was evaporated in 
vacuo, the crude product was taken up in DCM (50 mL) and the solution was washed 
with two portions of sodium bicarbonate (2 x 50 mL). The organic layer was dried over 
sodium sulphate and concentrated to produce a yellow gum. The crude product was 
purified by flash column chromatography using a methanol : hexanes : ethyl acetate (0 : 1 




λmax(ACN) = 276 nm. 
1
H NMR (500 MHz, CDCl3, ppm): 8.00 (s, 1H, H6), 7.29-7.40 
(m, 2H, Ar), 7.18-7.27 (m, 9H, Ar), 6.94-6.97 (m, 1H, Ar), 6.87-6.88 (m, 2H, Ar), 6.79-
6.81 (m, 4H, Ar), 6.37 (dd, 1H, H1’, J = 6.2 Hz), 4.61 (s, 2H, PhOCH2CO), 4.52 (m, 1H, 
H3’), 4.34 (t, 2H, ArOCH2), 4.18 (t, 2H, CH2OCO), 4.07 (m, 1H, H4’), 3.78 (s, 6H, 
OCH3), 3.47 (dd, 1H, H5’), 3.36 (dd, 1H, H5’’), 2.60 (m, 1H, H2’), 2.33 (s, 1H, OH), 
2.25 (m, 1H, H2’’), 1.72 (quintet, 2H, CH2), 1.64 (quintet, 2H, CH2), 1.56 (s, 3H, 
CH3Ar), 1.33-1.37 (m, 6H, (CH2)3). 
13
C NMR (125.7 MHz, CDCl3, ppm): 170.6, 169.1, 
158.6, 157.8, 156.3, 144.5, 139.7, 135.6, 135.5, 130.09, 130.07, 129.5, 128.1, 127.9, 
127.0, 121.7, 114.6, 113.2, 105.0, 86.8, 86.5, 86.3, 72.0, 67.3, 65.4, 65.3, 63.5, 55.2, 42.2, 
28.8, 28.5, 28.4, 25.8, 25.7, 11.7. IR (thin film); νmax (cm
−1
) = 3346, 3060, 2934, 1757, 
1663, 1532, 1509, 1251, 1177, 1091, 735. HRMS (ESI-MS) m/z calculated for 
C46H52N2O10Na
+ 





6a (0.200 g, 0.266 mmol) and DIPEA (0.051 g, 0.398 mmol) were dissolved in 
THF (2.5 mL), followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride 
(0.076 g, 0.319 mmol). The reaction was allowed to stir at room temperature for 30 min, 
where TLC revealed the presence of starting material. DIPEA (0.006 g, 0.049 mmol) 
followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride (0.011 g, 0.045 
mmol) were added and the reaction was allowed to proceed for another 30 min. Upon 
completion, the reaction was quenched by the addition of ethyl acetate (50 mL), and the 
solution was washed with sodium bicarbonate (3%, 2 x 25 mL) and brine (25 mL). The 
107 
 
organic layer was dried over sodium sulphate, decanted, and evaporated. The product, a 
colorless powder, was precipitated from hexanes (0.116 g, 46.2 %).  
Rf (SiO2 TLC): 0.49, 0.67 hexanes : ethyl acetate (2 : 8). λmax(ACN) = 276 nm. 
1
H 
NMR (500 MHz, d6-acetone, ppm): 7.90-7.94 (s, 1H, H6), 7.46-7.51 (m, 2H, Ar), 7.24-
7.39 (m, 9H, Ar), 6.89-6.96 (m, 7H, Ar), 6.31-6.36 (m, 1H, H1’), 4.73-4.75 (m, 3H, H3’, 
PhOCH2CO), 4.33 (m, 2H, ArOCH2), 4.18-4.24 (m, 3H, H4’ & CH2OCO), 3.60-3.89 (m, 
10H, CH2OP, OCH3), 3.40-3.50 (m, 2H, H5’, H5’’), 2.76 (t, 2H. CH2CN), 2.54-2.63 (m, 
4H, H2’,CH2CN), 2.35-2.42 (m, 1H, H2’’), 1.79-1.81 (m, 4H, (CH2)2), 1.57-1.61 (m, 3H, 
ArCH3), 1.17-1.23 (m, 9H, CH3), 1.09-1.10 (m, 3H, CH3). 
31
PNMR (202.3 MHz, d6-
acetone, ppm): 148.28, 148.08. 
13
C NMR (125.7 MHz, d6-acetone, ppm): 170.00, 169.99, 
168.6, 158.9, 158.2, 154.7, 144.9, 140.1, 140.0, 135.7, 135.64, 135.62, 135.58, 130.18, 
130.15, 129.4, 128.2, 128.1, 127.9, 127.0, 126.9, 121.1, 117.9, 114.5, 113.1, 103.5, 103.4, 
86.64, 86.60, 86.0, 85.9, 85.5, 85.3, 85.2, 73.1, 66.1, 64.3, 63.2, 63.0, 58.7, 58.5, 54.70, 
54.68, 43.1, 43.0, 40.4, 40.3, 25.1, 25.0, 24.05, 24.03, 23.99, 23.9, 19.9, 19.84, 19.79, 
13.6, 11.17, 11.16. IR (thin film); νmax (cm
−1
) = 3060, 2966, 1758, 1671, 1607, 1508, 
1330, 1251, 1180, 1034, 755. HRMS (ESI-MS) m/z calculated for C52H63N4O11PNa
+
 





6b (0.205 g, 0.242 mmol) and DIPEA (0.050 g, 0.390 mmol) were dissolved in 
THF (1 mL), followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride 
(0.073 g, 0.310 mmol). The reaction was allowed to stir at room temperature for 30 min, 
where TLC revealed the presence of starting material. DIPEA (0.006 g, 0.049 mmol) 
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followed by N,N-diisopropylaminocyanoethylphosphonamidic chloride (0.011 g, 0.045 
mmol) were added and the reaction was allowed to react another 30 min. Upon 
completion, the reaction was quenched by the addition of ethyl acetate (50 mL), and the 
solution was washed with sodium bicarbonate (3%, 2 x 25 mL) and brine (25 mL). The 
organic layer was dried over sodium sulphate, decanted, and evaporated. The product, a 
colorless powder, was precipitated from hexanes (0.079 g, 32.2 %).  
Rf (SiO2 TLC): 0.70, 0.83 hexanes : ethyl acetate (2 : 8). λmax(ACN) = 276 nm. 
1
H 
NMR (500 MHz, d6-acetone, ppm): 7.90-7.93 (s, 1H, H6), 7.46-7.51 (m, 2H, Ar), 7.24-
7.39 (m, 9H, Ar), 6.89-6.97 (m, 7H, Ar), 6.31-6.36 (m, 1H, H1’), 4.72-4.75 (m, 3H, H3’, 
PhOCH2CO), 4.29 (m, 2H, ArOCH2), 4.16-4.25 (m, 3H, H4’ & CH2OCO), 3.60-3.90 (m, 
10H, CH2OP, OCH3), 3.40-3.52 (m, 2H, H5’, H5’’), 2.76 (t, 2H. CH2CN), 2.53-2.63 (m, 
4H, H2’,CH2CN), 2.34-2.42 (m, 1H, H2’’), 1.71-1.77 (m, 2H, CH2), 1.57-1.68 (m, 5H, 
CH2 & ArCH3), 1.37-1.44 (m, 6H, (CH2)3), 1.16-1.23 (m, 9H, CH3), 1.09-1.10 (m, 3H, 
CH3). 
31
PNMR (202.3 MHz, d6-acetone, ppm): 148.28, 148.08.
 13
C NMR (125.7 MHz, 
d6-acetone, ppm): 170.09, 170.08, 168.6, 158.9, 158.2, 154.7, 145.0, 140.0, 139.9, 135.7, 
135.64, 135.62, 135.58, 130.18, 130.16, 129.4, 128.20, 128.15, 127.87, 127.86, 126.91, 
126.88, 121.2, 118.1, 117.9, 114.5, 113.2, 103.54, 103.46, 86.64, 86.61, 86.0, 85.9, 85.51, 
85.47, 85.3, 73.6, 73.5, 73.1, 66.6, 64.8, 64.6, 63.2, 63.0, 59.7, 58.7, 58.5, 54.71, 54.69, 
43.1, 43.0, 40.4, 40.3, 25.7, 25.5, 24.1, 24.04, 24.01, 23.9, 19.91, 19.85, 19.8, 13.7, 11.20, 
11.18, 11.14. IR (thin film); νmax (cm
−1
) = 3060, 2965, 1758, 1671, 1607, 1509, 1252, 
1180, 1086, 1035, 755. HRMS (ESI-MS) m/z calculated for C55H69N4O11PNa
+
 





3.2.3 Oligonucleotide synthesis and purification 
DNA duplexes (XLTT4 and XLTT7, whose sequences are shown in Figure 3.1) 
and single stranded DNA (control strands, O
4
-butyl-4-ol dT (T4) and O
4
-heptyl-7-ol dT 
(T7)), were assembled on an Applied Biosystems Model 3400 synthesizer on a 1 µmole 
scale employing standard β-cyanoethylphosphoramidite cycles as described in Section 
2.2.3 with the modifications indicated below. 
The modified 3’-O-2’-deoxyphosphoramidites (7a and 7b) were dissolved in 
anhydrous ACN to a concentration of 0.15 M and the modified bis-3’-O-2’-
deoxyphosphoramidites (4a and 4b) to 0.05 M. The coupling times for the modified 
phosphoramidites 7a and 7b were 10 min. For the modified bis-phosphoramidite 4a and 
4b the coupling times were 30 min.  
The oligomer-derivatized CPG support was removed from the column and placed 
into screw cap microfuge tubes fitted with teflon lined caps. The oligonucleotides 
containing O
4
dT modifications were removed from the support by incubation of the CPG 
in 500 μL of a 10% DBU in the respective alcohol (1,4-butanediol for O4-butyl-4-ol dT 
and 1,7-heptanediol for O
4
-heptyl-7-ol dT), or ethanol for cross-linked oligonucleotides, 
for 5 days in the dark at room temperature. The DBU was neutralized with acetic acid 
and the DNA solubilised in ACN prior to being transferred into clean vials to eliminate 
the CPG. The DNA was dried down in a speed vacuum and then desalted using C-18 SEP 
PAK cartridges (Waters Inc.) prior to purification. 
The cross-link and mono-adduct final products were purified from pre-terminated 
products by 20% 7 M urea denaturing PAGE (19 : 1) using 1 X TBE (89 mM Tris HCl, 
89 mM boric acid, 2 mM EDTA (pH 8.0)) as running buffer to eliminate any residual 
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DBU, which could not be removed by SAX-HPLC. Prior to gel separation, 25 O.D. of 
each sample were dried via a speed-vac concentrator and resuspended in 100 μL of 
formamide. The bands corresponding to the desired products were excised from the gels 
and placed into 15 mL falcon tubes and the gel slices submerged in 0.1 M sodium acetate. 
The tubes were allowed to shake overnight and the extracted oligomers desalted using C-
18 SEP PAK cartridges. 
3.2.4 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
ESI mass spectra and exonuclease analysis for oligonucleotides were obtained as 
described in Section 2.2.4. 
The retention times of the eluted peaks were compared to the standard nucleotides 
which eluted at the following times: dC (4.4 min), dG (7.5 min), dT (8.2 min), dA (9.2 
min), O
6
-MedG (12.0 min), O
4
-MedT (13.4 min), O
4
-Butyl-4-ol dT (15.3 min), O
4
-
Heptyl-7-ol dT (25.6 min) and the cross-link dimers (21.7 for the four carbon and 29.9 
min for the seven carbon cross-link), and the ratio of nucleosides was determined. The 
molecular weights of the modified oligomers were determined by ESI-MS, which 
correlated with the calculated mass. 
3.2.5 UV thermal denaturation studies 
Thermal denaturation studies were performed and processed as described in 
Section 2.2.5. 
Thermodynamic parameters of the non-crosslinked control DNA were obtained by 
performing thermal denaturation studies in triplicate at concentrations of 0.6, 2.7, 12.6 
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and 58.5 μM duplex DNA in 1, 0.5, 0.2 and 0.1 cm cuvettes, respectively. A plot of 
ln(Ctot) as a function of 1/Tm, typically used for a non-self-complimentary bimolecular 
systems, was employed to obtain ΔH˚ and ΔS˚ for the system as described by Puglisi and 
Tinoco.(191) A similar procedure was employed with the cross-linked DNA at 
concentrations of 0.6 and 2.7 μM. The Tm of the ICL were independent of oligonucleotide 
concentration due to the uni-molecular nature of the DNA and therefore the 
thermodynamic parameters were obtained by plotting ln(K) versus 1/T at a single 
concentration of 2.95 μM. The experiments were performed in triplicate. (see Appendix 
III). 
3.2.6 CD spectroscopy  
CD experiments were carried out as described as in Section 2.2.6. 
3.2.7 Protein expression and purification  
All proteins were purified under native conditions as described in Section 2.2.8. 
3.2.8 Mono-adduct repair assay 
A general oligonucleotide sequence was created with a BclI cut site to monitor the 
amount of repair of mono-adduct based on restriction digestion. The sequence of the 





-butyl-4-ol dT (T4) or O
4
-heptyl-7-ol dT (T7). The 
sequence of the complement strand was 5’ CTG GT/G ATC AAG CC where the "/" 
represent the BclI cut site.  
The damage containing strand was 
32
P labelled at its 5’ end as previously 
described.(14) Briefly, a 20 µM solution of DNA was made in 1X PNK buffer along with 
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1 μL [γ-32P]ATP (10 μCi/μL) and 5 units of T4 PNK. The labelling reaction was 
conducted for 1 h at 37 °C after which the reaction was terminated by boiling the sample 
for 10 min. 
40 pmol of labelled DNA was added to 50 pmol of the complement strand in a total 
volume of 20 µL of water making a 2 µM dsDNA solution with 20 % excess of the non-
damaged strand. The solution was boiled for 5 min, cooled slowly to room temperature 
and placed at 4 °C overnight to ensure proper duplex formation. 
The repair reaction mixtures were constituted of 2 pmol of the duplex DNA and 10 
pmol of AGT in a total volume of 15 µL in Activity Buffer (10 mM Tris HCl (pH 7.6), 
100 mM NaCl and 1 mM DTT) and allowed to react at 37 °C for 30 min, unless 
otherwise indicated. The reaction was terminated by boiling for 10 min. Prior to BclI 
digestion, MgCl2 was added at a final concentration of 10 mM and the reaction mixture 
allowed to cool to room temperature. 7.5 units (0.5 µL) of BclI was added to the mixture 
and the solution incubated for 1 h at 37 °C. 24 µL of stop buffer (81 mM Tris HCl, 81 
mM boric acid, 1.8 mM EDTA and 1% SDS (pH 8.0) in 80 % formamide) was added, 
boiled for 10 min and loaded on a 14 cm × 16 cm, 20 % 7 M urea denaturing 
polyacrylamide gel (19 : 1) for separation. The gels were run using 1 X TBE for 40 min 
at 400 V and the gels exposed to a storage phosphor screen. The image was captured on a 
Typhoon 9400 (GE Healthcare, Piscataway, NJ) and the autoradiography counts obtained 
by ImageQuant™ (Amersham Biosciences). 
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3.2.9 Binding studies of C145S hAGT variant with mono-adduct 
substrates 
Binding reactions of the 14 bp mono-adduct DNA substrates consisted of 0.5 nM 
dsDNA (where an excess of 5% of undamaged strand was present to force duplex 
formation) and increasing C145S hAGT (ranging from 1 to 35.69 μM) in a total solution 
volume of 20 μl of binding buffer (10 mM Tris HCl (pH 7.6), 100 mM NaCl, 1 mM 
DTT, 10 μg mL-1 BSA and 2.5 % glycerol). The samples were equilibrated for 30 min at 
room temperature and loaded on a 10 % native polyacrylamide gel (75 : 1) and pre-ran 
with 10 mM Tris acetate (pH 7.6) and 100 mM NaCl. Electrophoresis was carried out at 
21 °C at 100 V for 45 min.  
3.2.10 Cross-link repair assay 
Cross-link repair assays were performed as described in Section 2.2.10. 
3.2.11 Binding studies of C145S hAGT variant with cross-linked 
substrates 
Binding reactions were conducted as for the mono-adduct substrates with minor 
modifications due to the different substrate size. Binding reactions consisted of 0.5 nM 
dsDNA, increasing C145S AGT ranging from 1 to 45.5 μM for the control duplex and 
from 1 to 6.5 μM for the cross-linked DNA in a total solution volume of 20 μl of binding 
buffer. The samples were equilibrated for 1 h at room temperature and loaded on a 15 % 
native polyacrylamide gel (75:1) and ran with 0.5 X TBE, which allowed the 
electrophoresis voltage to be increased without heating the system. Electrophoresis was 
carried out at 21 °C at 250 V for 25 min. 
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The monomeric dissociation constant (Kd) and stoichiometry (n) of AGT binding to 
DNA were obtained from the EMSA as described previously.(14) The binding of n 
molecules of AGT protein [P] to 1 molecule of DNA [D] can be expressed by the 
equation: nP + D ↔ PnD. Taking the logarithm and rearranging the variables yields: log 
([PnD]/[D]) = n log [P]free + log Kd. 
The data can be expressed with a plot of log [PnD]/[P] as a function of log [P]. The 
slope of the graph represents the stoichiometry (n) and the observed Kd can be obtained 
by the relationship: Kd = 10
-(y-intercept)
. The monomeric Kd shown in the tables was 
obtained by taking the nth root of the observed Kd. 




-butyl-4-ol dT in hAGT active 
site 





-MedT. The placement of O
4
-MedT was verified with PDB 
1YFH. PDB 1T38 was used as the template for hAGT where Ser 145 was mutated back 
to Cys and the proper rotamer used as based on PDBs 1T39, 1EH6 and 1YFH. This 
primary model was used as the template for the addition of the butyl-4-ol adduct, which 
was added manually by PyMol.  
The preliminary models underwent conjugate gradient minimization, simulated 
annealing, and torsion angle dynamics using Crystallography & NMR System.(222) 
CHARMM (Chemistry at HARvard Macromolecular Mechanics) topology files were 
modified to use the altered nucleotides by adding restraints to keep the α-carbon of the 
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lesion in a syn conformation with respect to the N3 atom of the base, as observed in 
PBDs 1T38, 1T39, and 1YFH.(223)  
The models were subjected to 2 sets of 100 steps of gradient minimization and 200 
steps of simulated annealing. The first cycle was carried out at 500 K with slow cooling 
at a rate of 4.5 K per cycle of dynamics. The second cycle was carried out at 350 K with 
slow cooling at a rate of 2.5 K per cycle of dynamics. The minimized models were 
displayed using PyMol with the absence of a few amino acids for clarity of the active 
site. 
3.3 Results and discussion 
3.3.1 Chemical synthesis of modified nucleosides 




dT cross-links and the mono-adducts are 
shown in Figure 3.1 in addition to the sequences of the respective cross-links (XLTT4 





dT cross-linked bis-phosphoramidites 4a and 4b, containing a four and 
seven carbon linker, is shown in Scheme 3.1. The convertible nucleoside 3’-O-(t-
butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-thymidine was 
transformed into adducts 1a or 1b with the sodium salt of 1,4-butanediol or 1,7-
heptanediol, respectively.(221) Reacting either 1a or 1b with the convertible nucleoside 
yielded the fully protected dimers 2a and 2b. The 3’-OH groups of these compounds, 
protected as silyl ethers, were liberated by treatment with TBAF to produce compounds 
3a and 3b which were then phosphitylated with N,N-
diisopropylaminocyanoethylphosphonamidic chloride in the presence of DIPEA to 
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produce bis-phosphoramidites 4a and 4b. 
31
P NMR signals at 148.07 and 148.28 ppm for 
4a and 148.07 and 148.28 ppm for 4b confirmed the presence of the phosphoramidite 



































3a, 3b (R =H)














Reagents and conditions: (i) sodium salt of 1,4-butanediol or 1,7-heptanediol, dioxane. 
(ii) 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-
thymidine, DBU, pyridine.(iii) TBAF (1M in THF), THF. (iv) N,N-
diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, THF. 
The mono-adduct lesions were introduced at the O
4
 atom of dT as shown in 
Scheme 3.2. Starting with compounds 1a or 1b, the free terminal alcohol functionality of 
these adducts were protected with phenoxyacetyl chloride to yield 5a and 5b. The 3’-OH 
group of these nucleosides were exposed prior to the phosphitylation step by treatment 
with TBAF to yield 6a and 6b. They were then converted to phosphoramidites as 
confirmed by the presence of two diagnostic signals in 
31
P NMR at 148.08 and 148.28 













6a, 6b (R =H)












Scheme 3.2: Synthesis of O
4
-alkyl dT mono-adduct amidites 
Reagents and conditions: (i) phenoxyacetyl chloride, triethylamine, THF. (ii) TBAF (1M 
in THF), THF. (iii) N,N-diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, 
THF. 
3.3.2 Synthesis of modified and ICL DNA 
The solid-phase synthesis of cross-linked duplexes XLTT4 and XLTT7 were 
performed on a 1 µmol scale using either bis-phosphoramidite 4a or 4b to prepare the 
oligomers containing the four or seven carbon cross-link, respectively. Given the lability 
of the cross-link, ‘fast-deprotecting’ 3’-O-2’-deoxyphosphoramidites were employed (0.1 
M in ACN) with phenoxyacetic anhydride as the capping agent to prevent an undesired 
N-acetylation reaction that could occur if acetic anhydride was used.(196) Moreover, the 
directly opposed motif allows for ICL duplex synthesis without the need to remove 
additional protecting groups around the cross-linked site which could compromise the 
ICL or the use of 5’-O-2’-deoxyphosphoramidites. The 3’-O-bis-phosphoramidite 
concentrations of 4a and 4b in ACN were 0.05 M and allowed to couple for an extended 
period (30 min) to ensure both phosphoramidite functionalities would couple to two 
oligonucleotide chains on the solid-support, to ensure ICL formation.(175,224) Solid-
phase assembly of the duplex was completed by extension with 3’-O-2’-
deoxyphosphoramidites at the cross-linked site.  
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A variation to the standard oligonucleotide deprotection protocol was required due 
to the labile nature of O
4
-alkyl dT adducts. These milder deprotection conditions 
involved a solution of 10% DBU in anhydrous ethanol for 48 h at room temperature to 
reduce the likelihood of ICL cleavage linking the O
4 
atoms upon deprotection.(221) The 
crude deprotection mixture containing duplexes of XLTT4 and XLTT7 were purified by 
PAGE, rather than SAX HPLC, due to difficulties in removing excess DBU used in the 
deprotection step. The purified oligonucleotides were eluted from the gels and desalted. 
ESI mass spectrometry analysis of XLTT4 and XLTT7 revealed they had molecular 
weights of 6715.6 and 6758.3 Da (expected 6716.5 and 6758.6 Da), consistent with the 
expected values. The composition of the cross-linked oligomers XLTT4 and XLTT7 
were further confirmed by digestion to their constituent nucleosides with a mixture of 
snake venom phosphodiesterase and calf intestinal alkaline phosphatase followed by C-
18 reversed phase HPLC analysis. The presence of cross-linked nucleosides was 
established by the appearance of one additional peak, other than the four standard 
nucleosides, that eluted from the HPLC with retention times of 21.7 for the four carbon 




dT cross-link. The later elution of 
the seven carbon cross-link can be attributed to the greater hydrophobicity of the longer 
alkyl linker. The ratios extracted from the chromatogram of the component 2’-
deoxynucleosides and cross-linked nucleosides were in good agreement with the 
theoretical compositions. 
For the mono-adduct lesions, O
4
-butyl-4-ol dT and O
4
-heptyl-7-ol dT introduced in 
sequences T4 and T7, similar solid-phase synthesis conditions as described for the ICL 
substrates were employed. For these oligonucleotides, cleavage and deprotection 
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conditions involved the incubation of the CPG with a solution composed of 10% DBU in 
1,4-butanediol (for T4) or 1,7-heptanediol (for T7) for 5 days at room temperature to 
ensure that the adducts were not compromised.(221) The DBU was neutralized with 
acetic acid the CPG rinsed with ACN (50 % in water) to solubilize the fully deprotected 
product as a result of the poor solubility of DNA in the diols. These oligonucleotides 
were also characterized by ESI mass spectrometry and nuclease digestion to ensure their 
composition. 
3.3.3 UV thermal denaturation studies 




dT ICL on duplex stability was 
assessed through UV thermal denaturation experiments. The melting profiles of XLTT4 
and XLTT7, shown in Figure 3.2, exhibit a sigmoidal denaturation and 
hyperchromicities comparable to the control duplex containing a T-A base pair instead of 
the cross-link. The melting temperatures observed for the cross-linked oligonucleotides 
XLTT4 and XLTT7 were 66 and 50 °C, respectively, higher than the control duplex 
(with a Tm of 44 °C).  
This melting temperature trend has been observed earlier by our group for duplexes 




dG mismatch present in an 11-bp duplex 
with increases of 23 and 33 °C in Tm for the heptylene and butylene linkages, 
respectively, over the control duplex.(145) This same tendency has also been reported 
when ICL of various lengths are introduced between the N3
 
atoms of dT where an 
increase in Tm of 16 and 31 °C were observed for heptylene and butylene linkages over 





Figure 3.2: Absorbance (A260) versus temperature profiles of cross-linked duplexes 
XLTT4 (― ―), XLTT7 (- - -) and non-cross-linked DNA (―) 
Thermodynamic parameters of the ICL and control duplexes were studied to 
investigate the origin of the increased thermal stability observed for the ICL DNA (Table 
3.1). Varying duplex concentration did not affect the Tm observed for the ICL duplexes 
but did influence that of the control, as expected. The thermodynamic parameters indicate 
a reduction in the enthalpy for the ICL containing duplex, which was more pronounced 
for the heptyl versus butyl linker. Possible reasons include disruption of the base pairs 
and base stacking around the cross-linked site as a result of steric effects of the larger 
linker. 
Table 3.1: Thermodynamic parameters of DNA Duplexes 
DNA ΔH˚ (KJ/mol) ΔS˚ (J/(mol K) 
Control (T-A) -298 ± 23 -823 ± 71 
XLTT4 -249 ± 7 -735 ± 20 
XLTT7 -179 ± 4 -551 ± 12 
The presence of the ICL caused an increase in the entropy of the duplex due to the 
preorganized nature of the unimolecular system thus favouring thermal stability of the 
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DNA. The contribution of the increased entropy outweighed the negative enthalpic effect 
in the ICL system, consistent with what has been previously observed with ICL formed 
by trans-diamminedichloroplatinum(II).(226) 
The influence of alkyl chain length of the mono-adducts at the O
4
 atom of dT on 





-butyl-4-ol dT (T4) or O
4
-heptyl-7-ol dT (T7) (48 °C) 
compared to the non-alkylated control (58 °C) demonstrating that for these adducts the 
length of the alkyl chain attached at the O
4
 atom of dT had no substantial effect on duplex 
stability (see Appendix III). These results are supported by previous studies 
demonstrating that O
4
-ethyl dT/dA base pair within a duplex decreased the Tm by 14°C 
with respect to the native control.(227) 
3.3.4 CD spectroscopy of DNA duplexes 
CD spectra of the cross-linked duplexes XLTT4 and XLTT7 exhibited signatures 
characteristic of B-form DNA with a positive signal centered around 275 nm, a crossover 
around 260 nm and a negative signal around 250 nm as shown in Figure 3.3.(200,201) 




dT ICL caused minimal distortion to the 
global B-form structure.  




-butyl-4-ol dT (T4) or O
4
-heptyl-7-ol 
dT (T7), showed little deviation in their CD signature relative to the unmodified control 
duplex demonstrating minimal distortion from the global B-form structure. These 
findings are in agreement with NMR reports on O
4
-MedT containing duplexes that 





Figure 3.3: Far-UV CD spectra of cross-linked duplexes XLTT4 (― ―), XLTT7 (- - -) 
and non-cross-linked DNA (―). 
3.3.5 Repair and binding of AGTs with cross-linked and mono-
alkylated substrates 
Repair studies conducted on the XLTT4 and XLTT7 duplexes revealed that none 
of the AGT proteins from human or E. coli were able to completely eliminate the cross-
links, as observed in Figure 3.4. Moreover none of the proteins were able to create the 
intermediate product, which consists of one repair step leading to an AGT-ssDNA 
species.(146,214)  
EMSA were conducted with XLTT4, XLTT7 and a non cross-linked control 
duplex, which has a T-A match where the T-T cross-link is located, to determine if the 
lack of activity of hAGT towards these lesions was inherent to the binding and detection 





Figure 3.4: Repair gel of XLTT4 and XLTT7 by hAGT, Ada-C and OGT.  
Denaturing gel of the repair of 2 pmol of DNA by 60 pmol of AGT. Lane 1, Control 
DNA; lane 2, XLGG7 + hAGT; lane 3, XLTT4; lane 4, XLTT4 + hAGT; lane 5, 
XLTT4 + Ada-C; lane 6, XLTT4 + OGT; lane 7, Control DNA; lane 8, XLGG7 + 
hAGT; lane 9, XLTT7; lane 10, XLTT7 + hAGT; lane 11, XLTT7 + Ada-C; lane 12, 
XLTT7 + OGT. 
Results of the EMSA indicate that the hAGT stoichiometry for the various DNA 
was the same with two proteins for every 11-bp duplex (see Appendix III). These results 
are consistent with findings of others, which stipulates that hAGT binds every 4 
nucleotides.(167,168) This stoichiometry was the same for the cross-linked DNA and for 
the control demonstrating that the presence of the cross-link did not affect how hAGT 
interact together when bound to the DNA. The dissociation constant of the control duplex 
was much higher than the cross-links, which was unanticipated. 
To address the low binding affinity of hAGT for the control duplex a set a oligos 
were designed where the central dT in the control sequence (5' CGA AAT TTT CG) was 
replaced by the other 3 natural 2’-deoxynucleotides and assessed for binding by hAGT. 
Binding reactions were conducted over a large range of protein to obtain a rough estimate 
of the Kd for the hAGT-DNA complexes. Results indicate that hAGT preferentially binds 
to DNA with a dG nucleotide that is further than 2 nucleotides from the ends (see 
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Appendix III). This same hAGT binding trend has been observed for long A-T 
tracts.(164) The lack of a central dG explains the low binding affinity observed for the 
control sequence. The increased binding affinity observed for XLTT4 and XLTT7 over 
the control may be attributed to a hydrophobic interaction between alkyl adduct and 
hAGT, which has been proposed previously as the basis of substrate discrimination by 




-BndG over dG.(148) 
Experiments probing the repair of larger alkyl adducts at the O
4
 atom of dT show a 
different trend than the ones observed for methylation (see Appendix III). For the larger 
lesions, O
4
-butyl-4-ol dT and O
4
-heptyl-7-ol dT, only OGT showed any ability to remove 
these adducts to a reasonable level, indicating only OGT out of all 3 proteins is capable 
of repairing large lesions at the O
4
 atom of dT. 
To assess the lack of repair of the adducts at the O
4
 atom of dT by hAGT, binding 
assays were conducted. A general trend from the EMSA could be observed for the 
binding affinity of hAGT to the various mono-adduct DNA (see Appendix III). First, 
hAGT had very similar binding affinities to all mono-adduct DNA, which was roughly 
1.8 times better than the non-alkylated control. Second, hAGT bound O
4
-alkyl dT lesions 
with very similar affinities as it did O
6
-MedG and the size of the lesion at the O
4
 atom of 
dT had no substantial effect on binding for the various alkyl chains. 
The observed increase in binding affinity for the adduct or ICL containing DNA 
and hAGT over their unalkylated controls suggests hAGT is capable of flipping out the 
alkylated dT and placing the lesion into its active site as required for repair, as 











-butyl-4-ol dT in hAGT active 
site 
To understand the underlying substrate discrimination observed for AGT with 
respect to the mono-adducts, molecular modelling was performed. hAGT is the only 
AGT that has been co-crystallized with a DNA substrate providing valuable insight into 
its active conformation. The substrate differences observed between various AGT 
homologues suggest substantial variations in the active sites amongst proteins. Attempts 
to model methyl and butyl-4-ol adducts with a homology model of OGT based on hAGT 
(generated from PDB 1T38) were performed. However, the minimized structures did not 
correlate with the experimental evidence. Our modelling results suggests the methyl 
adduct fits in the active site of hAGT without steric clashes. The model of the butyl-4-ol 
adduct proposes a steric clash in the active site of the protein between the γ-carbon of the 
lesion and the protein due to the adoption of the gauche conformation at the β-carbon of 
the adduct. This interaction causes Cys 145 to adopt the incorrect rotamer for the alkyl 
transfer reaction to take place when the butyl-4-ol adduct is present. In the hAGT repair 
mechanism, His 146 is responsible for proton abstraction of a nearby water molecule 
from Cys 145 allowing the formation of the thiolate anion. In the case where Cys 145 is 
rotated away from His 146 (as observed for the butyl-4-ol lesion) the thiolate anion will 








-butyl-4-ol dT in the active site of hAGT  
The adopted rotamer of Cys 145 are shown for O
4
-MedT (cyan) and O
4
-butyl-4-ol dT 
(pink) and His 146 in grey. 
3.4 Conclusions 




dT ICL were synthesized 
using a convertible nucleoside strategy to prepare a cross-linked nucleoside dimer that 
was converted into a bis-phosphoramidite. Solid phase synthesis was employed to 
incorporate the cross-link into a specific orientation and position in a DNA duplex. This 
method is versatile and allows for various linker lengths to be introduced for numerous 
studies including DNA repair. ICL duplexes containing a four and seven carbon linker 
evaded repair from various AGT proteins from human and E. coli. 
Studies to investigate AGT proteins that can be engineered to repair these ICL and 
their repair by other systems are ongoing to enhance our understanding of how ICL 
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lesions may be processed. Furthermore this may result in increasing the potency of 
bifunctional chemotherapeutic agents which create ICL lesions and hopefully limit their 
mutagenicity and other side effects such as the onset of resistance to these drugs. 
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Preparation of Covalently Linked Complexes Between DNA and 
O
6
-Alkylguanine-DNA Alkyltransferase Using Interstrand Cross-





Graphical Abstract: Representation of hAGT-ICL covalent complex 
Published as:  
McManus FP, Khaira A, Noronha AM, Wilds CJ. 




AGT are responsible for the removal of alkylation at both the O
6
 atom of dG and O
4
 atom 
of dT. AGT homologues show vast substrate differences with respect to the size of the 
adduct and which alkylated atoms they can restore. hAGT has poor capabilities for the 
removal of methylation at the O
4 
atom of dT, which is not the case in the majority of 
homologues. No structural data is available to explain this poor hAGT repair. We 









(XLGT7) ICL DNA as probes for hAGT, OGT and Ada-C for the formation of DNA-
AGT covalent complexes. XLGT7 reacted only with hAGT and did so with a cross-
linking efficiency of 25%, while XLGT4 was inert to all AGT tested. The hAGT 
mediated repair of XLGT7 occurred slowly, on the order of hours as opposed to the 
repair of O
6
-MedG which requires seconds. Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis of the repair reaction revealed the formation of a 
covalent complex with an observed migration in accordance with a DNA-AGT complex. 
The identity of this covalent complex, as determined by mass spectrometry, was 
composed of a heptamethylene bridge between the O
4
 atom of dT (in an 11-mer DNA 
strand) to residue Cys 145 of hAGT. This procedure can be applied to produce well 




Modified nucleic acids with novel properties have had a long standing interest and 
application in the field of bioorganic chemistry.(228) One example of how these probes 
can be employed involves the formation of covalent complexes with proteins where weak 
binding was previously observed leading to a wide range of applications.(229,230,231) 
Formation of covalent complexes for crystallographic purposes can be employed 
for various systems due to the control one can have on the nature of the chemical 
modification, which can be tailored to specific protein complexes.(232,233) For example, 
the structure of hAGT complexed with DNA has been determined with the aid of 
modified nucleic acids.(151,155) One of these structures, significant in enhancing our 
understanding of the mechanism of hAGT, contains a chemical cross-link formed 
between the hAGT active site and DNA containing the modified nucleoside N1,O
6
-
ethanoxanthosine. hAGT has also been employed in an elegant method to observe the 




AGT proteins, which are found in all kingdoms of life, are responsible for the 




-MedT lesions.(4,13,189) The mutagenicity of 
these lesions rise from the wobble base pair that these modified nucleotides adopt with 
respect to their natural compliments. These wobble base pairs adversely affect the 
processivity of DNA polymerase during DNA replication. O
6
-MedG adopts a non-
wobble base pair with dT causing a GC to AT transition while O
4
-MedT adopts a non-
wobble base pair with dG causing a TA to CG transition. These two modifications 
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account for 8% of the total DNA damage caused by MNU.(12) Endogenously, O
6
-MedG 
is formed at a rate of 10-30 events daily by S-adenosylmethionine.(46) 
The formation of O
6
-MedG is detrimental to cells where the bioaccumulation of 6 
650 O
6







-MedT is not affected by the levels of hAGT nor by 





-MedT in mammalian cells is believed to rely solely on the NER pathway.(31) 
hAGT and Ada-C, the most thoroughly characterized AGT proteins, repair 
alkylated DNA by flipping the damaged nucleotide out of the DNA duplex and into the 
active site where the alkyl group is transferred from the point of lesion to the active site- 
Cys residue.(173)
 
Once alkylated, this suicide protein is degraded by the ubiquitin 
pathway in mammalian cells.(104) There are interesting differences in the ability of 
AGTs to process alkylation damage. For example, hAGT is unable to process O
4
-MedT 
efficiently, unlike OGT and Ada-C.(117,131)
 
 
Mimics of the ICL generated by hepsulfam have been studied by our 
group.(146,214,235) Results from our previous work indicate hAGT, but not the E. coli 
homologues, can repair ICL that involve two O
6
 atoms of dG that are either directly 
opposed, in a 1,2 stagger or in the more clinically relevant 1,3 staggered orientation. On 
the other hand, ICL DNA containing a heptamethylene linkage bridging the O
4
 atoms of 
dT are inert to hAGT and the E. coli homologues. 





dT cross-links are described. The approach to prepare these ICL involves the method 
described by Swann's group to prepare a "convertible" dT to introduce an alkyl chain 
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with a terminal alcohol at the O
4
 atom of dT followed by a Mitsunobu reaction at the O
6
 
atom of protected dG to form the alkylene linkage (Figure 4.1A).(187,221) hAGT, OGT 





















































dT cross-links, (B) Oligonucleotides 
XLGT4 and XLGT7 and (C) AGT-DNA complex formed if XLGT4 and XLGT7 are 
repaired by AGT. 
Aside from providing further insight into the substrate discrimination patterns of 
the various AGT, these ICL DNA have a potential use for the preparation of site specific 
covalently liked AGT-DNA adducts. The formation of AGT-oligonucleotide complexes 
between the various nucleobases have been shown to occur with 1,2-dibromoethane, 
attributed to the formation of an S-(2-bromoethyl) intermediate.(236) In our approach, 
repair by AGT at the O
6
 atom of the modified dG by the active site Cys of AGT 
covalently links AGT to the O
4 
atom of dT by an alkylene linker. The added facet of this 
approach is the ease with which the ICL linker can be varied allowing control over the 
length and chemical nature of the tether between the O
4
 atom of dT and the active site of 
AGT (Figure 4.1C). 






-thymidine and N,N-diisopropylamino cyanoethyl phosphonamidic chloride were 
purchased from ChemGenes Inc. (Wilmington, MA). 5’-O-Dimethoxytrityl-2’-
deoxyribonucleoside-3’-O-(β-cyanoethyl-N,N’-diisopropyl)phosphoramidites and 
protected 2’-deoxyribonucleoside-CPG supports were purchased from Glen Research 
(Sterling, Virginia). All other chemicals and solvents were purchased from the Aldrich 
Chemical Company (Milwaukee, WI) or EMD Chemicals Inc. (Gibbstown, NJ). Flash 
column chromatography was performed using silica gel 60 (230–400 mesh) obtained 
from Silicycle (Quebec City, QC). Thin layer chromatography (TLC) was performed 
using precoated TLC plates (Merck, Kieselgel 60 F254, 0.25 mm) purchased from EMD 
Chemicals Inc. (Gibbstown, NJ). NMR spectra were recorded either on a Varian INOVA 
300 MHz NMR spectrometer or on a Varian 500 MHz NMR spectrometer at room 
temperature. 
1
H NMR spectra were recorded at a frequency of 300.0 MHz and chemical 





H decoupled) were recorded at a frequency of 202.3 MHz with H3PO4 used as 
an external standard. Ampicillin, IPTG, DTT, EASY-BLUE, Protein Stain and most other 
biochemical reagents including polyacrylamide gel materials were purchased from 
Bioshop Canada Inc (Burlington, ON). Ni-NTA Superflow Resin was purchased from 
Qiagen (Mississauga, ON). Complete, Mini, EDTA-free Protease Inhibitor Cocktail 
Tablets were obtained from Roche (Laval, QC) XL-10 Gold E. coli cells were obtained 
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from Stratagene (Cedar Creek, TX). T4 PNK and Unstained Protein Molecular Weight 
Marker were obtained from Fermentas (Burlington, ON). [γ-32P]ATP was purchased from 
Amersham Canada Ltd. (Oakville, ON). 







deoxyguanosine (0.150 g, 0.183mmol) was added 5′-O-dimethoxytrityl-3′-O-t-
butyldimethylsilyl-O
4
-(hydroxybutyl)-thymidine (0.135 g, 0.185mmol) and 
triphenylphosphine (0.208 g, 7.70 mmol) in dioxane (2 mL) followed by drop wise 
addition of DIAD (1.521 g, 7.52 mmol) at room temperature. After 30 min the solvent 
was evaporated in vacuo, the crude product taken up in ethyl acetate (100 mL) and the 
solution washed with two portions of 3% sodium bicarbonate (2 x 100 mL). The organic 
layer was dried over sodium sulphate (4g) and concentrated to produce a yellow gum. 
The crude product was purified by flash column chromatography using a hexane / ethyl 
acetate (3:7) solvent system to afford 0.166 g (59 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.17 hexane / ethyl acetate (3:7). 
1
H NMR (300 MHz, DMSO-d6, 
ppm): 10.63 (s, 1H, NH), 8.45 (s, 1H, H8), 7.93 (s, 1H, H6), 7.46-6.79 (m, 31H, Ar), 
6.45-6.40 (dd, 1H, H1’a, J=6.3Hz), 6.23-6.17 (dd, 1H, H1’b, J=6.6), 5.06 (s, 2H, 
PhOCH2CO), 4.74-4.70 (m, 1H, H3’a), 4.68-4.63 (t, 2H, CH2-O
6
), 4.50-4.46 (m, 1H, 
H3’b), 4.43-4.39 (m, 2H, CH2-O
4
), 3.95-3.90 (m, 2H, H4’a & H4’b), 3.78 (s, 6H, O-
CH3), 3.76 (s, 6H, O-CH3), 3.42-3.22 (m, 4H, H5’a, H5”a, H5’b & H5”b), 3.04-2.97 (m, 
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1H, H2’a), 2.43-2.28 (m, 3H, H2”a, H2’b & H2”b), 2.03-1.90 (m, 4H, O4-CH2-CH2-CH2-
CH2-O
6
), 1.64 (s, 3H, C5-CH3), 0.83 (s, 18H, Si-C(CH3)3), 0.06 (s, 6H, Si-CH3), 0.01 (s, 
3H, Si-CH3), 0.00 (s, 3H, Si-CH3). HRMS (ESI-MS) m/z calculated for C86H104N7O15Si2
+ 









deoxyguanosine (0.700 g, 0.851 mmol) was added 5′-O-dimethoxytrityl-3′-O-t-
butyldimethylsilyl-O
4
-(hydroxyheptyl) thymidine (0.600 g, 0.774 mmol) and 
triphenylphosphine (0.850 g, 3.25 mmol) in dioxane (8.46 mL) followed by drop wise 
addition of DIAD (0.720 g, 3.56 mmol) at room temperature. After 22 hours the solvent 
was evaporated in vacuo, the crude product taken up in ethyl acetate (100 mL) and the 
solution washed with two portions of 3% sodium bicarbonate (2 x 100 mL). The organic 
layer was dried over sodium sulphate (4g) and concentrated to produce a yellow gum. 
The crude product was purified by flash column chromatography using a hexane / ethyl 
acetate (1:1 → 4:6) solvent system to afford 0.77 g (70 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.33 hexane / ethyl acetate (4:6). 
1
H NMR (300 MHz, CDCl3, ppm): 
8.72 (s,1H, NH), 8.10 (s, 1H, H8), 8.00 (s, 1H, H6), 7.50-6.84 (m, 31H, Ar), 6.52-6.48 
(dd, 1H, H1’a, J=6.6 Hz), 6.43-6.39 (dd, 1H, H1’b, J=6.0 Hz), 4.86 (s, 2H, PhOCH2CO), 
4.68-4.64(m, 2H, CH2-O
6
), 4.58-4.52 (m, 1H, H3’a), 4.46-4.41 (t, 2H, CH2-O
4
), 4.19-
4.16 (m, 1H, H3’b), 4.05-4.01 (m, 2H, H4’a & H4’b), 3.86 (s, 6H, O-CH3), 3.84 (s, 6H, 
O-CH3), 3.60-3.31 (m, 4H, H5’a, H5’’a, H5’b & H5’’b), 2.82-2.73 (m, 1H, H2’a), 2.61-
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2.48 (m, 2H, H2’’a& H2’b), 2.32-2.24 (m, 1H, H2’’b), 2.00-1.95 (m, 2H, R-CH2-CH2-
O
6
), 1.85-1.80 (m, 2H, R-CH2-CH2-O
4
), 1.66 (s, 3H, C5-CH3), 1.58 (m, 2H, R-CH2-CH2-
CH2-O
6
), 1.50 (m, 4H, R-CH2-CH2-CH2-CH2-O
4
), 0.93 (s, 9H, Si-C(CH3)3), 0.88 (s, 9H, 
Si-C(CH3)3), 0.12 (s, 3H, Si-CH3), 0.07 (s, 3H, Si-CH3), 0.00 (s, 6H, Si-CH3). HRMS 
(ESI-MS) m/z calculated for C89H110N7O15Si2
+ 









To compound 1a (0.150 g, 0.100 mmol) was added TBAF (1M in THF) (0.059 g, 
0.21 mmol) in THF (1 mL). After 30 min, the solvent was evaporated in vacuo and the 
crude product taken up in ethyl acetate (50 mL). The solution was washed with three 
portions of sodium bicarbonate (3 x 50 mL) followed by a two back extractions of the 
sodium bicarbonate washes with ethyl acetate (2 x 25 mL). The organic layer was dried 
over sodium sulphate, evaporated in vacuo and purified by flash column chromatography 
using an ethyl acetate / methanol (95:5) solvent system to afford 0.083 g (64 %) of 
product as a colorless foam.  
Rf (SiO2 TLC): 0.14 ethyl acetate / methanol (95:5). 
1
H NMR (300 MHz, DMSO-
d6, ppm): 10.60 (s, 1H, NH), 8.36 (s, 1H, H8), 7.81 (s, 1H, H6), 7.42-6.71 (m, 31H, Ar), 
6.43-6.38 (dd,1H,H1’a, J=6.3Hz), 6.22-6.17 (dd, 1H, H1’b J=6.3), 5.36-5.33 (m, 2H, 
OHa & OHb), 5.04 (s, 2H, PhOCH2CO), 4.63-4.58 (t, 2H, CH2-O
6
), 4.53-4.49 (m, 1H, 
H3’a), 4.39-4.34(m, 3H, CH2-O
4& H3’b), 4.02-3.95 (m, 2H, H4’a & H4’b), 3.74 (s, 6H, 
O-CH3), 3.72 (s, 3H, O-CH3), 3.71 (s, 3H, O-CH3), 3.32-3.08 (m, 4H, H5’a, H5’b,H5’’a 







). HRMS (ESI-MS) m/z calculated for C74H76N7O15
+ 









To compound 1b (0.760g, 0.480mmol) was added TBAF (1M in THF) (0.282 g, 
1.01 mmol) in THF (3 mL). After 30 min, the solvent was evaporated in vacuo and the 
crude product taken up in ethyl acetate (50 mL). The solution was washed with three 
portions of sodium bicarbonate (3 x 75 mL) followed by two back extractions of the 
sodium bicarbonate washes with ethyl acetate (2 x 25 mL). The organic layer was dried 
over sodium sulphate, evaporated in vacuo and purified by flash column chromatography 
using an ethyl acetate / methanol (199:1 → 19:1) solvent system to afford 0.620 g (95 %) 
of product as a colorless foam.  
Rf (SiO2 TLC): 0.20 ethyl acetate / methanol (49:1). 
1
H NMR (300 MHz, CDCl3, 
ppm): 8.79 (s,1H, NH), 8.02 (s, 1H, H8), 7.85 (s, 1H, H6), 7.43-6.78 (m, 31H, Ar), 6.59-
6.55 (dd, 1H, H1’a, J=6.6 Hz), 6.44-6.37 (dd, 1H, H1’b, J=6.3 Hz), 4.83 (m, 1H, OHa), 
4.72 (s, 2H, PhOCH2CO), 4.61-4.57 (m, 3H, CH2-O
6 & H3’a), 4.39-4.35 (t, 2H, CH2-O
4
), 
4.22-4.18 (m, 1H, H3’b), 4.16-4.11 (m, 2H, H4’a & H4’b), 3.80 (s, 6H, O-CH3), 3.77 (s, 
6H, O-CH3), 3.51-3.33 (m, 4H, H5’a, H5’’a, H5’b & H5’’b), 2.99 (m, 1H, OHb), 2.82-
2.76 (m, 1H, H2’a), 2.67-2.59 (m, 2H, H2’’a & H2’b), 2.32-2.23 (m, 1H, H2’’b), 1.93-
1.86 (m, 2H, R-CH2-CH2-O
6
), 1.76-1.70 (m, 5H, R-CH2-CH2-O
4





). HRMS (ESI-MS) m/z calculated for 
C77H82N7O15
+














2a (0.200 g, 0.154 mmol) and DIPEA (0.060 g, 0.461 mmol) were dissolved in 
THF (1.5 mL). Then N,N-diisopropylaminocyanoethylphosphonamidic chloride (0.091 g, 
0.383 mmol) was added dropwise and the reaction allowed to stir at room temperature for 
30 min. This was followed by two subsequent additions of DIPEA (2 x 0.012 g, 0.091 
mmol) and N,N-diisopropylaminocyanoethylphosphonamidic chloride (2 x 0.019 g, 0.081 
mmol) with 1 hour intervals. Upon completion the solvent was evaporated in vacuo, the 
crude product taken up in ethyl acetate (25 mL), and the solution washed with 3% sodium 
bicarbonate (25 mL) and brine (50 mL). The organic layer was dried over sodium 
sulphate, decanted, and evaporated. The product, a colorless powder, was precipitated 
from hexanes (0.221 g, 85 %).  
Rf (SiO2 TLC): 0.56, 0.61, 0.66, 0.73 ethyl acetate. 
31
P NMR (202.3 MHz, d6-
acetone, ppm): 153.61, 153.41, 153.40, 153.23. HRMS (ESI-MS) m/z calculated for 
C92H110N11O17P2
+












2b (0.200 g, 0.149 mmol) and DIPEA (0.058 g, 0.446 mmol) were dissolved in 
THF (1.5 mL). Then N,N-diisopropylaminocyanoethylphosphonamidic chloride (0.088 g, 
0.372 mmol) was added and the reaction allowed to stir at room temperature for 30 min. 
This was followed by two subsequent additions of DIPEA (2 x 0.012 g, 0.091 mmol) and 
139 
 
N,N-diisopropylaminocyanoethylphosphonamidic chloride (2 x 0.019 g, 0.081 mmol) 
with 1 hour intervals. Upon completion the solvent was evaporated in vacuo, the crude 
product taken up in ethyl acetate (25 mL), and the solution washed with 3% sodium 
bicarbonate (25 mL) and brine (50 mL). The organic layer was dried over sodium 
sulphate, decanted, and evaporated. The product, a colorless powder, was precipitated 
from hexanes (0.218 g, 84 %).  
Rf (SiO2 TLC): 0.50, 0.58, 0.67, 0.75 ethyl acetate. 
31
P NMR (202.3 MHz, d6-
acetone, ppm): 153.60, 153.40, 153.39, 153.22. HRMS (ESI-MS) m/z calculated for 
C95H116N11O17P2
+
 1745.8032: found 1745.8059 [M+H]
+
 
4.2.3 Oligonucleotide synthesis and purification 
DNA duplexes XLGT4 and XLGT7 were assembled as described in Section 3.2.3, 
with the modifications indicated below. 
Commercially available fast deprotecting 3'-O-2'deoxynucleoside phosphoramidites 
were dissolved in anhydrous ACN at a concentration of 0.1 M and the modified bis-3’-O-
2’-deoxyphosphoramidites (3a and 3b) at 0.05 M. Phosphoramidite coupling times for 
the commercial 3’-O-2’-deoxyphosphoramidites were 2 min and for the modified bis-
phosphoramidites 3a and 3b 30 min. 
Due to the presence of an O
4
-alkyl dT adduct deprotection of the oligonucleotide 
was achieved by incubating the CPG in 500 μL of 10% DBU in ethanol for 3 days in the 
dark at room temperature. 
XLGT4 and XLGT7 were purified as described in Section 3.2.3. 
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4.2.4 ESI-MS of small molecules and DNA 
ESI-MS of XLGT4 and XLGT7 were conducted at the Concordia University 
Centre for Biological Applications of Mass Spectrometry using a Micromass Q-tof2 mass 
spectrometer (Waters) equipped with a nanospray ion source. The mass spectrometer was 
operated in full scan, negative ion detection mode. ESI mass spectra for small molecules 
were recorded on a LTQ Orbitrap Velos-ETD (Thermo Scientific) in positive ion mode in 
ACN. 
4.2.5 Exonuclease digestion  
Exonuclease analysis of XLGT4 and XLGT7 were conducted as described in 
Section 2.2.4. 
The retention times of the eluted peaks were compared to the standard nucleotides 









dT (25.3 min), and the 
ratio of nucleosides was determined based on known extinction coefficients, aside from 










4.2.6 UV thermal denaturation studies 
The molar extinction coefficients for XLGT4 and XLGT7 were determined using 




) assuming a central G-C match. Thermal 
denaturation profiles were obtained and processed as described in Section 2.2.5. 
141 
 
4.2.7 CD spectroscopy 
CD signatures were obtained on a Jasco J-815 spectropolarimeter as described in 
Section 2.2.6. 
4.2.8 Protein expression and purification 
All AGT homologues were expressed under the promoter of the pQE30 vector in 
XL-10 Gold E. coli cells as described in Section 2.2.8. 
4.2.9 Cross-link repair assay 
Repair studies of XLGT4 and XLGT7 were performed as described in Section 
2.2.10. 
4.2.10 Identification of XLGT7 repair product by SDS-PAGE 
600 pmol of hAGT was incubated with 625 pmol of XLGT7 in 15 μL of Activity 
Buffer for 5 h at 37 °C. The reaction was terminated by adding 10 μL of SDS Buffer (125 
mM Tris HCl (pH 7.6), 2% SDS, 30% glycerol and 7.5% 2-mercaptoethanol), boiling the 
sample for 5 min and separated on a 15% SDS-PAGE. The gel was stained with EASY-
BLUE, Protein Stain as per the manufacturer's protocol. 
4.2.11 Identification of XLGT7 repair product by ESI-MS 
4000 pmol of hAGT was incubated with 1200 pmol of XLGT7 in 100 μL of 
Activity Buffer for 3 h at 37 °C. 10 μL of the sample was loaded on a Spursil® C-18 
column (3 µm, 2.1 mm × 150 mm) using an Agilent 1200 Series LC system at a flow rate 
of 0.2 mL/min with a gradient program of: 0-5 min, hold at 5% B; 5-30 min, linear 
gradient from 5% B to 50% B; 30-40 min, linear gradient from 50% B to 90% B; 40-42 
min, hold at 90% B; 42-50 min, linear gradient from 90% B to 5% B (buffer A, 0.1% 
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formic acid in water and buffer B, 0.1 % formic acid in ACN). ESI-MS was conducted on 
a Micromass Q-Tof Ultima API with the following conditions: source voltage 3.5 kV, 
mass range of 700-1999 m/z in positive ion mode. The theoretical masses of the hAGT-
DNA species were calculated to be either 25303.6 Da if the repair event occurred at the 
modified dG (21876.2 Da (hAGT) + 96.2 Da (Linker) + 3331.2 Da (CGAAATTTTCG)) 
or 25328.6 Da if the repair event occurred at the modified dT (21876.2 Da (hAGT) + 
96.2 Da (Linker) + 3356.2 Da (CGAAAGTTTCG)). 
4.2.12 Binding studies of C145S hAGT 
Cross-link binding assays were conducted as described in Section 3.2.11. 
4.3 Results 
4.3.1 Substrate preparation  









dT (3b) cross-linked amidites were prepared 
as shown in Scheme 4.1 which began with the nucleoside adduct containing a tetra- or 
heptamethylene linker with a terminal alcohol which was prepared by reacting the 
appropriate di-alcohol with 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-
(1,2,4-triazol-1-yl)-thymidine.(235) The 3' and 5' bis-protected dT adducts were 
subsequently reacted with 5'-O-dimethoxytrityl-3'-O-t-butyldimethylsilyl-N
2
-
(phenoxyacetyl)-2’-deoxyguanosine via a Mitsunobu reaction to give the fully protected 
dimers 1a and 1b.(188) Desilylation of the dimers gave 2a and 2b and was followed by a 
phosphitylation reaction yielding the cross-linked bis-amidites 3a and 3b, which were 
employed for solid phase synthesis. 
31
P NMR signals at 153.61, 153.41, 153.40 and 
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153.23 ppm for 3a and 153.60, 153.40, 153.39 and 153.22 ppm for 3b confirmed the 
presence of both phosphoramidite groups. As a result of the asymmetry for the 
phosphitylated cross-linked nucleosides four 
31


























1a, 1b (R = TBS)
2a, 2b (R =H)














Reagents and conditions: (i) 5'-O-dimethoxytrityl-3'-O-t-butyldimethylsilyl-N
2
-
(phenoxyacetyl)-2’-deoxyguanosine, triphenylphosphine, DIAD, dioxane. (ii) TBAF (1M 
in THF), THF. (iii) N,N-diisopropylamino cyanoethyl phosphonamidic chloride, DIPEA, 
THF. 
4.3.2 ESI-MS and exonuclease digestion of DNA 
XLGT4 and XLGT7 were analyzed by mass spectrometry to ensure that the base 
modifications were present after the deprotection and purification steps. The observed 
masses were in agreement with calculated values. 
XLGT4 and XLGT7 nucleoside compositions were confirmed by exonuclease 
digestion to their constituent nucleosides with a mixture of snake venom 
phosphodiesterase and calf intestinal alkaline phosphatase, then analyzed by C-18 
reversed phase HPLC. The presence of modified nucleosides was established by the 
appearance of additional peaks, aside from the four standard nucleosides, on the HPLC 
chromatogram. The extracted ratios of the component 2’-deoxynucleosides were in good 
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agreement with the theoretical compositions except for the lower than anticipated 
proportion of cross-linked modifications due to their assumed extinction coefficients.  
4.3.3 UV thermal denaturation studies 
The stability of XLGT4 and XLGT7 containing duplexes were determined by UV 
thermal denaturing studies by monitoring A260 at increasing temperatures, as illustrated in 
Figure 4.2. Both modified duplexes displayed sigmoidal denaturation patterns 
comparable to the control duplex. The presence of the ICL stabilized the DNA duplex 
with the 4 methylene linker having a greater contribution than the 7 methylene linker. 
The melting temperatures for XLGT4, XLGT7 and the control (G-C pair instead of a G-
T cross-link) were 68, 56 and 46 °C, respectively. 
 
Figure 4.2: Tm curves of XLGT4, XLGT7 and control DNA duplexes.  
Control DNA (_____), XLGT4 (_ _ _ _) and XLGT7 (……..). 
4.3.4 CD spectroscopy  
The alkylene linkers present in XLGT4 and XLGT7 showed little effect on overall 
secondary structure as indicated by the characteristic B-form DNA signatures observed 
for all samples with positive signals centered around 275 nm, cross overs around 260 nm 
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and negative signals around 250 nm, as shown in Figure 4.3.(200,201) These results 











Figure 4.3: Far-UV CD spectra of XLGT4, XLGT7 and control DNA duplexes. 
Control DNA (_____), XLGT4 (_ _ _ _) and XLGT7 (……..). 
4.3.5 Cross-link repair 
16 h repair reactions with the various AGT and XLGT4 or XLGT7 were 
conducted to detect the total amount of repair by the different AGT homologues. The 




dG ICL) incubated with hAGT was used as 
a marker since the various species produced by this reaction are known and aid in the 
identification of the various products formed in our assay, including two slowly 
migrating bands corresponding to AGT-DNA complexes that are believed to be either 
fully reduced or partially reduced by 2-mercaptoethanol.  
No appreciable repair was observed by any of the AGT tested with XLGT4 (data 
not shown). Repair of XLGT7, shown in Figure 4.4, was achieved only by hAGT, where 
25% of the starting material was converted to the AGT-DNA covalent complex. 
Moreover the ratio of the released DNA strand and AGT-DNA complex was 1:1 
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suggesting hAGT only repaired one of the alkylated atoms involved in the cross-link. 
This hAGT repair activity was abolished by introducing the C145S mutation (data not 
shown). 
 
Figure 4.4: Denaturing PAGE gel illustrating the repair of XLGT7 by hAGT, Ada-C and 
OGT  
Repair reactions were composed of 2 pmol of DNA and 60 pmol AGT at 37 °C for 16 h. 
Lane 1, Control DNA + hAGT; lane 2, XLGT7; lane 3, XLGT7 + hAGT; lane 4, 
XLGT7 + OGT; lane 5, XLGT7 + Ada-C; lane 6, XLGG7 + hAGT. 
The repair rate of XLGT7 and formation of the hAGT-DNA complex was 
monitored over the course of three hours to obtain information on the kinetics of this 
reaction, as shown in Figure 4.5. The results indicate that the repair occurred slowly 
where only 13% of the AGT-DNA species is present after the three hour period. As was 
the case for the repair assay conducted overnight, the ratio of AGT-DNA complex to 






















Figure 4.5: Time course repair of XLGT7 by hAGT.  
Substrate (♦), hAGT-DNA complex (▲) and released DNA strand (■). 
4.3.6 Identification of XLGT7 repair product by SDS-PAGE and 
ESI-MS 
Since the radioactivity based repair assays only show the DNA species, SDS-PAGE 
was conducted on the hAGT mediated repair of XLGT7 to observe the various protein 
species formed. The SDS-PAGE shown in Figure 4.6 reveals the formation of a protein 
complex with a greater molecular weight than unmodified hAGT. Based on the results 
from Figure 4.4 and Figure 4.6 we hypothesize that the new species corresponds to an 
hAGT-DNA covalent complex, which coincides with the calculated mass of (25.3 kDa). 
The identity of the hAGT-DNA complex hypothesized from Figure 4.6 was 
determined using ESI-MS. Since the cross-link involves two different alkylated 
nucleotides that could potentially be repaired by hAGT, it was necessary to identify the 
hAGT-DNA species in order to establish the site of repair. Repair at either of the 
















Figure 4.6: 15% SDS-PAGE of hAGT mediated repair of XLGT7.  
Repair of 625 pmol XLGT7 by 600 pmol hAGT for 5 h at 37 °C. Unstained Protein 
Molecular Weight Marker (left); XLGT7 + hAGT reaction (right). 
 
Figure 4.7: Identification of hAGT-DNA covalent complex by ESI-MS 
The ESI-MS spectrum of the hAGT mediated repair of XLGT7 is shown in Figure 
4.7. Two major signals are observed in the deconvoluted spectrum. The first corresponds 
to the unalkylated form of hAGT and the second the hAGT-DNA covalent complex. 
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Based on the observed and calculated masses, the hAGT-DNA complex occurs between 
the protein and the DNA strand alkylated at the O
4
 atom of dT, indicating hAGT 

























Figure 4.8: hAGT mediated repair of XLGT7  
4.3.7 Binding studies of C145S hAGT  
Binding assays were carried out to study the effect of the ICL on hAGT substrate 
discrimination in hopes of understanding the preferential repair observed for XLGT7 
over XLGT4 (see Appendix IV). Results presented in Table 4.1 indicate that hAGT 
binds both ICL DNA in a 2:1 (protein:DNA) stoichiometry, similar to the control DNA, 
suggesting the cross-links have no evident effect on the mode of hAGT binding. The Kd 
values extracted from the EMSA indicate that hAGT binds XLGT7 2-fold better than the 
control DNA and XLGT4, which are both bound in the low μM range. 
Table 4.1: Kd and stoichiometry of binding by hAGT to XLGT4, XLGT7 and control 
duplex. 
DNA Duplex Kd (µM) Stoichiometry  
Control (G-C) 3.55 ± 0.14 2.03 ± 0.08 
XLGT4 3.64 ± 0.20 1.99 ± 0.17 









dT ICL were prepared using a combination of 
solution synthesis to create the cross-linked phosphoramidite and solid phase synthesis to 
incorporate the cross-link into an oligonucleotide. The identities of the ICL DNA 
XLGT4 and XLGT7 were confirmed by ESI-MS and exonuclease digestion. The 
nucleoside ratios extracted from the digestion were in accordance with the theoretical 
composition of the oligonucleotide except for a lower than anticipated ratio of the cross-
linked nucleosides. These deviations in ratios are attributed to the unknown extinction 





-MedG was used to get an estimate of the relative ratio of these modifications. The 
complimenting nature of the ESI-MS validates the presence of only one ICL modification 
per DNA molecule.  
The presence of the cross-links increased the thermal stability of the DNA duplex, 
where the presence of a four methylene bridge had a greater stabilizing effect than the 
seven as observed by our UV thermal denaturation studies. The smaller increase in 
thermal stability brought upon by the larger ICL is believed to be due to a greater 
reduction in the enthalpy for the heptylene versus butylene linker containing DNA, which 
may be attributed to the disruption of the base pairs around the cross-linked site as a 
result of steric effects of the larger linker.(235) A comparable trend has been observed 




dT mismatch, where an increase in Tm 
of 9 °C and 25 °C was observed over the control duplex for the heptylene and butylene 




dG mismatch in 
151 
 
a similar oligonucleotide sequence with 12 °C and 24 °C increases in Tm for the heptylene 
and butylene linkages over our control DNA, respectively.(145)
 
Indeed, the presence of 
an ICL, irrespective of the length, causes a reduction in the change of entropy upon 
denaturation of the duplex due to the organized nature of the unimolecular system. As 
previously observed, the contribution of the entropy factor overrides the negative 
enthalpic effect on the ICL system affording a more stable species.(226)  
The control DNA, XLGT4 and XLGT7 all assumed B-form structures as assessed 
by far-UV CD. These results are in accordance with previously studied ICL DNA having 
cross-links between the N3 atoms of dT and the N
4
 atoms of dC.(225,237) Moreover, 
NMR studies on ICL DNA containing an N3T-butylene-N3T cross-link revealed no 
change in the overall B-form structure of the DNA but did show widening of the major 
groove without compromising the size of the minor groove.(238)
  
The conformation of the DNA probe might play a substantial role on hAGT repair. 




-methyl-riboG) in a DNA strand by hAGT is non-
existent as opposed to its natural substrate, O
6
-MedG which is efficiently processed by 
the protein.(239)
 
Based on hAGT-DNA co-crystals, the lack of RNA repair by hAGT has 
been attributed to a potential steric clash between the 2’ hydroxyl of the modified 
ribonucleoside and the alpha-carbon of Gly131.(155) This only partially addresses the 
discriminatory pattern. Other nucleic acid properties may be responsible for this 
discerning trend. Notably, differences in the ribose and 2’-deoxyribose sugar puckers, 
affecting the overall secondary structure of nucleic acids, could play a part in poor RNA 
repair by hAGT. For this reason the B-form structure of DNA may be primordial for 
AGT repair.  
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Our radioactivity based repair assay revealed no repair of XLGT4 by any AGT 
tested. Lack of repair by OGT and Ada-C was anticipated based on previous work, which 
indicates that both proteins are inactive to ICL DNA.(146,235)
 
The absence of any 





dG ICL (XLGG4) in a virtually identical sequence.(146) The 
difference in size between dT and dG may be responsible for the lack of XLGT4 repair 
as opposed to XLGG4. Replacing one dG by a dT reduces the linear distance between 
the anomeric carbons of the modified nucleosides by roughly 1 Å. 
 
A molecular model generated by Fang et al. of hAGT in complex with XLGG7 
suggests the preferential repair of longer cross-links by hAGT is brought upon by the 
shape of the hAGT active site in the DNA bound conformation which can be represented 
as a tunnel.(146) In effect, the larger the distance between the anomeric carbons of the 
modified nucleosides, the greater the ICL repair since the cross-linked nucleobases will 
sit at each end of the hAGT active site "tunnel". This allows the linker to lay in the 
"tunnel" while at the same time placing the alpha-carbon of the adduct in close proximity 
to the reactive Cys residue.  
Local denaturation of the DNA duplex upon hAGT binding may be the cause for 
the extension of the cross-link, separating the tethered nucleotides.(240) As eluded to in 
earlier studies based on the thermal denaturation results, the larger cross-link causes the 
disruption of the base pairs around the lesion itself generating a substrate that is already 
denatured around the point of alkylation prior to protein binding. 
Repair of XLGT7 was achieved only by hAGT, as was anticipated based on the 
"tunnel" model. Increasing the length of the ICL allowed the nucleobases to span the 
153 
 
distance of the hAGT active site, permitting repair to occur. Repair of XLGT7 by hAGT 
shown in lane 3 of Figure 4.4 suggests the formation of a species that corresponds to a 
AGT-DNA complex, based on the migration pattern of the XLGG7 control from lane 6, 
as well as a fully repaired DNA strand, which migrated similarly to the control DNA in 
lane 1. The formation of the AGT-DNA complex and the release of the repaired strand in 
a 1:1 ratio implies that repair by hAGT only occurred at one site per DNA molecule. 
Repair of XLGT7 by hAGT required hours for completion as indicated by the time 
course assay shown in Figure 4.5. The C145S variant of hAGT was unable to repair 
XLGT7 identifying Cys 145 as the reactive residue.  
To overcome the limitations of the radioactivity based assay, which only monitors 
the DNA species, an SDS-PAGE analysis of the reaction was performed to analyze the 
various proteinaceous materials formed. The absence of a protein band at 43.8 kDa, 
which would indicate an hAGT dimer linked by the seven methylene linker, supports the 
finding that hAGT only reacts at one location on XLGT7. A band just above the 25 kDa 
marker correlates to a covalent species migrating with a molecular weight corresponding 
to an AGT-DNA complex in a 1:1 ratio (roughly 25.3 kDa), which is in agreement with 
our radioactivity based repair assay. 
The identity of the covalent complex was determined by ESI-MS. The spectrum 
shown in Figure 4.7, displays some unreacted hAGT (21875.5 Da) and a peak with a 
mass of 25303.3 Da, corresponding to an hAGT-(CH2)7-CGAAATTTTCG molecule. The 
absence of a peak at 25328.6 Da entails that hAGT reacts selectively at one location on 
the DNA duplex. To form this hAGT-(CH2)7-CGAAATTTTCG product, where the 
underlined nucleotide depicts the cross-linked position, hAGT must react on the modified 
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CGAAAGTTTCG strand whereby releasing the repaired CGAAAGTTTCG 
oligonucleotide in the process. The absence of any formation of a covalent complex when 
reacting hAGT with the control DNA signifies the reactive moiety on the DNA as the O
6
 
atom of the cross-linked dG. The repair events of XLGT7 by hAGT have been 
summarized in Figure 4.8. These results are consistent with our previous results that 










hAGTs inability to repair XLGT4 was not attributed to poor substrate binding as 
established from our EMSA results, shown in Table 4.1. A two-fold decrease in Kd 
observed for XLGT7 over XLGT4 and the control DNA is not substantial enough to 
support the repair trend. Also the ICL had no consequence on the binding stoichiometry 
of hAGT to the DNA. This is in agreement with the minor groove binding property of 
hAGT and the solution structure of similar ICL DNA showing the cross-link spanning the 




Using our approach a well-defined hAGT-DNA covalent complex was generated 
covalently linking an O
4
 alkylated dT via a seven methylene linker to hAGT. 
Unfortunately, the protein-DNA cross-linking reaction was limited to the human 
homologue where no complex was observed for Ada-C and OGT E. coli proteins. No 
complex was observed with the four methylene linker containing DNA XLGT4. The 
reason for this substrate discrimination by hAGT is not known but we hypothesize that 
the longer cross-link found in XLGT7 allows for easier access to the point of lesion since 
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1) the two modified nucleosides can be separated further apart due to the increased length 
of the tether 2) the larger cross-link allows for substantial local destabilization of the 
DNA duplex at the point of repair granting easier access to hAGT.  
We conclude the use of ICL DNA as substrates for the formation of site specific 
AGT-DNA covalent complexes is promising. Synthesis of these modified 
oligonucleotides is straightforward and allows great control over the length of the desired 
tether. As demonstrated herein, hAGT specifically reacts with the O
6
 alkyated dG of the 
cross-link allowing the formation of defined covalent complexes that may find 
applications in experiments involving the labeling of hAGT. 
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A soluble human hAGT chimera was engineered containing the active site of OGT 
(residues 139-159) and an additional S134P mutation. The resulting hAGT chimera not 
only retained hAGT’s ability to repair bulky O6dG-alkylene-O6dG ICL DNA damage but 
also displayed enhanced repair of various O
4






-MedT in the genome that results from exposure to tobacco derived 
N-nitrosamines or chemotherapeutic agents is highly mutagenic because of its ability to 
form altered hydrogen bonding patterns.(25,54,242,243) The stable O
4
-MedT:dG pair 
resulting from a single round of replication, causes a dT to dC transition mutation, which 
is especially detrimental to the cell if this event occurs on proto-oncogenes or tumour 
suppressor genes.(4)  
O
6
-MedG, another well known mutagenic nucleobase modification, generates 
dG:dC to dA:dT transition.(5) Unlike its dT counter-part the O
6
-MedG:dT intermediate 
(formed after a single round of replication) is a substrate for mismatch repair and direct 
repair in humans.(126,244,245) The O
4
-MedT:dG mismatch persists in the cell since it is 
neither a good substrate for mismatch repair nor direct repair, contributing to the 




-MedT, which is believed to be a minor 
lesion, has been found at similar levels as O
6
-MedG in the liver tissue of healthy 
volunteers, demonstrating its importance and prominence in the absence of exogenous 
alkylating agents.(246) 
AGT are part of the direct repair pathway and are responsible for the removal of 
both O
6
-alkyl dG and O
4
-alkyl dT adducts.(132,247) The repair occurs in a single step 
process where the active site Cys thiolate anion performs a nucleophilic attack on the α-
carbon of the adduct located on the exocyclic oxygen.(155) In the process the native 
DNA is restored and the AGT protein is irreversibly alkylated where it eventually 
undergoes degradation by the ubiquitin mediated pathway.(104,248) AGT homologues 
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show vast substrate differences. hAGT has been studied extensively and is believed to 
possess the greatest substrate range for O
6
-alkyl dG adducts. Among some of the 
“bulkier” substrates that have been shown to undergo repair by this protein are O6dG-
alkylene-O
6
dG ICL, which are DNA lesions that covalently link complementary DNA 
strands inhibiting DNA unwinding and segregations and in the process inhibits cell 
proliferation due to physical obstruction.(146,214,235,249)  
E. Coli OGT is believed to be the most efficient AGT at eliminating O
4
-alkyl 
dT.(33,117) This is contrary to hAGT, which is extremely poor at removing even O
4
-
MedT. hAGT recognizes and binds O
4
-MedT but cannot remove them efficiently, 
physically shielding the lesion from the NER machinery and increasing the lesion's 
toxicity.(133)  
The Loeb and Pegg groups have dedicated some effort to generate hAGT variants 
capable of increased repair of O
4
-MedT. The Loeb laboratory employed a random 
sequence mutagenesis approach to generate multiple variants followed by a functional 
complementation assay to obtain a variant with 8 alterations (C150Y, S152R, A154S, 
V155G, N157T, V164M, E166Q, and A170T).(134) This variant showed a rate of repair 
of O
4
-MedT that was roughly 11.5 times greater than that of hAGT.(135,250) A 
horizontal gene transfer from OGT to hAGT was invoked by the Pegg group to generate 
their hAGT-OGT chimera. Their most promising construct harboured 8 alterations 
(V149I, C150G, S151R, S152N, A154T, V155M, G156T and N157G) and was achieved 
by substituting the hAGT amino acids by their respective residues in OGT. 
Unfortunately, incorporating numerous successive mutations generated a chimeric 
protein that was not soluble, requiring refolding procedures to be adopted. Their chimera 
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displayed valuable properties when expressed in alkyltransferase and NER deficient E. 
Coli cells, where reduced levels of mutations at dT:dA sites were observed upon cell 
exposure to methylating, ethylating and propylating agents when compared to similar 
cells expressing wild-type hAGT.(123) 
In the present work, we extended the portion of OGT residues in the chimera 
towards the C-terminal but kept Pro 140 from hAGT to generate a soluble construct.(126) 
The chimeras ability to repair alkylation adducts and ICL at both the O
4
 atom of dT and 
O
6
 atom of dG was investigated using the substrates shown in Figure 5.1, which were 




































































































































Figure 5.1: Structures of (A) O
4
-alkyl dT monoadducts and DNA sequence where X 




dG ICL and duplex where G-G is 









dT ICL and duplex where T-T is the ICL. 
5.2 Experimental 
Note: This manuscript was published as a communication and as such lacked a detailed 
experimental section. All novel methods are described here and previously explained 
methods are refered to. 
5.2.1 Materials 
XL-10 Gold and BL21(DE3) E. coli cells were obtained from Stratagene (Cedar 





Phusion polymerase (New England BioLabs, Ipswich, MA, USA), Pfu, T4 DNA ligase, 
KpnI, EcoRI, DpnI, Unstained Protein Molecular Weight Marker, O'GeneRuler™ 1 kb 
Plus DNA Ladder (Fermentas, Burlington, ON, CAN), 5' Phosphorylated Primers 
(Biocorp, Montreal, QC, CAN), 10 mM stock dNTPs , Agarose, Tris base, Borate, 
EDTA, Imidazole, Ampicillin, IPTG, and most other biochemical reagents as well as 
polyacrylamide gel materials (Bioshop Canada Inc, Burlington, ON, CAN), Ni-NTA 
Superflow Resin (Qiagen, Mississauga, ON, CAN) and Complete, Mini, EDTA-free 
Protease Inhibitor Cocktail Tablets (Roche, Laval, QC, CAN). 
5.2.2 Creating pQE30-Chimera plasmid  
An overview of the procedures is shown in Scheme 5.1. The primers, shown in 
Table 5.1, used in this study were designed such that the 3' portion of the primers that 
annealed to the template had a Tm > 50 °C, while having either a G or a C at the 3' end of 
the primer to ensure proper annealing. The 5' end of the reverse primer coded for the first 
33 mutations while the 5' end of the forward primers coded for the remaining 30 
mutations. 5' phosphate groups were incorporated into the primer via solid phase 
synthesis as these phosphates were needed to carry out the blunt-end ligation. These 
primers allowed for a GTC CCC ATC CTC ATC CCG TGC CAC AGA GTG GTC TGC 
AGC AGC GGA GCC GTG GGC AAC TAC TCC to ATC CCC ATC GTC GTA CCT 
TGC CAT CGG GTT ATC GGC CGA AAC GGT ACC ATG ACC GGA TAT GCA 
mutation. The italisized codons were coded for by the reverse primer while the bolded 




Scheme 5.1: Modified inverted site-directed mutagenesis.  
(A) Annealing of the two 5' phosphorylated contiguous primers, (B) Extension by 
Phusion polymerase to give the linear mutated DNA, (C) Digestion of parental DNA by 
DpnI and (D) Blunt-end ligation of cleaned-up PCR product to yield the circularized 
mutated plasmid. 
Table 5.1: Primers used to design the chimera gene from hAGT 
Primer Sequence  Additional Information 
Reverse P-GAT AAC CCG ATG GCA AGG 
TAC GAC GAT GGG GAT AGG 
ATT GCC TCT CAT GGC 
Mutation of first 33 nucleotides 
Forward 
 
P-GGC CGA AAC GGT ACC ATG 
ACC GGA TAT GCA GGA GGG 
CTA GCC GTG AAG G 
Mutation of remaining 30 
nucleotides 
Underlined nucleotides represent the non-annealing 5' moiety of the primers that 
are mutagenic 
Introduced KpnI cut-site in forward primer shown in bold 
P- Phosphate group 
The PCR reaction mixtures were constituted of 10 ng of hAGT template DNA, 30 
pmol of each primer, 200 μM of dNTPs, 10 μL of 5 X Phusion buffer, 1 μL of dimethyl 
sulfoxide and water to a total volume of 49.5 μL. Once the solution heated to its 
denaturation temperature (95 
o
C), 0.5 μL (1 unit) of Phusion polymerase was added.  
The conditions used to perform the PCR reactions on the Applied Biosystems 
GeneAmp PCR System 9700 thermocycler were: a hot start of 1 min at 95 °C; 25 cycles 
of denaturation at 95 °C for 1 min followed by annealing at 60 °C for 1 min followed by 
(A) (B) (C) (D) 
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elongation at 72 °C for 12 min; a final cycle at 72 °C for 15 min was performed in order 
to establish proper termination of the PCR product strands for blunt end ligations. 
The Phusion PCR reaction mixture was digested for 2 h at 37 °C using 10 units of 
DpnI to digest the template DNA. The resulting mixture was loaded on a 0.8 % agarose 
gel and electrophoresed at 80 V for 1 h. The band of the appropriate size (4 kb) was 
excised and the DNA extracted from the gel as specified by the Illustra GFX PCR DNA 
and Gel Band Purification Kit (GE Health, Baie d’Urfe, QC, CAN) using 30 μL of 
elution buffer type 4.  
A blunt-end ligation reaction was performed for 2 h at 22 °C using 450 ng of the 
purified DNA (obtained above), 5 μL of 10 X T4 DNA ligase buffer, 34 μL of water and 
1 μL (5 units) T4 DNA ligase. The ligase was subsequently inactivated by incubating the 
mixture at 70 °C for 5 min. 
45 ng of DNA from the ligation mixture was transformed into 100 μL of competent 
XL-10 Gold cells. Briefly, the cells were thawed on ice and then transferred into a pre-
chilled sterile 15 mL polypropylene tube. 5 μL of the ligation mixture was added to the 
tube and allowed to sit on ice for 5 min. The tube was subsequently placed in a 42 °C 
water bath for 40 sec, placed on ice for 2 min and the resulting mixture spread on LB + 
100 μg/mL ampicillin agarose plates. 
5.2.3 Creating the pET15-Chimera plasmid 
Overlap extension PCR cloning was used to place the chimera gene into 
pET15b.(251) The tube for the 1
st
 PCR step was made up of 10 ng of pQE30-Chimera 
template created in Section 5.2.2, 30 ng of the two primers, whose sequences are shown 
in Table 5.2, 200 μM of dNTPs, 10 μL of 5 X Phusion buffer and water to a total volume 
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of 49.5 μL. Once the solution heated to its denaturation temperature (98 oC) 0.5 μL (1 
unit) of Phusion polymerase was added. 
Table 5.2: Primers used to create pET15-Chimera 
Primer Sequence  
pET-f CCT CTA GAA ATA ATT TTG TTT AAC TTT AAG AAG GAG ATA 




CAA CTC AGC TTC CTT TCG GGC TTT GTT AGC AGC CGG ATC CTC 
TCA GTG ATG GTG ATG GTG GTG GGA GCC 
 
Underlined nucleotides represent the portion of the primer which anneal to pET15b  
Non-underlined nucleotides represent the nucleotides that anneal to the Chimera gene 
The PCR conditions were as follows: a hot start of 2 min at 98 °C; 32 cycles of 
denaturation at 98 °C for 1 min followed by annealing at 60 °C for 1 min followed by 
elongation at 72 °C for 1.5 min; a final cycle at 72 °C for 10 min was performed. The 
PCR reaction was analyzed on a 1 % agarose gel and the desired band excised as 
indicated previously. 
The tube for the 2
nd
 PCR step was made up of 5 ng of pET15b, 160 ng of PCR 
product from step 1, 200 μM of dNTPs, 10 μL of 5 X Phusion buffer and water to a total 
volume of 49.5 μL. Once the solution heated to its denaturation temperature (98 oC) 0.5 
μL (1 unit) of Phusion polymerase was added.  
The PCR conditions were as follows: a hot start of 2 min at 98 °C; 20 cycles of 
denaturation at 98 °C for 1 min followed by annealing at 55 °C for 1.5 min followed by 
elongation at 72 °C for 12 min; a final cycle at 72 °C for 10 min was performed. The 
PCR reaction was then digested with DpnI, and transformed into XL-10 Gold cells and 
plated as indicated above.  
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A colony was picked from the plate and inoculated into 10 mL of LB + 100 μg/mL 
ampicillin overnight. The plasmids were extracted from the cells using GeneJET™ 
Plasmid Miniprep Kit. The purified plasmids, whose identities was confirmed by 
sequencing, were subsequently transformed into BL21(DE3) cells for protein expression 
under the T7 promoter. 
5.2.4 Protein expression and purification under pQE30 vector 
All proteins were purified under native conditions as described in Section 2.2.8. 
5.2.5 Protein expression and purification under pET vector 
Purification of the insoluble AGT protein was attempted using previously published 
protocols without success.(123) The only insoluble protein, the P140S chimera variant, 
was expressed in high copy under the pET15 system and purified under denaturing 
conditions. Purification of the P140S chimera variant was similar to the protocol used to 
purify the proteins under native condition with a few changes. The supernatant from the 
spin at 17000 x g after lyses of the cells using French press was discarded to remove all 
soluble proteins. The inclusion body pellet was taken up in resuspension buffer 
supplemented with 8 M urea. This was followed by a spin at 17000 x g for 45 min at 
room temperature. The supernatant was applied to a Ni-NTA column pre-equilibrated 
with equilibration buffer supplemented with 8 M urea. The column was extensively 
washed with equilibration buffer supplemented with 8 M urea and 10 mM imidazole. The 
protein was eluted with equilibration buffer supplemented with 8 M urea and 200 mM 
imidazole and immediately dialyzed versus refolding buffer (1 M Tris HCl (pH 8.5), 1 M 
NaCl, 0.3 M L-Arginine, 1 mM DTT, 10% glycerol, 0.1 mM EDTA) supplemented with 
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5 M urea using 8000 Da cutoff dialysis tubing for 16 hours. The protein was subsequently 
dialyzed against refolding buffer without urea and finally against storage buffer (50 mM 
Tris HCl (pH 7.6), 250 mM NaCl, 20 mM β-mercaptoethanol and 0.1 mM EDTA). This 
procedure yielded 30 mg of protein per L of culture, which was limited as a result of 
using only 3 mL of Ni-NTA resin during purification. It is noteworthy to include that on 
column refolding was attempted with no success as observed by the formation of a white 
precipitate on column when the urea concentration approached 2 M. 
5.2.6 Protein characterization 
CD, ESI-MS and intrinsic fluorescence analysis of the proteins were conducted as 
described in Section 2.2.9. 
5.2.7 Mono-adduct repair assay 
The mono-adduct repair assays were conducted as described in Section 3.2.8. 
5.2.8 Modelling of chimera bound to O
4
-alkyl dT mono-adducts 
The initial model of the chimera was generated using Modeller 9.10 using PDB 
1T38 as template. The modified DNA was placed in the chimera active site based on 






-butyl-4-ol dT or O
4
-heptyl-7-ol dT. 
The placement of the modified nucleotides were verified with PDB 1YFH. 
The preliminary models underwent conjugate gradient minimization, simulated 
annealing, and torsion angle dynamics using Crystallography & NMR System.(222) 
CHARMM topology files were modified to use the altered nucleotides by adding 
restraints to keep the α-carbon of the lesion in a syn conformation with respect to the N3 
atom of the heterocycle, as observed in PBDs 1T38, 1T39, and 1YFH.(223) 
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The models underwent 2 sets of 100 steps of gradient minimization and 200 steps 
of simulated annealing. The first cycle was carried out at 500 K with slow cooling at a 
rate of 4.5 K per cycle of dynamics. The second cycle was carried out at 350 K with slow 
cooling at a rate of 2.5 K per cycle of dynamics and the minimized models displayed 
using PyMol. 
5.2.9 Cross-link repair assay 
Cross-link repair assays were conducted as described in Section 2.2.10. 
5.2.10 C145S chimera variant binding studies with ICL DNA 
Binding reactions consisted of 0.5 nM dsDNA, increasing the C145S chimera 
variant ranging from 1 to 45.5 μM for the control (T-A) and from 1 to 6.5 μM for the ICL 
DNA and control (G-C) in a total solution volume of 20 μl of binding buffer (10 mM Tris 
HCl (pH 7.6), 100 mM NaCl, 1 mM DTT, 10 μg mL-1 and 2.5% glycerol). The samples 
were equilibrated for 1 hour at room temperature and loaded on a 15% native 
polyacrylamide gel (75 : 1) and run with 0.5 X TBE, which allowed the electrophoresis 
voltage to be increased without heating the system. Electrophoresis was carried out under 
liquid cooled gels at 21 °C at 250 V for 25 minutes. 
The monomeric Kd and stoichiometry (n) of AGT binding to DNA were obtained 
from the EMSA as described in Section 2.2.11. 
5.3 Results and discussion 
5.3.1 Protein characterization 
A slight variation of inverted PCR was employed to introduce residues 139-159 
from OGT into the hAGT scaffold, while retaining Pro 140 (see Table 5.3 for 
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sequences), which is known to confer hAGT with the ability to repair larger adducts such 
as ICL and O
6
-benzyl guanine.(146,202,203,214,249) The protein was expressed and 
purified as previously reported for hAGT.(214) The protein was obtained in >90% purity 
as assessed by SDS-PAGE and its mass was in accordance with the calculated value, 
indicating no post-translational modification of the foreign protein (see Appendix V). The 
successive mutations introduced into the chimera did not substantially affect the 
secondary structure of the overall protein as assessed by far-UV CD, which revealed a 
similar signature to hAGT. The alterations destabilized the protein with respect to hAGT 
reducing the Tm by 7.5 °C. Characterization of the chimera by intrinsic fluorescence 
showed a blue shift in tryptophan emission indicating a slight change in tertiary structure. 
This change in fluorescence is most likely a result of a variation in the local environment 
of Trp 65 to a less polar position. Trp 65 is located in the N-terminal domain of the 
protein but packs next to the altered region and is perhaps affected by the V139I 
alteration.(147) C145S and R135G variants of the chimera protein were created by site-
directed mutagenesis, purified and characterized (see Appendix V). 
Table 5.3: Amino acid sequence of hAGT, OGT and chimera active sites 










 Amino acid numbering based on hAGT sequence. 
b
 Most active chimera designed in reference 123. 
The P140S variant (introducing Ser 140 found in OGT) of the chimera created an 
insoluble construct when expressed under the pQE30 vector. This protein was also 
expressed using pET15b and purified under denaturing conditions in order to obtain a 
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higher protein yield to be used in refolding attempts. Previously published refolding 
protocols for hAGT did not yield an appreciable amount of properly folded protein.(105) 
Dialysis mediated refolding of the P140S chimera variant was greatly aided by high salt, 
Tris and L-arginine. Unfortunately, the refolded protein had an improper conformation as 





-MedT readily (data not shown).  
5.3.2 Mono-adduct repair 
The chimeras ability to repair O
6
-MedG in a 14 bp oligonucleotide (5’ GGC TTX 
ATC ACC AG, where X is O
6
-MedG) appeared to be unaffected given the repair of O
6
-
MedG occurred in less than 15 sec at room temperature, as was the case with hAGT (data 
not shown). The alterations improved the AGTs ability to remove O
4
-MedT in a similar 
oligonucleotide (5’ GGC TXG ATC ACC AG, where X is O4-MedT). As observed in 
Figure 5.2, the chimera repaired O
4
-MedT 30 times faster than hAGT, which is 
comparable to results reported by the Pegg group for their insoluble constructs, where 
their most proficient variant had a 47-fold increase over hAGT.(123) Repair of O
4
-MedT 
by OGT required less than 15 sec making it at least 100-fold more proficient than the 




Figure 5.2: Time course dealkylation of O
4
-MedT  
Repair assays was conducted at room temperature with hAGT (■) and the chimera (▲). 
5.3.3 Modelling of chimera bound to O
4
-alkyl dT mono-adducts 
Molecular modelling and molecular dynamics were employed to comprehend the 
reason for the chimeras increased ability to remove O
4
-MedT over its human equivalent. 
Modelling of the chimera was performed using the hAGT-O
6
MeG co-crystal (PDB 1T38) 
as template and placement of the Cys 145 side chain was guided by the hAGT crystal 
structures, PDBs 1YFH, 1T39 and 1EH6. O
6
-MedG was mutated to O
4
-MedT and the 
placement of O
4
-MedT verified with PDB 1YFH, as reference. Conjugate gradient 
minimization, simulated annealing and torsion angle dynamics were conducted using 
Crystallography & NMR System as done previously by our group.(222,235)  
The modelling data suggest the increased repair of O
4
-MedT by the chimera may be 
due to changes in the shape of the loop that better accommodates the modified nucleotide 
as observed in Figure 5.3. The N157G and S159A alterations in the chimera also make 
the loop more flexible resulting in a reduction in distance between the Cys 145 thiolate 
anion in the chimera to the methyl adduct of O
4
-MedT by 0.65 Å relative to the native 






-MedT (white) in the active site of hAGT (cyan/grey) and the chimera 
(green/black).  
The side chains of Cys 145, Asn 157 and Ser/Ala 159 are represented as sticks. 
hAGT has two unfavourable interactions; Asn 157 which sterically clashes with the 
O
4
-MedT sugar moiety and Ser 159 that is in close proximity with the C5 methyl of O
4
-
MedT hindering the flexibility of the loop and consequently inhibiting any penetration of 
O
4
-MedT into the protein's active site. 
The pre-minimized model of the chimera in complex with O
4
-MedT revealed a 
potential clash between Arg 135 and the C5 methyl of the modified nucleotide. This 
residue is replaced by a Gly in OGT and Ala in Ada-C, suggesting that small amino acids 
are usually located at this position in AGTs capable of repairing O
4
-MedT with 
appreciable ease. For this reason the R135G variant of the chimera was generated in hope 
of creating a more active variant. The repair capabilities of the chimera were compared to 
its R135G variant using a small library of O
4
-alkyl dT adducts. Overnight incubation at 
37 °C of the AGT with the various O
4
-alkylated DNA revealed the R135G alteration was 
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detrimental to the chimera. The R135G variant maintained the ability to repair O
4
-MedT, 
but lost its capability to repair substrates T4 and T7 (see Appendix V). Repair of T4 and 
T7 by the original chimera was moderate, showing only 40% repair after an overnight 
incubation. These results are still promising since its human counterpart is unable to react 
with these substrates to a detectable extent.(235)
 
5.3.4 Cross-link repair 
hAGT is the only AGT shown to date to repair ICL DNA and several independent 
alterations in its amino acid sequence are known to abolish this ability. These alterations 
(aside from those involved in the proteins activity) include: P140A, P140K, V148L and 
Y158H,
 
all of which are located in the portion of hAGT that is altered to form the 
chimera.(146,214) To verify the effect of the alterations on the proteins ability to process 
ICL DNA time course repair assays with various ICL containing oligonucleotides were 
conducted. The time course assays revealed that the chimera is similar to hAGT and can 
repair ICL DNA involving the O
6
 atom of dG. The repair of cross-linked substrates 
XLGG4 and XLGG7, where the O
6
 atoms of dG are attached by an alkylene linker, were 
carried out at virtually identical rates by hAGT and the chimera. The chimera, much like 
hAGT, repaired XLGG7 more rapidly and extensively than it did XLGG4, 50% repair in 
3 h for XLGG7 as opposed to 30% repair in 8 h for XLGG4 (see Appendix V).  
Similar repair trends were observed for the XLGT series, where the O
6
 atom of dG 
and O
4
 atom of dT are attached by an alkylene linker. XLGT7 was repaired with 
comparable rates by both AGTs whereas the repair of XLGT4 was virtually non-existent 
(see Appendix V). ESI-MS analysis of the repair reaction revealed the chimera 
selectively repairs the cross-link at the O
6
 atom of dG. The repair event produces a 
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complex comprised of the chimera covalently attached through its Cys 145 to the O
4
 
atom of the cross-linked dT via the seven methylene linkage (see Appendix V). The same 
repair specificity was reported by our group for hAGT.(249)
 
 
In light of the positive results with mono-adducts T4 and T7 repair assays with 
cross-linked DNA, where the O
4
-atoms of dT were attached by an alkylene linker 
(XLTT4 and XLTT7), were undertaken with the chimera. Unfortunately, the chimera 
was unable to repair XLTT4 nor XLTT7 (see Appendix V). As was the case with hAGT 
and OGT, XLTT4 and XLTT7 ICL DNA evaded repair by the chimera.(235)  
5.3.5 Binding studies 
The chimera bound XLTT4 and XLTT7 with low μM Kd as determined by EMSA 
indicating good binding of the ICL DNA by the protein. The chimera bound the XLTT 
DNA series more tightly than it did the XLGT, which the protein is able to partially 
repair, suggesting the absence of XLTT repair is not due to recognition of the substrate 
by the protein (see Table 5.4).  
Table 5.4: Kd and stoichiometry of the C145S chimera variant binding to ICL DNA 
DNA Kd (μM) Protein:DNA Stoichiometry 
Control (T-A)
a
 37.57±6.48 1.91 ± 0.09 
XLTT4   2.56±0.42 1.86 ± 0.16 
XLTT7   1.99±0.12 1.80 ± 0.16 
Control (G-C)
b
   3.96±0.82 1.89 ± 0.18 
XLGT4   6.10±0.10 2.12 ± 0.20 
XLGT7   3.88±0.47 1.99 ± 0.13 
a
 DNA sequence is 5'-CGAAATTTTCG/3'-GCTTTAAAAGC 
b 
DNA sequence is 5'-CGAAAGTTTCG/3'-GCTTTCAAAGC 
The chimera interacts with dsDNA in a virtually identical fashion to hAGT, as 
indicated by our binding experiments. Like hAGT, the chimera displays a preference for 
DNA with a dG that is more than 2 nucleotides from the 5' ends, as observed between the 
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T-A and G-C controls. The chimera bound all DNA species with comparable dissociation 
constants and stoichiometry as those reported for hAGT using identical substrates and 
conditions.(235,249) hAGT is believed to bind every 4 nucleotides where an observed 
stoichiometry of 2:1 hAGT:DNA has been documented for both 11-mer dsDNA and 
ssDNA, consistent with our findings with the chimera.(166,167) 
Binding experiments with the R135G chimera variant showed no association of 
DNA in the tested range (0 to 30 μM) establishing the role of Arg 135 as a binding 
residue. The R135G alteration in the chimera appears to cause a decrease in binding 
affinity between the protein and DNA, limiting the proteins ability to repair bulkier 
adducts (such as T4 and T7) since they require a longer time to react with the proteins 
thiolate anion as a result of the distance between the reacting groups. The role of Arg 135 
in the chimera is equivalent to its function in hAGT, where it is speculated that this 
residue is 1 of only 3 basic amino acids involved in the ionic interaction between the 
protein and dsDNA as well as being 1 of 2 residues involved in the interaction with 
ssDNA.(168) 
5.4 Conclusions 
We successfully generated a hAGT-OGT chimera that can be purified under native 
conditions. The chimera, containing a portion of the hAGT active site changed to the 
respective amino acids in OGT, displays some properties from OGT since it can repair 
O
4
-MedT 30 times faster than hAGT. In addition, the chimera can remove larger adducts 
at the O
4
 atom of dT, such as those found in T4 and T7, but does so poorly. The chimera 
maintained the ability to repair cross-links involving the O
6
 atom of dG, a property that 
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was previously thought to be unique to hAGT (see Table 5.5 for repair summary). The 
alterations in the primary construct were shown to have no effect on DNA binding 
affinity or stoichiometry, suggesting the modified residues are not involved in substrate 
recognition  
Such a chimera may play a role in combinational chemotherapeutic regimens due to 
its added ability to repair undesired, highly mutagenic, O
4
-alkyl dT adducts that are 
generated during cancer treatment and which are known to persist in mammalian 
cells.(252) Since the chimera is based mostly on the hAGT scaffold many of the 
biological properties of the protein are maintained. For example, the presence of the 125-
KAAR sequence responsible for targeting and maintaining the protein in the nucleus and 
the presence of Met 134, which is required for the steric clash that allows hAGT to be 
ubiquitinated and degraded are retained; the presence of the terminal regions of hAGT 
that impart the protein with the ability to interact with DNA with a high inter-protein 
cooperativity, which is required for concentrating the protein to segments of DNA that 
are undergoing transcription are also preserved.(153,154,155,171). 
Table 5.5: Summary of AGT mediated DNA repair 





 + +++ ++ 
T4
a (235)
 - ++ + 
T7
a (235)
 - + + 
XLGG4
b (146)
 + - + 
XLGG7
b (146)
 + - + 
XLGT4
b (249)
 - - - 
XLGT7
b (249)
 + - + 
XLTT4
b (235)
 - - - 
XLTT7
b (235)
 - - - 
a
10 pmol AGT with 2 pmol DNA at 37 °C. b60 pmol AGT 
with 2 pmol DNA at 37 °C. (+++) >80% repair within 1 
minute, (++) >80% repair within 1 h, (+) >10% repair 
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AGT are responsible for the removal of O
6
-alkyl dG and O
4
-alkyl dT adducts from the 
genome. Unlike the E. coli OGT protein, which can repair a vast range of O
4
-alkyl dT 
lesions, hAGT is only able to remove O
4
-MedT and does so poorly. We set out to 
uncover the cause of this substrate discrimination pattern by determining the effect of the 
C5 methyl of dT on AGT mediated repair of O
4
-alkyl dT. The rate at which the E. coli 
AGTs, hAGT and an OGT/hAGT chimera removed methyl, butyl-4-ol and heptyl-7-ol 
adducts from the O
4
 atom of dU were determined and compared to those of O
4
-alkyl dT, 
which we previously reported under identical conditions. The presence of the C5 methyl 
hindered the repair of the methyl adducts by hAGT and the chimera by 25 and 30-fold, 
respectively. The absence of the C5 methyl allowed the chimera to repair the butyl-4-ol 
and heptyl-7-ol adducts with appreciable rates. The presence of the C5 methyl did not 
greatly affect the rate of repair of the butyl-4-ol adduct by OGT but had a 30-fold 
inhibitory affect on the removal of the heptyl-7-ol lesion. The ability of the various AGT 
to repair O
4
-benzyl dU in an oligonucleotide was also investigated. This molecule was 
repaired efficiently by all AGTs except for Ada-C. No correlation was observed between 
the binding affinity of the AGT homologous to the adduct containing oligonucleotides 




The formation of O
6
-alkyl dG and O
4
-alkyl dT lesions in DNA through exposure to 
chemotherapeutic agents and environmental carcinogens such as tobacco derived N-
nitrosamines is well documented.(54,242) Such modifications also occur endogenously 
where the formation of O
6
-MedG is observed at a rate of 10-30 events daily by S-
adenosylmethionine.(46) These lesions are often used as benchmarks to determine the 
mutagenic potential of DNA damaging agents due to their potency.(243) The source of 
the mutagenic potential of these modifications come from the wobble base pairs adopted 





-MedT lead to G to A and T to C transitions, respectively.(21,25)  
In the genome, O
4
-MedT is formed less readily than O
6
-MedG. DNA treated with 




-MedT.(24) Though formed to a lesser 
extent, O
4
-MedT is observed at similar steady state levels as O
6
-MedG in the liver tissue 
of healthy humans, proving its incidence, even in the absence of exogenous alkylating 
agents.(246) Moreover, O
4
-MedT is more toxic than O
6
-MedG in both normal and repair 
deficient mammalian cells.(29,30) 
As the source of genetic information the nucleotide sequence found in DNA must 
be maintained and therefore the prevalence of O
6
-alkyl dG and O
4
-alkyl dT lesions 
limited. Organisms have evolved AGT proteins to remove these lesions and limit their 
effects on the cell. AGTs are virtually omnipresent and are found in all kingdoms of life 
apart from plants.(189) hAGT is the most thoroughly characterized AGT and has been 
crystallized in the absence and presence of different substrates.(148,155,151) AGTs 
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repair DNA damage by flipping the damaged nucleotide out of the duplex and into the 
active site of the protein allowing the alkyl group to be transferred from the modified 
nucleotide to the active site Cys residue.(173)
 
The alkylated protein is subsequently 
ubiquitinated and targeted for degradation by the proteosome causing the protein to act 
only once.(104)  
The augmented persistence of O
4
-MedT in the genome and it's mutagenic potential 
is not based on its chemical nature but is rather attributed to its ability to evade repair by 
hAGT and MMR, unlike O
6
-MedG.(31,132,133) The preferential repair of O
6
-alkyl dG 
observed by hAGT is not ubiquitous amongst AGTs. For example, the E. Coli OGT and 
Ada-C proteins are capable of repairing O
4
-MedT readily, where OGT is documented as 




-MedG with comparable 
rates.(33,117) 
Unfortunately, the origin of the substrate discrimination patterns by the AGT 
homologues is not known. Moreover the reason for hAGTs inability to process O
4
-MedT 
is unknown and few hypothesis have been proposed. To date, there is no crystal structure 
of hAGT with a DNA duplex containing O
4
-MedT. hAGT has been crystallized with the 
modified pyrimidine N
4
-p-xylylenediamine, a cytosine analogue, but the nature of the 
modification may cause some potential interactions to be lost.(155) Notably, the absence 
of an O
4
 atom in dC removes the Ser 159 backbone interaction with the O
4
 atom of dT 
(observed with O
6
 of dG in PDB 1T38).  





-MedG in PDB 1T38.(235) The resulting model placed the methyl group 
on the O
4
 atom of dT 2.39 Å further away from the thiolate anion of Cys 145 with respect 
182 
 
to the methyl group of O
6
-MedG. These results are in agreement with experimental 
evidence but they did not explain the root cause of hAGTs reduced capacity to repair O
4
-
MedT. A closer look at the pre-minimized model revealed a potential clash between the 
C5 methyl of dT and Arg 135 of hAGT. Unfortunately, altering Arg 135 in hAGT would 
create a protein that has reduced DNA binding affinity because this residue is believed to 
be 1 of only 3 basic amino acids involved in the ionic interaction between the protein and 
phosphate backbone of dsDNA.(168)  
We previously engineered a soluble chimera of OGT-hAGT where residues 139-
159 of hAGT were replaced with their equivalents in OGT with the addition of an S140P 
alteration for solubility purposes.(253) This chimera possesses increased repair 
capabilities of O
4
-alkyl dT damage with respect to its human homologue, while 
maintaining the ability to repair large adducts at the O
6
-atom of dG. The R135G 
alteration in this chimera lead to a protein with reduced repair capabilities of O
4
-alkyl dT, 
which was attributed to reduced DNA binding affinity, supporting the proposed role of 
Arg 135 in hAGT. Since only the active site is altered in the chimera and the HTH motif 
is essentially unchanged from that of hAGT, this protein will allow to determine the role 




Since the residue involved in the potential clash cannot be altered due to its role in 
substrate binding, a synthetic approach was undertaken to synthesize similar 
oligonucleotides as used previously by our group for repair studies of O
4
-alkyl dT. For 
this study, the O
4
-alkyl dT nucleotide is substituted to its C5 lacking equivalent, O
4
-alkyl 
dU. The synthesized substrates, shown in Figure 6.1, were prepared using methods 
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described by Swann's group for the modification of dT using a convertible nucleoside 
approach without the need for alterations.(221)  








































O4-Heptyl-7-ol dU, U7  
Figure 6.1: Structures of (A) O
4
-alkyl dU adducts and (B) DNA sequence where X 
contains the adduct. 
6.2 Experminental 
6.2.1 Materials 
2’-Deoxyuridine (dU) and N,N-diisopropylamino cyanoethyl phosphonamidic 
chloride were purchased from ChemGenes Inc. (Wilmington, MA). 5’-O-
Dimethoxytrityl-2’-deoxyribonucleoside-3’-O-(β-cyanoethyl-N,N’-
diisopropyl)phosphoramidites and protected 2’-deoxyribonucleoside-CPG supports were 
purchased from Glen Research (Sterling, Virginia). All other chemicals and solvents 





Chemicals Inc. (Gibbstown, NJ). Flash column chromatography was performed using 
silica gel 60 (230–400 mesh) obtained from Silicycle (Quebec City, QC). TLC was 
performed using precoated TLC plates (Merck, Kieselgel 60 F254, 0.25 mm) purchased 
from EMD Chemicals Inc. (Gibbstown, NJ). NMR spectra were either recorded on a 
Varian INOVA 300 MHz NMR spectrometer or on a Varian 500 MHz NMR 
spectrometer at room temperature. 
1
H NMR spectra were recorded at a frequency of 300 
or 500 MHz and chemical shifts were reported in parts per million downfield from 
tetramethylsilane. 
31
P NMR spectra (
1
H decoupled) were recorded at a frequency of 202.3 
MHz with H3PO4 used as an external standard. Ampicillin, IPTG, DTT and most other 
biochemical reagents as well as polyacrylamide gel materials were purchased from 
Bioshop Canada Inc (Burlington, ON). Ni-NTA Superflow Resin was purchased from 
Qiagen (Mississauga, ON). Complete, Mini, EDTA-free Protease Inhibitor Cocktail 
Tablets were obtained from Roche (Laval, QC). XL-10 Gold and B834(DE3)pLysS E. 
coli cells were obtained from Stratagene (Cedar Creek, TX). T4 PNK, Unstained Protein 
Molecular Weight Marker, NdeI and EcoRI restriction enzymes were obtained from 
Fermentas (Burlington, ON). [γ-32P]ATP was purchased from Amersham Canada Ltd. 
(Oakville, ON).  
6.2.2 Solution synthesis of small molecules 
3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-2’-
deoxyuridine (1) was prepared by a three step synthesis as previously described.(254) 
5’-O-(4,4’-dimethoxytrityl)-O4-(methyl)-2’-deoxyuridine (2a)  
To an ice cold solution of (1) (0.600 g, 0.86 mmol) in ACN (4.7 mL) was added 
methanol (0.355 mL, 8.77 mmol) followed by DBU (0.295 mL, 1.97 mmol) and the 
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reaction allowed to progress on ice for 30 min then placed at room temperature. After 16 
h, the solvent was evaporated in vacuo, the crude product taken up in DCM (50 mL) and 
the solution washed with two portions of brine (2 x 100 mL) followed by a back 
extraction of the brine washes with 5 mL of DCM. The organic layer was dried over 
sodium sulphate, concentrated and placed on the high vacuum for 2 hours to produce a 
brown foam. 
To a solution of the brown foam in THF (10.0 mL) was added TBAF (1M) in THF 
(1.03 mL, 1.03 mmol). After 30 min, the solvent was evaporated in vacuo, the crude 
product taken up in DCM (25 mL), the solution was washed with two portions of sodium 
bicarbonate (2 x 125 mL) followed by a back extraction of sodium bicarbonate washes 
with DCM (5 mL). The organic layer was dried over sodium sulphate and concentrated to 
produce a brown gum. The crude product was purified by flash column chromatography 
using a DCM / methanol (49 : 1 → 97 : 3) solvent system to afford 0.460 g (98.2 %) of 
product as a colorless foam. 
Rf (SiO2 TLC): 0.20 DCM / methanol (49:1). 
1
H NMR (500MHz, CDCl3, ppm): 
8.03 (d, 1H, H6, J= 7.6 Hz), 7.19-7.36 (m, 9H, Ar), 6.79-6.82 (m, 4H, Ar), 6.25 (dd, 1H, 
H1’, J= 5.5 Hz), 5.60 (d, 1H, H5, J= 7.6 Hz), 4.47 (m, 1H, H3’), 4.02 (m, 1H, H4’), 3.92 
(s, 3H, ArOCH3), 3.78 (s, 6H, OCH3), 3.50 (dd, 1H, H5’, J= 10.8, 3.4 Hz), 3.41 (dd, 1H, 
H5’’, J= 10.8, 3.4 Hz), 2.60 (m, 1H, H2’), 2.25 (m, 1H, H2’’), 1.90 (d, 1H, OH). HRMS 






To an ice cold solution of (1) (0.600 g, 0.86 mmol) in ACN (4.7 mL) was added 
benzyl alcohol (0.909 mL, 8.77 mmol) followed by DBU (0.295 mL, 1.97 mmol). The 
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reaction was allowed to progress on ice for 30 min then placed at room temperature. 
After 16 h, the solvent was evaporated in vacuo, the crude product taken up in DCM (100 
mL) and the solution washed with two portions of brine (2 x 250 mL) followed by a back 
extraction of the brine washes with DCM (5 mL). The organic layer was dried over 
sodium sulphate and concentrated and placed on the high vacuum for 2 hours to produce 
a brown foam. 
To a solution of the brown foam in THF (10.0 mL) was added TBAF (1M) in THF 
(1.58 mL, 1.58 mmol). After 30 min, the solvent was evaporated in vacuo, the crude 
product taken up in DCM (25 mL), the solution washed with two portions of sodium 
bicarbonate (2 x 125 mL) followed by a back extraction of the sodium bicarbonate 
washes with DCM (5 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a brown gum. The crude product was purified by flash column 
chromatography using a DCM / methanol (99 : 1 → 49 : 1) solvent system to afford 
0.443 g (83.0 %) of product as a colorless foam. 
Rf (SiO2 TLC): 0.225 DCM / methanol (49:1). 
1
H NMR (500MHz, CDCl3, ppm): 
8.05 (d, 1H, H6, J= 7.4 Hz), 7.18-7.36 (m, 14H, Ar), 6.79-6.81 (m, 4H, Ar), 6.28 (dd, 1H, 
H1’, J= 5.5 Hz), 5.65 (d, 1H, H5, J= 7.4 Hz), 5.38 (s, 2H, ArOCH2Ar), 4.49 (m, 1H, 
H3’), 4.04 (m, 1H, H4’), 3.77 (m, 6H, OCH3), 3.50 (dd, 1H, H5’, J= 10.6, 3.3 Hz), 3.41 
(dd, 1H, H5’’, J= 10.6, 3.3 Hz), 2.62 (m, 1H, H2’), 2.26 (m, 1H, H2’’), 2.09 (d, 1H, OH). 









deoxyuridine (3a)  
To a solution of (2a) (0.350 g, 0.643 mmol) in THF (3.0 mL) was added DIPEA 
(168 μL, 0.964 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (172 μL, 0.770 mmol). After 30 min, the solvent 
was evaporated in vacuo, the crude product taken up in ethyl acetate (50 mL), the 
solution washed with two portions of sodium bicarbonate (2 x 100 mL) and once with 
brine (100 mL). The organic layer was dried over sodium sulphate and concentrated. The 
product, a colorless powder, was resuspended in 3 mL of ethyl acetate and precipitated 
from 1L of hexanes (0.177 g, 37.0 %).  
Rf (SiO2 TLC): 0.36, 0.55 hexanes / ethyl acetate (2:8).
 31
P NMR (202.3 MHz, d6-






deoxyuridine (3b)  
To a solution of (2b) (0.413 g, 0.665 mmol) in THF (3.0 mL) was added DIPEA 
(191 μL, 1.089 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (196 μL, 0.871 mmol). After 30 min, the solvent 
was evaporated in vacuo, the crude product taken up in ethyl acetate (50 mL), the 
solution washed with two portions of sodium bicarbonate (2 x 100 mL) and once with 
brine (100 mL). The organic layer was dried over sodium sulphate and concentrated. The 
product, a colorless powder, was resuspended in 3 mL of ethyl acetate and precipitated 
from 1L of hexanes (0.265 g, 48.8 %).  
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Rf (SiO2 TLC): 0.72, 0.84 hexanes / ethyl acetate (2:8).
 31
P NMR (202.3 MHz, d6-







deoxyuridine (4a)  
To an ice cold solution of (1) (1.50 g, 2.16 mmol) in ACN (21.6 mL) was added 
1,4-butanediol (0.960 mL, 10.80 mmol) followed by DBU (0.743 mL, 4.97 mmol), the 
reaction allowed to progress on ice for 30 min and placed at room temperature. After 1.5 
h, the reaction was quenched with 7 mL of saturated sodium bicarbonate, the solvent was 
evaporated in vacuo and the crude product taken up in DCM (100 mL); then the solution 
was washed with two portions of sodium bicarbonate (2 x 150 mL) followed by a back 
extraction of the sodium bicarbonate washes with DCM (5 mL). The organic layer was 
dried over sodium sulphate and concentrated to produce a brown gum. The crude product 
was purified by flash column chromatography using a hexane / ethyl acetate solvent 
system (1 : 1 → 7 : 13) to afford 1.30 g (74.2 %) of product as a colorless foam. 
Rf (SiO2 TLC): 0.24 hexane / ethyl acetate (2:3). 
1
H NMR (300MHz, CDCl3, ppm): 
8.28 (d, 1H, H6, J= 7.3 Hz), 7.29-7.45 (m, 10H, Ar), 6.87-6.90 (m, 3H, Ar), 6.31 (dd, 1H, 
H1’, J= 4.2 Hz), 5.59 (d, 1H, H5, J= 7.3 Hz), 4.52 (m, 1H, H3’), 4.44 (t, 2H, ArOCH2, J= 
6.7 Hz), 4.00 (m, 1H, H4’), 3.85 (s, 6H, OCH3), 3.74 (dt, 2H, CH2OH, J= 6.6, 5.3 Hz), 
3.58 (dd, 1H, H5’, J= 10.8, 3.0 Hz), 3.36 (dd, 1H, H5’’, J= 10.8, 3.0 Hz), 2.56 (m, 1H, 
H2’), 2.25 (m, 1H, H2’’), 1.88 (m, 2H, CH2), 1.72 (m, 2H, CH2), 1.63 (s, 1H, OH), 0.84 










To an ice cold solution of (1) (1.70 g, 2.44 mmol) in ACN (21.6 mL) was added 
1,7-heptanediol (1.70 mL, 12.2 mmol) followed by DBU (1.11 mL, 7.46 mmol), the 
reaction allowed to progress on ice for 30 min and placed at room temperature. After 7 h, 
the reaction was quenched with 7 mL of saturated sodium bicarbonate, the solvent was 
evaporated in vacuo, the crude product taken up in DCM (100 mL). The solution washed 
with two portions of sodium bicarbonate (2 x 150 mL) followed by a back extraction of 
the sodium bicarbonate washes with DCM (5 mL). The solution washed with brine (150 
mL) followed by a back extraction with DCM (5 mL). The organic layer was dried over 
sodium sulphate and concentrated to produce a brown gum. The crude product was 
purified by flash column chromatography using a DCM / methanol solvent system (49 : 1 
→ 97 : 3) to afford 1.16 g (68.2%) of product as a colorless foam. 
Rf (SiO2 TLC): 0.5 DCM / methanol (19:1). 
1
H NMR (300MHz, CDCl3, ppm): 8.25 
(d, 1H, H6, J= 7.4 Hz), 7.27-7.43 (m, 10H, Ar), 6.85-6.88 (m, 3H, Ar), 6.30 (dd, 1H, H1’, 
J= 4.5 Hz), 5.58 (d, 1H, H5, J= 7.4 Hz), 4.49 (m, 1H, H3’), 4.37 (t, 2H, ArOCH2, J= 6.7 
Hz), 3.97 (m, 1H, H4’), 3.83 (s, 6H, OCH3), 3.67 (dt, 2H, CH2OH, J= 6.6, 5.2 Hz), 3.56 
(dd, 1H, H5’, J= 10.7, 2.7 Hz), 3.33 (dd, 1H, H5’’, J= 10.7, 2.7 Hz), 2.52 (m, 1H, H2’), 
2.23 (m, 1H, H2’’), 1.75 (m, 2H, CH2), 1.59 (m, 2H, CH2), 1.40 (s, 6H, (CH2)3), 0.83 (s, 









 To an ice cold solution of (4a) (0.500 g, 0.697 mmol) in THF (7.0 mL) was added 
triethylamine (0.157 µL, 1.12 mmol) followed by the dropwise addition of phenoxyacetyl 
chloride (0.122 µL, 0.715 mmol). The reaction was allowed to progress on ice for 5 min 
and then allowed to come up to room temperature. After 10 min, the solvent was 
evaporated in vacuo, the crude product taken up in DCM (50 mL), washed with sodium 
bicarbonate (2 x 100 mL) followed by a back extraction of the sodium bicarbonate 
washes with DCM (5 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was placed on high vacuum for 
1 hour. 
To a solution of the yellow gum in THF (7.0 mL) was added dropwise TBAF (1M) 
in THF (1.68 mL, 1.68 mmol). After 30 min, the solvent was evaporated in vacuo, the 
crude product taken up in DCM (50 mL), the solution washed with sodium bicarbonate (2 
x 150 mL) followed by a back extraction of the sodium bicarbonate washes with DCM (5 
mL). The organic layer was dried over sodium sulphate and concentrated to produce a 
yellow gum. The crude product was purified by flash column chromatography using a 
DCM / methanol solvent system (49 : 1 → 193 : 7) to afford 0.462 g (77.7 %) of product 
as a colorless foam.  
Rf (SiO2 TLC): 0.26 DCM / methanol (19 : 1). 
1
H NMR (500MHz, CDCl3, ppm): 
8.02 (d, 1H, H6, J= 7.3 Hz), 7.19-7.37 (m, 11H, Ar), 6.80-6.97 (m, 7H, Ar), 6.24 (dd, 1H, 
H1’, J = 6.0 Hz), 5.59 (d, 1H, H5, J= 7.3 Hz), 4.62 (s, 2H, PhOCH2CO), 4.46 (m, 1H, 
H3’), 4.34 (m, 2H, ArOCH2), 4.23 (m, 2H, CH2OCO), 4.01 (m, 1H, H4’), 3.78 (s, 6H, 
OCH3), 3.50 (dd, 1H, H5’, J= 10.7, 3.4 Hz), 3.41 (dd, 1H, H5’’, J= 10.7, 3.4 Hz), 2.58 
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(m, 1H, H2’), 2.24 (m, 1H, H2’’), 1.75 (m, 4H, (CH2)2). HRMS (ESI-MS) m/z: Observed 






 To an ice cold solution of (4b) (0.500 g, 0.660 mmol) in THF (6.6 mL) was added 
triethylamine (0.194 µL, 1.39 mmol) followed by the dropwise addition of phenoxyacetyl 
chloride (0.183 µL, 1.32 mmol). The reaction was allowed to progress on ice for 5 min 
and allowed to come up to room temperature. After 10 min, the solvent was evaporated in 
vacuo, the crude product taken up in DCM (50 mL), the solution washed with sodium 
bicarbonate (2 x 150 mL) followed by a back extraction of the sodium bicarbonate 
washes with DCM (5 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was placed on high vacuum for 
1 hour. 
To a solution of the yellow gum in THF (6.6 mL) was added TBAF (1M) in THF 
(1.58 mL, 1.58 mmol) dropwise. After 30 min, the solvent was evaporated in vacuo, the 
crude product taken up in DCM (50 mL), the solution washed with sodium bicarbonate (2 
x 150 mL) followed by a back extraction of the sodium bicarbonate washes with DCM (5 
mL). The organic layer was dried over sodium sulphate and concentrated to produce a 
yellow gum. The crude product was purified by flash column chromatography using a 
hexanes / ethyl acetate solvent system (4 : 6) to afford 0.790 g (84.3 %) of product as a 
colorless foam.  
Rf (SiO2 TLC): 0.29 hexanes / ethyl acetate (4 : 6).
1
H NMR (500MHz, CDCl3, 
ppm): 8.02 (d, 1H, H6, J= 7.5 Hz), 7.20-7.37 (m, 12H, Ar), 6.80-6.97 (m, 6H, Ar), 6.26 
(dd, 1H, H1’, J = 6.0 Hz), 5.60 (d, 1H, H5, J= 7.5 Hz), 4.61 (s, 2H, PhOCH2CO), 4.47 
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(m, 1H, H3’), 4.32 (t, 2H, ArOCH2, J= 6.6 Hz), 4.18 (t, 2H, CH2OCO, J= 6.6 Hz), 4.02 
(m, 1H, H4’), 3.78 (s, 6H, OCH3), 3.50 (dd, 1H, H5’, J= 10.7, 3.4 Hz), 3.41 (dd, 1H, 
H5’’, J= 10.7, 3.4 Hz), 2.59 (m, 1H, H2’), 2.25 (m, 1H, H2’’), 1.80 (s, 1H, OH), 1.63-







(phenoxyacetyloxybutyl)-2’-deoxyuridine (6a)  
To a solution of (5a) (0.440 g, 0.597 mmol) in THF (3.0 mL) was added DIPEA 
(172 μL, 0.986 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (176 μL, 0.789 mmol). After 30 min, the solvent 
was evaporated in vacuo, the crude product was taken up in ethyl acetate (50 mL), the 
solution washed with two portions of sodium bicarbonate (2 x 100 mL) and once with 
brine (100 mL). The organic layer was dried over sodium sulphate and concentrated. The 
product, a colorless gum, was resuspended in 3 mL of ethyl acetate and precipitated from 
1L of hexanes (0.452 g, 80.4 %).  
Rf (SiO2 TLC): 0.53, 0.69 hexanes / ethyl acetate (2:8).
 31
P NMR (202.3 MHz, d6-







(phenoxyacetyloxyheptyl)-2’-deoxyuridine (6b)  
To a solution of (5b) (0.400 g, 0.514 mmol) in THF (3.0 mL) was added DIPEA 
(147 μL, 0.848 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (151 μL, 0.678 mmol). After 30 min, the solvent 
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was evaporated in vacuo, the crude product taken up in ethyl acetate (50 mL), the 
solution was washed with two portions of sodium bicarbonate (2 x 100 mL) and once 
with brine (100 mL). The organic layer was dried over sodium sulphate and concentrated. 
The product, a colorless gum, was resuspended in 3 mL of ethyl acetate and precipitated 
from 1L of hexanes (0.348 g, 69.0 %).  
Rf (SiO2 TLC): 0.69, 0.80 hexanes / ethyl acetate (2:8).
 31
P NMR (202.3 MHz, d6-






6.2.3 Oligonucleotide synthesis and purification 
The solid-phase synthesis of O
4
-alkyl dU containing oligonucleotides U-Me, U-Bn, 
U4 and U7 (Figure 6.1) were performed on an Applied Biosystems Model 3400 
synthesizer on a 1 µmole scale employing standard β-cyanoethylphosphoramidite cycles 
as indicated by the manufacturer with certain modifications to coupling times as indicated 
below. ‘Fast-deprotecting’ 3’-O-2’-deoxyphosphoramidites were utilized at 0.1 M in 
ACN and modified phosphoramidites 3a, 3b, 6a and 6b (Scheme 6.1) at 0.15 M in ACN 
with phenoxyacetic anhydride as the capping agent due to the documented labile nature 
of adducts at the O
4
-atom of dT upon extended deprotection times, which also applies to 
dU.(196) 
Assembly of sequences was performed as described for T4 and T7 in Section 3.2.3 
with a phosphoramidite coupling time for modified phoshoramidites 3a, 3b, 6a and 6b of 
10 min. 
The support bound oligonucleotides were deprotected in a solution of 10% DBU in 
methanol (for U-Me), benzyl alcohol (for U-Bn), 1,4-butanediol (for U4) or 1,7-
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heptanediol (for U7) for 5 days at room temperature in the dark to ensure that the adducts 
were not compromised.(221) For U7, which was deprotected with 1,7-heptanediol, an 
extraction of the aqueous layer with DCM was required prior to applying to the solution 
to a C-18 SEP PAK cartridge. 
6.2.4 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
ESI mass spectra and exonuclease analysis for oligonucleotides were obtained as 
described in Section 2.2.4. 
The retention times of the eluted peaks were compared to the standard nucleotides 
which eluted at the following times: dC (4.6 min), dU (5.5 min), dG (6.7 min), dT (7.6 
min), dA (8.9 min), O
4
-MedU (9.6 min), O
4
-BndU (27.8 min), O
4
-butyl-4-ol dU (12.3 
min) and O
4
-heptyl-7-ol dU (22.7 min), and the ratio of nucleosides determined. 
6.2.5 UV thermal denaturation studies 
Thermal denaturation studies were performed and processed as described in 
Section 2.2.5. 
6.2.6 CD spectroscopy 
CD experiments were carried out as described as in Section 2.2.6. 
6.2.7 Protein expression and purification 
All AGT proteins except for the C146S Ada-C variant were expressed under the T5 
promoter of the pQE30 vector as described in Section 2.2.8. 
Due to the highly toxic nature of the inactive C146S Ada-C variant the gene was 
introduced into a tightly regulated system that would inhibit leaky expression of the 
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protein.(173,255) The wild-type Ada-C gene was introduced into the pET24B vector 
which harbours a lacI gene. The Ada-C gene was amplified from pQE30-Ada-C (127) by 
PCR using these primers: forward, 5'-GA GCA CAT ATG AGA GGA TCG CAT CAC 
CAT CAC CAT; reverse, 5'-CG GAT GAA TTC TTA CCT CTC CTC ATT TTC AGC 
TTC GCG, where the underlined nucleotides depict the NdeI and EcoRI cut-sites in the 
forward and reverse primers, respectively. PCR was conducted with Phusion polymerase 
with the following conditions: Hot start, 30 s, 98 °C; 35 cycles of denaturation at 98 °C 
for 10 s followed by annealing at 65 °C for 20 s followed by extension at 72 °C for 15 s; 
final extension at 72 °C for 10 s. 
The amplified product was cleaned up using E. Z. N. A. Cycle Pure Kit (Omega 
bio-tek) digested with NdeI and EcoRI, separated on a 1% agarose gel, the band 
corresponding to 586 bp DNA fragment excised and extracted from the gel slice using E. 
Z. N. A. Gel Extraction Kit (Omega bio-tek). The digested product was ligated into 
pET24B, which was digested with NdeI, EcoRI and treated with calf intestinal alkaline 
phosphatase, and the ligation mixture transformed into XL-10 gold cells. The resulting 
mixture was plated on LB + 50 μg/mL kanamycin media. The plasmids were extracted 
from the colonies that grew and transformed into B834(pLysS) cells after the identity of 
the plasmids were verified by restriction digestion and sequencing. 
Cells containing a plasmid coding for the C146S Ada-C variant were grown in 1L 
of LB broth supplemented with kanamycin (50 μg/mL) and chloramphenicol (100 
μg/mL) until an OD600 = 0.8. IPTG was added at a concentration of 0.5 mM and the cells 
incubated for 4 h, 225 rpm at 37 °C. The cells were harvested by centrifugation at 6000 x 
g at 4 °C for 20 min, the supernatant discarded and the cell pellets taken up in 
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resuspension buffer composed of 20 mM Tris HCl (pH 8.0), 250 mM NaCl, 20 mM β-
mercaptoethanol supplemented with Complete, Mini, EDTA-free Protease Inhibitor 
Cocktail Tablets at 5 mL buffer per gram of wet pellet. The cells were lysed using two 
passes on the French press followed by centrifugation at 17000 x g for 45 min at 4 °C. 
The cell lysate was introduced on a Ni-NTA column pre-equilibrated with equilibration 
buffer (resuspension buffer lacking the Complete, Mini, EDTA-free Protease Inhibitor). 
The column washed with equilibration buffer supplemented with 20 mM imidazole and 
the protein eluted with equilibration buffer supplemented with 200 mM imidazole. The 
pooled fractions were dialyzed against a buffer made up of 50 mM Tris HCl (pH 7.6), 
250 mM NaCl, 20 mM β-mercaptoethanol and 0.1 mM EDTA using 8000 Da cutoff 
tubing. 
6.2.8 Mono-adduct repair assay 
An oligonucleotide sequence used by our group to monitor the repair of O
4
-alkyl 
dT was used where an intrinsic diagnostic BclI cut site allows for the monitoring of 
dealkylation at the O
4
 atom of dT or O
6
 atom dG.(235) The sequence of the damage 





-butyl-4-ol dU (U4) and O
4
-heptyl-7-ol dU (U7). 
The sequence of the complement strand was 5’ CTG GT/G ATC AAG CC where the "/" 
represent the BclI cut site.  
Radiolabelling and repair reactions with the substrates were conducted as described 
in Section 3.2.8. 
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6.2.9 Binding studies 
Binding studies of the mono-adduct containing oligonucleotides were conducted as 
described in Section 3.2.9. 
6.2.10 Modelling of O
4
-alkyl dU into AGT active sites 
The initial model of the chimera was generated using Modeller 9.10 using PDB 
1T38 as template as previously described by our group.(253) The modified DNA was 







-butyl-4-ol dU or O
4
-heptyl-7-ol dU. The placement of the modified 
nucleoside was verified with PDB 1YFH. 
The preliminary models underwent conjugate gradient minimization, simulated 
annealing, and torsion angle dynamics using Crystallography & NMR System.(222) 
CHARMM topology files were modified to use the altered nucleotides by adding 
restraints to keep the α-carbon of the lesion in a syn conformation with respect to the N3 
atom of the nucleotide, as observed in PBDs 1T38, 1T39, and 1YFH.(223) 
The models underwent 2 sets of 100 steps of gradient minimization and 200 steps 
of simulated annealing. The first cycle was carried out at 500 K with slow cooling at a 
rate of 4.5 K per cycle of dynamics. The second cycle was carried out at 350 K with slow 




6.3 Results and discussion 
6.3.1 Substrate preparation 
The structures of the O
4
-alkyl dU substrates generated and the oligonucleotide 
sequence into which they were incorporated for use in this study are shown in Figure 6.1. 
The adducts varied in size and shape to obtain an understanding on how different classes 
of lesions are acted upon by AGT. U-Me, U4 and U7 were synthesized to make the 
parallel with similar adducts studied by our group at the O
4 
atom of dT in the same DNA 
context. U-Bn on the other hand was prepared to gain an understanding of : 1) substrate 
placement of adducts at the O
4
 atom of dU in AGT active sites and 2) if this could be an 
O
6
-BndG analogue with potent hAGT inhibiting properties.(127,137,142) 
The synthesis of the phosphoramidite precursors required for solid phase synthesis 
are shown in Scheme 6.1. The synthesis began with a previously reported protected 
convertible dU derivative 1.(254) The convertible nucleoside was transformed into 
various O
4





-BndU, 1,4-butanediol for O
4
-butyl-4-ol dU and 1,7-heptanediol for O
4
-





-BndU precursors), the 3'-OH were directly exposed via a fluoride 
treatment to afford compounds 2a and 2b, which were phosphitylated to generate 3a and 
3b, respectively. For the terminal alcohol containing adducts 4a and 4b, the hydroxyl 
groups required introduction of protective groups that would be compatible with solid 
phase synthesis and easy to remove during oligonucleotide deprotection. This was 
achieved with a phenoxyacetyl group, which was the capping functionality to be used 
199 
 
during solid phase synthesis. For these compounds the 3'-OH were exposed via a fluoride 
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Scheme 6.1: Synthesis of O
4
-alkyl dU amidites 3a, 3b, 6a (n=3) and 6b (n=6). 
Reagents and conditions: i) MeOH (a) or BnOH (b), DBU, ACN, 16 h; TBAF (1 M in 
THF), 30 min; ii) N,N-diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, 
THF, 30 min; iii) 1,4-butanediol (a) or 1,7-heptanediol (b), DBU, ACN, 1.5 h (a) or 7 h 
(b); iv) phenoxyacetyl chloride, triethylamine, THF, 10 min; TBAF (1 M in THF), 30 
min; v) N,N-diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, THF, 30 
min. 
The solid phase synthesis of the oligonucleotides was conducted using standard 
phosphoramidite chemistry, but some prospective hurdles involving the use of O
4
-alkyl 
dU and deprotection conditions were circumvented by using a mixture of alcohol and 
DBU instead of the conventional ammonia ethanol treatment which is known to remove 
O
4
-alkyl dT adducts.(256,257) Another difficulty, which was not foreseen, was the 
incompatibility between 1,7-heptanediol, used for the deprotection of U7, and the C-18 
SEP PAK cartridges. The non-polar property of the diol obstructed binding of the DNA 
to the resin and hence desalting could not be achieved. To circumvent this issue a DCM 
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extraction was required prior to applying the aqueous layer to the C-18 SEP PAK 
cartridges. 
6.3.2 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
The molecular weights of the modified oligomers obtained from HR-MS were in 
agreement with the calculated masses indicating that the lesions were not compromised 
by the solid phase synthesis procedure or deprotection steps. The ESI-MS data was 
supported by the nucleoside ratios extracted from the exonuclease digestion. Exonuclease 
digestion of the oligonucleotides each revealed the presence of an additional peak aside 
from the 4 natural nucleosides, supporting the presence of the O
4
-alkyl dU modifications 
or dU for DNA U. 
6.3.3 UV thermal denaturation studies 
The effect of the adducts at the O
4
 atom of dU on thermal stability of the DNA 
duplex were examined. The melting temperatures of the different duplexes are shown in 
Table 6.1 and their curves in Appendix VI. The non-alkylated control (U) displayed the 
highest thermal stability with a Tm of 58 °C, identical to the one observed for the same 
DNA having dT at X.(235) Introduction of an alkyl group at the O
4
 atom of dU lead to a 
drop of ~10 °C in Tm, irrespective of the size or functionality of the lesion for the 
modifications investigated. This is also in agreement with previously published work, 
where methylation, hydroxybutylation and hydroxyheptylation of the O
4
 atom of dT at X 
decreased the Tm of the duplex by 9-11 °C with respect to the non-alkylated control. 
201 
 
Clearly the absence of the C5 methyl of dU or of O
4
-alkyl dU at X has no effect on DNA 
stability. 
Table 6.1: Effect of O
4
-alkyl dU modifications on thermal stability of DNA 
DNA
1







 5'-GGC TXG ATC ACC AG 
           CCG AAC TAG TGG TC-5' 
6.3.4 CD spectroscopy 
CD analysis of dsDNA containing U, U-Me, U-Bn, U4 and U7 exhibited virtually 
identical spectroscopic signatures characteristic of B-form DNA having a positive signal 
at 275 nm, a crossover at 260 nm and a negative signal at 250 nm, see Figure 6.2.(200) 
The adducts did not cause a dramatic effect on the overall structure of the DNA duplex.  
 
Figure 6.2: Far-UV CD spectra of duplex containing oligonucleotides U (——), U-Me 




6.3.5 Mono-adduct repair  
The repair of our O
4
-alkyl dU substrate library was studied with 3 natural AGT 
homologues (and their variants) and a chimera (and its variants). Initially, the different 
substrates were incubated overnight with the various AGT to determine which proteins 
could repair our substrates (See Appendix VI). Time course repair studies with the "wild-
type" proteins were conducted, with the omission of Ada-C since it only repaired U-Me 
and did so rapidly. 
Figure 6.3A shows the repair of U-Me by hAGT at room temperature. The reaction 
required 45 min to reach completion. This represents a ~25-fold increase in rate over the 
repair of the alkylated dT counterpart. Complete repair of U-Me by the chimera occurred 
in less than 3 min, as observed in Figure 6.3B, making this protein ~20 times more 
efficient at repairing this lesion than its human equivalent. Repair of U-Me by the 
chimera occurred ~30 times faster than it did for O
4
-MedT. The chimera was still less 
active than OGT since the later protein achieved total repair of the substrate in less than 







Figure 6.3: Time course repair of U-Me at room temperature by (A) hAGT and (B) 
chimera. 
Repair studies of U-Bn (Figure 6.4) displayed hAGTs preference for the benzyl 
adduct over the methyl at the O
4
 atom of dU. Once more, hAGT fell short of OGT and 
the chimera, where both proteins completely repaired the lesion in less than 15 sec. U-Bn 
was repaired ~100 times faster than U-Me by hAGT. These data correlates well with the 




-BndG, where the latter lesion is repaired ~80 
faster by hAGT.(160) These similar results suggest that the benzyl adduct, whether at the 
O
6
 atom of dG or O
4
 atom of dU orient in similar fashions in the hAGT active site. 
Despite these promising data, O
4





hAGT since the repair of O
6
-MedG in an identical sequence and under the same 
conditions was achieved in less than 15 sec.(235) The effect of the added phenyl ring 
appeared to have the same consequence on the chimera where an increase in rate of repair 
was observed for U-Bn over U-Me.  
 
Figure 6.4: Time course repair of U-Bn at room temperature by hAGT 
hAGT was unable to repair U4 or U7, which follows the trend we observed 
previously for the repair of these same adducts on the O
4
 atom of dT.(235) Unlike what 
was discovered for dT, the chimera was able to repair both U4 and U7 at reasonable rates. 
U4 was fully repaired in ~2 hours (Figure 6.5A) representing a 60-fold decrease in 
activity with respect to OGT which repaired the damage in ~2 minutes (Figure 6.5B). 
The effect of the C5 methyl had a reduced influence on OGT, with respect to both the 






Figure 6.5: Time course repair of U4 at room temperature by (A) the chimera and (B) 
OGT. 
Repair of U7 by OGT and the chimera occurred at virtually identical rates as shown 
in Figure 6.6. The time course repair of this adduct highlights large substrate 
discrimination patterns amongst AGTs. 1) Removing the C5 methyl of O
4
-heptyl-7-ol dT 
not only permitted the chimera to repair the lesion but allowed the repair to occur at a rate 
similar to OGT, further demonstrating the more accrued effect of the C5 methyl on the 
chimera (and therefore hAGT) than on OGT. 2) The absence of the C5 methyl in this 
case increased OGTs ability to remove the adduct by 30-fold, suggesting a steric 





for the chimera. 3) Repair of the longer U7 lesion occurred 10-fold slower by OGT than 
U4, while the chimera repaired U7 8 times faster than U4. 
 
Figure 6.6: Time course repair of U7 at room temperature by the chimera (– •  • –) and 
OGT (- -) 
The kinetic data support the notion that the active site cavities of OGT and hAGT 
differ considerably. By substituting a number of amino acids of the hAGT active site with 
the respective amino acids from OGT, the chimera was capable of removing all adducts 
in our substrate library. Indeed, residues 139-159 of hAGT, which are altered in the 
chimera, play a substantial role in the mediation of O
4
-alkyl damage repair. Since part of 
the active site is still hAGT in nature some properties belonging to the human homologue 
persist in the chimera. The active site of hAGT can be viewed as a tunnel more than a 
pocket, allowing it, and the chimera, to process longer lesions. This was best exemplified 
when comparing the U4 versus U7 substrates. In OGT, U7 seemed to spatially saturate 
the active-site, perhaps due to the more pocket-like shape active site of this protein, 
therefore reducing the processing rate of the protein. For the chimera, the longer alkyl 
chain may have allowed the terminal hydroxyl moiety to be occluded from the active site 
permitting repair to occur more efficiently. Since the effect of the C5 methyl of dT 
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hindered hAGT and the chimera to a similar degree, it can be infered that the amino acids 
that are substituted in the chimera (139-159) do not participate in the steric clash.  
6.3.6 Binding studies 
Other factors aside from the shape of the active site may play a role on substrate 
discrimination by AGTs. The substrate recognition amongst AGTs is of importance 
considering that of 3 basic amino acids that are believed to govern the hAGT-DNA ionic 
interaction (Lys 125, Arg 128 and Arg 135), only Arg 128 is present at a similar location 
in OGT.(168) Different interaction patterns amongst AGTs with DNA could dictate the 
orientation of the modified nucleotide into the active-site and contribute to the distance 
between the lesion's α-carbon and the reactive active site Cys residue. We conducted 
EMSAs with the inactive AGT variants to help determine if the various AGTs studied 
interact differently with our substrates to aid in the understanding of our kinetic data.  
The binding data shown in Table 6.2 reveal no correlation between repair kinetics 
and binding affinity or stoichiometry (all stoichiometries indicated 2 AGT per dsDNA). 
Indeed, OGT showed the fastest repair kinetics but interacts with the DNA with the 
lowest affinity with Kd values in the low μM range while the other AGTs display high 
nM Kd values. Perhaps binding affinity does not govern the reaction kinetics but the 
difference in affinities does support the concept that OGT binds DNA in a different 
fashion than the other homologues. 
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Table 6.2: Kd of AGTs binding to dsDNA containing U, U-Me, U-Bn, U4 and U7 
DNA
1
 OGT (μM) Ada-C (μM) hAGT (μM) Chimera (μM) 
U 3.77 ± 0.08 0.330 ± 0.014 0.381 ± 0.019 0.258 ± 0.013 
U-Me 2.69 ± 0.26 0.660 ± 0.041 0.269 ± 0.010 0.149 ± 0.003 
U-Bn 3.44 ± 0.22 0.603 ± 0.044 0.298 ± 0.010 0.179 ± 0.003 
U4 3.72 ± 0.13 0.887 ± 0.049 0.593 ± 0.045 0.426 ± 0.004 
U7 3.81 ± 0.08 0.974 ± 0.052 0.619 ± 0.021 0.414 ± 0.003 
1
 5'-GGC TXG ATC ACC AG 
          CCG AAC TAG TGG TC-5' 
The chimera bound the DNA with similar affinities as hAGT but displayed 
different affinities than OGT. This is logical considering that the altered amino acids in 
the chimera are around the active site and not in the helix-turn-helix motif which makes 
up the AGT-DNA binding interface. The chimera's conferred ability to repair our 
substrates is therefore not caused by alteration in the binding interface and must therefore 
come from the shape of the active site that permits these substrates to fit such that the 
substrate and Cys side chain adopt a spatial arrangement that allow for the alkyl transfer 
to occur. 
6.3.7 Modelling of O
4
-alkyl dU into AGT active sites 
To gain more insight into the interaction of the chimera with the O
4
-alkyl dU 
adducts, relative to hAGT, molecular modelling was performed. In view of the chimeras 
similar binding properties to those of hAGT it is reasonable to prepare a molecular model 
based on the hAGT-DNA co-crystal 1T38 to model the adducts into both the hAGT and 
chimera active sites. Attempts to generate models of OGT based on the same template 
proved unsuccessful as the repair data and OGT models did not correlate due to the 
different binding properties of OGT and hAGT to DNA. 
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Table 6.3: Extracted distance between α-carbon of lesion and AGT reactive Cys 145 
sulphur atom as determined by molecular modelling 




















ROTO signifies Cys 145 side chain is not in 
correct rotamer for thiolate anion formation 
In general, the modelling data agrees with our experimental results where the 
shorter distance between reactive groups is manifested by quicker reaction kinetics. 
hAGT is limited to O
4
-MedU because of the rigidity of the active site producing steric 
clashes with the longer adducts, which was observed in our models as improper 
placement of the Cys 145 side chain for thiolate anion formation, see Figure 6.7A. 
Adoption of this rotamer by Cys 145 is not unreasonable considering the crystal structure 
of the C145S hAGT in complex with O
6
-MedG has its Ser 145 in a similar rotameric 
state as those produced in our modelling.(155) 
Amongst the many alterations in the chimera the N157G and S159A variations can 
be partially attributed as the basis for the chimera's ability to repair a vast array of lesions 
as opposed to hAGT. These point substitutions grant flexibility to the active site helping 
to orient the modified nucleoside for repair, see Figure 6.7B. Studies with similar 
chimera proteins by Dr. Anthony Pegg lead to comparable finding where the increased 
activity of their chimera were attributed to the flexibility of the proteins active site.(123)  
According to the modelling, the increased rate of repair of U-Me over its dT 
counterpart by hAGT arises from the alleviation of a steric clash between the C5 group of 
dT and α-carbon of Ser 159 and the side chain of Arg 135. In the chimera, Arg 135 still 
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remains and the S159A alteration does not alleviate the former clash explaining why the 
chimera is affected in a similar fashion as hAGT by the C5 appendage.  
U7 repair occurred more rapidly by the chimera than U4 due to steric effects as 
noted in Figure 6.7C. The longer alkyl chain of O
4
-heptyl-7-ol dU spans a distance vast 
enough to permit the terminal hydroxyl group to be solvent exposed. This manifested 
itself in a reduction in distance between the reactive moieties for O
4
-heptyl-7-ol dU over 
O
4




















Figure 6.7: Molecular modelling results of O
4
-alkyl dU adducts in hAGT and chimera 
active sites. 
(A) Rotamer adoption of Cys 145 side chain of hAGT when bound to DNA containing 
O
4
-MedU (green sticks) or O
4
-butyl-4-ol dU (yellow sticks). (B) Mobility of the loop 
made up of amino acids 157- GYAGG (represented as ribbons) when the chimera is 




-butyl-4-ol dU (yellow) and O
4
-heptyl-7-
ol dU (cyan), where Cys 145 side chain is shown as white sticks. (C) Active site of the 
chimera showing the space filling of O
4
-butyl-4-ol dU (yellow) and wireframe of O
4
-







The C5 appendage of dT displays a negative effect on processing of O
4
-alkyl 
pyrimidine lesions by AGTs. Its inhibitory effect is most observed by hAGT and the 
chimera protein. As the lesion at the O
4
 position augments in size from a butyl-4-ol to a 
heptyl-7-ol, the role of the C5 methyl is greatly amplified on OGT mediated repair. These 
disparities between homologues signify substantial differences in active site shapes 
and/or sizes as well as DNA binding interfaces, the latter supported by our binding 
experiments. Modelling suggests substrate orientation as the determining factor for O
4
-
alkyl pyrimidine repair. The C5 methyl group, present in dT, clashes with Ser 159 and 
Arg 135 and limits the inclination of the nucleotide into the hAGT active (Figure 6.8). 
This clash also holds true for the chimera but the added mobility of the loop made up of 
157- GYAGG allows the nucleotide to penetrate further into the active site and 
contributes to the promiscuity of this protein over its human equivalent. 
 
Figure 6.8: Effect of C5 methyl on O
4
-alkyl pyrimidine repair. 
C5 methyl (white stick) inhibits inclination of the modified nucleoside (yellow sticks) 
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AGT are responsible for the removal of alkylation damage from the O
6
 atom of dG and 
the O
4
 atom of dT. hAGT is capable of repairing ICL lesions between two O
6
 atoms of 
dG when tethered by a butylene (XLGG4) or heptylene (XLGG7) chain but is inactive 
when the ICL involves the O
4
 atoms of dT. We present the synthesis and biophysical 









dU (XLUU7) ICL to study the effect of the C5 methyl of dT on AGT 
mediated repair of ICLs. XLUU4 and XLUU7 evaded repair by all AGTs analyzed. The 
AGT homologous interact with the ICL DNA with comparable low μM dissociation 
constants and 2:1 or 4:1 protein:DNA stoichiometries. The solution structures of XLUU7 
and XLGG7 were solved and compared. The global structures are virtually identical with 
a RMSD of 1.22 Å. Moreover, the cross-link resides in the major groove for both DNA 
species. At a local level, the heptylene linkage adopts an E conformation about the C4-O
4
 
bond in XLUU7 whereas a Z conformation about the C6-O
6
 bond is observed for 
XLGG7. This E versus Z conformation may be the underlying cause for hAGTs substrate 
discrimination since substrates proficient at undergoing repair by hAGT have been shown 




It was once believed that DNA, the source of the genetic code, was an inert 
molecule. This conjecture has been disproven and research now focuses on studying both 
the causes and consequences of modifying events. It is well accepted that many sites in 
DNA are susceptible to modifications, including the exocyclic atoms of the nitrogenous 
bases.(12) The sources of DNA damage are vast and can stem from both exogenous and 
endogenous agents.(258)  
One class of chemicals that modify DNA are bi-functional alkylating agents. These 
agents are extremely cytotoxic due to the nature of the lesion they induce. Unlike their 
mono-adduct forming counterparts, bi-functional alkylating agents have two reactive 
moieties, which allow them to form cross-links between reactive residues. ICLs formed 
by bi-functional alkylating agents tether two complimentary strands of DNA together.(7) 
The potency and cytotoxic property of bi-functional alkylating agents are attributed to 
their ability to form these ICL since they inhibit many cellular processes such as DNA 
replication and RNA transcription. In a study of 234 DNA alkylating chemicals, bi-
functional alkylating agents classify themselves as the most toxic where half of the top 20 
agents were bi-functional in nature.(40) Moreover, 12 out of the 20 most potent anti-
cancer drugs are cross-linking agents, with all of these ranking in the top 15.(41) Indeed, 
ICLs are cytotoxic, where 40 ICLs in repair deficient mammalian cell is enough to cause 




This cytotoxic nature has been exploited in chemotherapy to target cancer cells. 
Since both transcription and replication are hindered, the faster proliferating cancerous 
cells are affected to a greater level by these lesions. Due to the success of ICL forming 
agents many classes of bi-functional alkylating agents have emerged and find use in 
chemotherapy. Examples include: aziridines, nitrosoureas, nitrogen mustards and alkyl 
sulphonates and their derivatives.(42) 
The chemistry of bifunctional alkylating agents is complex and many products can 
arise from their reaction within the cell. Specific lesions in DNA have been isolated and 
characterized such as the major ICL product formed when treating DNA with 
hepsulfam.(75) This product, composed of two dG crosslinked through their N7 atoms by 
a heptylene linkage, is unstable and leads to depurination and the imidazole ring opened 
formamidopyrimidine derivative over time. For this reason we synthesized stable mimics 
of the ICL formed by hepsulfam by linking the O
6
 atoms of dG and O
4
 atoms of dT by 
heptylene tethers to conduct biophysical and repair assays.(146,214,235) We have 
expanded on these mimics by varying the length of the linker by introducing a butylene 
linker within identical DNA sequences. Tetramethylene intrastrand cross-links have been 
shown to be produced by the agent busulfan.  
Repair of ICL is complex and the mechanisms involved appear to be lesion 
specific.(208,209) No single repair mechanism can be attributed to ICL repair on its own 
but rather many mechanisms act together to achieve total removal of the damage. ICL 
removal is difficult since the genetic material on both strands of DNA are affected thus 
counteracting nature's failsafe template assisted resynthesis. Removal of the damage from 
one strand by an excision repair mechanism generates an intermediate that cannot be 
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resynthesized using the compliment strand since itself contains the remnant of the 
damage. NER, HR and TLS have shown activity in ICL repair.(reviewed in 259)  
AGT proteins are part of the direct repair pathway. Unlike most repair mechanisms 
in the cell this protein acts autonomously to achieve removal of DNA damage. The 
substrate range is quite limited where AGT is documented to repair O
6
-alkyl dG, and in 
some homologues, O
4
-alkyl dT lesions. O
6
-alkyl dG and O
4
-alkyl dT are mutagenic and 
if left unrepaired cause G to A and T to C transitions, respectively.(21,25) The human 
homologue has been extensively characterized and repairs DNA by flipping the modified 
nucleotide out of the DNA duplex and into its active site. This rotation positions the 
reactive Cys residue (Cys 145 in hAGT) in close proximity to the adduct promoting the 
nucleophilic attack by the Cys thiolate anion through an SN2-type mechanism, restoring 
the natural nucleotide in the process.(151,155) The resulting alkylated AGT is 
subsequently targeted for proteolysis through the ubiquitin mediated pathway.(104) 
Substrate discrimination patterns amongst AGT homologues exist, where the E. coli 
homologues, Ada-C and OGT, are capable of removing O
4
-MedT efficiently while hAGT 
shows virtually no repair of this adduct.(33,117) In contrast, hAGT repairs larger adducts 
at the O
6
 atom of dG as opposed to its E. coli equivalents.(127,128) 





dG cross-links containing a tetra- or heptamethylene lesion in a mismatched, 1,2 
staggered and 5’-GNC sequence context, where the O6dG-heptylene-O6dG cross-link is 
repaired more efficiently in all sequence contexts.(146,214) Ada-C and OGT lacked this 





dT cross-links containing a tetra- or heptamethylene lesion in a 
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mismatched sequence revealed hAGT and the E. coli homologues could not process the 
ICL.(235) These findings are in accordance with hAGTs poor capability to repair O
4
-




dT cross-link containing DNA with reasonable 
affinity supporting the notion that the protein can recognize the lesion. Unfortunately, the 
substrate discrimination patterns observed between AGTs is not yet understood. 
An AGT chimera composed of mainly hAGT residues and part of the active site of 
OGT has shown promise in conferring hAGT the ability to process O
4
-MedT while 
maintaining its ability to process ICLs.(253) The chimera showed poor repair of larger 
O
4
-butyl-4-ol dT and O
4





dT cross-links. Removal of the C5 methyl, such as is the case for O
4
-butyl-4-
ol dU and O
4


















































dU cross-links and (B) 
oligonucleotides XLUU4 and XLUU7 









dU (XLUU7) as shown in Figure 7.1, their characterization and interaction with AGT 
to elucidate the role of the C5 methyl of the cross-linked dT of the XLTT ICL series on 




solved and compared to aid in the understanding of the selective ICL repair pattern 
exhibited by hAGT and its chimera.  
7.2 Experimental 
7.2.1 Materials 
See Section 6.2.1 for materials. 
7.2.2 Solution synthesis of small molecules 
The solution and solid-phase synthesis of XLGG7 have been described previously 
by our group.(146) 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-(1,2,4-
triazol-1-yl)-2’-deoxyuridine was prepared by a three step synthesis.(254) 3’-O-(t-
butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-O4-(hydroxybutyl)-2’-deoxyuridine and 
3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-O4-(hydroxyheptyl)-2’-









deoxyuridine (0.500 g, 0.697 mmol) was dissolved in ACN (6 mL) and stirred on an ice 
bath. To this was added 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-
(1,2,4-triazol-1-yl)-2’-deoxyuridine (0.582 g, 0.837 mmol) followed by the dropwise 
addition of DBU (0.313 μL, 2.09 mmol). The reaction allowed to proceed at 0 °C for 5 
min and then allowed to warm up to room temperature. After 4 days, the solvent was 
evaporated in vacuo, the crude product was taken up in DCM (100 mL), the solution 
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washed with two portions of sodium bicarbonate (2 x 100 mL) and one portion of brine 
(100 mL). The organic layer was dried over sodium sulphate and concentrated to produce 
a yellow gum. The crude product was purified by flash column chromatography using a 
hexanes : ethyl acetate (2 : 3) solvent system to afford 0.790 g (84.3%) of product as a 
colorless foam.  
Rf (SiO2 TLC): 0.29 hexane / ethyl acetate (2 : 3). 
1
H NMR (300MHz, CDCl3, 
ppm): 8.27 (d, 2H, H6), 7.28-7.44 (m, 20H, Ar), 6.87-6.90 (m, 6H, Ar), 6.31 (dd, 2H, 
H1’, J= 4.2 Hz), 5.60 (d, 2H, H5), 4.52 (m, 2H, H3’), 4.44 (m, 4H, ArOCH2), 3.99 (m, 
2H, H4’), 3.84 (s, 12H, OCH3), 3.57 (dd, 2H, H5’), 3.36 (m, 2H, H5’’), 2.55 (m, 2H, 
H2’), 2.25 (m, 2H, H2’’), 1.88 (m, 4H, (CH2)2), 0.85 (s, 18H, SiC(CH3)3), 0.04 (s, 12H, 













deoxyuridine (0.510 g, 0.672 mmol) was dissolved in ACN (6 mL) and stirred on an ice 
bath. To this was added 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-dimethoxytrityl)-C4-
(1,2,4-triazol-1-yl)-2’-deoxyuridine (0.582 g, 0.837 mmol) followed by the dropwise 
addition of DBU (0.313 μL, 2.09 mmol). The reaction allowed to proceed at 0 °C for 5 
min and then allowed to warm up to room temperature. After 4 days, the solvent was 
evaporated in vacuo, the crude product was taken up in DCM (100 mL), the solution 
washed with two portions of sodium bicarbonate (2 x 100 mL) and one portion of brine 
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(100 mL). The organic layer was dried over sodium sulphate and concentrated to produce 
a yellow gum. The crude product was purified by flash column chromatography using a 
hexanes : ethyl acetate (1 : 1) solvent system to afford 0.776 g (83.3%) of pure product as 
a colorless foam. 
Rf (SiO2 TLC): 0.47 hexane / ethyl acetate (2 : 3). 
1
H NMR (300MHz, CDCl3, 
ppm): 8.22 (d, 2H, H6), 7.22-7.41 (m, 20H, Ar), 6.83-6.86 (m, 6H, Ar), 6.28 (dd, 2H, 
H1’, J= 4.0 Hz), 5.57 (d, 2H, H5), 4.48 (m, 2H, H3’), 4.35 (m, 4H, ArOCH2), 3.96 (m, 
2H, H4’), 3.80 (s, 12H, OCH3), 3.54 (dd, 2H, H5’), 3.32 (dd, 2H, H5’’), 2.51 (m, 2H, 
H2’), 2.23 (m, 2H, H2’’), 1.73 (m, 4H, (CH2)2), 1.39 (m, 6H, (CH2)3), 0.81 (s, 18H, 










To a solution of (1a) (0.767 g, 0.570 mmol) in THF (7.0 mL) was added TBAF (1 
M in THF) (2.57 mL, 2.57 mmol) dropwise. After 10 min, the solvent was evaporated in 
vacuo, the crude product taken up in DCM (50 mL), the solution washed with sodium 
bicarbonate (2 x 150 mL) followed by a two back extraction of the sodium bicarbonate 
washes with DCM (2 x 5 mL). The organic layer was dried over sodium sulphate and 
concentrated to produce a yellow gum. The crude product was purified by flash column 
chromatography using a DCM / methanol solvent system (49 : 1 → 9 : 1) to afford 0.634 
g (99.6 %) of product as a colorless foam.  
Rf (SiO2 TLC): 0.24 dichloromethane (DCM) / methanol (19 : 1). 
1
H NMR 
(500MHz, CDCl3, ppm): 8.06 (d, 2H, H6), 7.19-7.37 (m, 20H, Ar), 6.80-6.82 (m, 6H, 
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Ar), 6.24 (dd, 2H, H1’, J= 5.6 Hz), 5.60 (d, 2H, H5), 4.47 (m, 2H, H3’), 4.37 (m, 4H, 
ArOCH2), 4.03 (m, 2H, H4’), 3.78 (s, 12H, OCH3), 3.50 (dd, 2H, H5’), 3.41 (dd, 2H, 
H5’’), 2.59 (m, 2H, H2’), 2.23 (m, 2H, H2’’), 2.00 (m, 2H, OH), 1.83 (m, 4H, (CH2)2). 









To a solution of (1b) (0.575 g, 0.415 mmol) in THF (4.0 mL) was added TBAF (1 
M) in THF (1.87 mL, 1.87 mmol) dropwise. After 10 min, the solvent was evaporated in 
vacuo, the crude product taken up in DCM (50 mL), the solution washed with sodium 
bicarbonate (150 mL), brine (150 mL) followed by a two back extraction of washes with 
DCM (2 x 5 mL). The organic layer was dried over sodium sulphate and concentrated to 
produce a yellow gum. The crude product was purified by flash column chromatography 
using a DCM / methanol solvent system (97 : 3 → 19 : 1) to afford 0.476 g (99.2 %) of 
product as a colorless foam.  
Rf (SiO2 TLC): 0.29 DCM / methanol (19 : 1). 
1
H NMR (500MHz, CDCl3, ppm): 
8.06 (d, 2H, H6), 7.20-7.37 (m, 20H, Ar), 6.79-6.82 (m, 6H, Ar), 6.25 (dd, 2H, H1’, J= 
5.5 Hz), 5.60 (d, 2H, H5), 4.48 (m, 2H, H3’), 4.32 (m, 4H, ArOCH2), 4.03 (m, 2H, H4’), 
3.77 (s, 12H, OCH3), 3.48 (dd, 2H, H5’), 3.40 (dd, 2H, H5’’), 2.60 (m, 2H, H2’), 2.29 (d, 
2H, OH), 2.25 (m, 2H, H2’’), 1.71 (m, 4H, (CH2)2), 1.38 (m, 6H, (CH2)3). HRMS (ESI-














To a solution of (2a) (0.614 g, 0.551 mmol) in THF (3.0 mL) was added DIPEA 
(288 μL, 1.65 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (308 μL, 1.38 mmol). After 30 min, the solvent was 
evaporated in vacuo, the crude product taken up in ethyl acetate (50 mL), the solution 
washed with two portions of sodium bicarbonate (2 x 100 mL) and once with brine (100 
mL). The organic layer was dried over sodium sulphate and concentrated. The product, a 
colorless gum, was resuspended in 3 mL of ethyl acetate and precipitated from 1L of 
hexanes at -78 °C (0.757 g, 90.8 %).  
Rf (SiO2 TLC): 0.24, 0.44, 0.58 ethyl acetate.
 31
P NMR (202.3 MHz, d6-acetone, 













To a solution of (2b) (0.456 g, 0.394 mmol) in THF (3.0 mL) was added DIPEA 
(203 μL, 1.17 mmol) followed by the dropwise addition of N,N-diisopropylamino 
cyanoethyl phosphonamidic chloride (218 μL, 0.98 mmol). After 30 min, the solvent was 
evaporated in vacuo, the crude product taken up in ethyl acetate (50 mL), the solution 
washed with two portions of sodium bicarbonate (2 x 100 mL) and once with brine (100 
mL). The organic layer was dried over sodium sulphate and concentrated. The product, a 
225 
 
colorless gum, was resuspended in 3 mL of ethyl acetate and precipitated from 1L of 
hexanes at -78 °C (0.488 g, 80.3 %).  
Rf (SiO2 TLC): 0.30, 0.44, 0.55 hexanes / ethyl acetate (2 : 8).
 31
P NMR (202.3 






7.2.3 Oligonucleotide synthesis and purification 
Solid-phase synthesis of XLUU4 and XLUU7 was conducted on an Applied 
Biosystems Model 3400 synthesizer on a 1 µmole scale (XLUU4) or 5 x 2 µmole scale 
(XLUU7) as described in Section 3.2.3. The modified bis-phosphoramidites 3a and 3b 
were dissolved in anhydrous ACN at a concentration of 0.05 M. The coupling time for 
the modified bis-phosphoramidites 3a and 3b were 30 min. 
The CPG was removed from the column, placed into screw cap microfuge tubes 
and 500 μL of a 10% DBU in n-propanol solution added to each µmole of material. 
Deprotection and cleavage of the oligonucleotide was conducted for 5 days in the dark at 
room temperature.  
XLUU4 and XLUU7 were purified as described in Section 3.2.3. 
7.2.4 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
ESI mass spectra and exonuclease analysis for oligonucleotides were obtained as 
described in Section 2.2.4. 
The retention times of the eluted peaks were compared to the standard nucleotides 
obtained which eluted at the following times: dC (4.3 min), dU (5.6 min), dG (6.8 min), 
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(26.5 min) and the ratio of nucleosides determined. 
7.2.5 UV thermal denaturation studies 
Thermal denaturation studies were performed and processed as described in 
Section 2.2.5. 
7.2.6 CD spectroscopy 
CD experiments were carried out as described as in Section 2.2.6. 
7.2.7 Protein expression and purification 
All AGT proteins except for the C146S Ada-C variant were expressed under the T5 
promoter of the pQE30 vector as described in Section 2.2.8.  The C146S Ada-C variant 
was expressed under the T7 promoter of the pET vector as described in Section 6.2.7. 
7.2.8 Cross-link repair assay 
Cross-link repair assays were conducted as described in Section 2.2.10. 
7.2.9 Binding assay 
Cross-link binding assays were conducted as described in Section 3.2.11. Binding 
reactions consisted of 0.5 nM radio-labelled dsDNA, increasing AGT (C139S OGT, 1.5-
10.6 μM; C146S Ada-C, 0.3-1.2 μM; C145S hAGT; 0.5-1.8 μM or C145S chimera, 1.5-
10.6 μM) in a total solution volume of 20 μL composed of 10 mM Tris HCl (pH 7.6), 100 
mM NaCl, 1 mM DTT, 10 μg mL-1 BSA and 2.5% glycerol. 
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7.2.10 NMR spectroscopy of ICL DNA 
The DNA samples were dissolved in 0.3 (XLUU7) or 0.4 mL (XLGG7) of 100% 
D2O or 9:1 H2O/D2O buffer containing 15 mM sodium phosphate (pH=7.5) and 100 mM 
NaCl to a final strand concentration of 0.5 (XLUU7) or 1.0 mM (XLGG7).  
The proton NMR spectra were recorded on Varian Unity Inova 500 and 800 MHz 
spectrometers equipped with cryoprobes. Duplex melting temperatures of approximately 
50 °C for XLUU7 and 60 °C for XLGG7 were confirmed by recording proton 1D NMR 
spectra at different temperatures. NOESY (nuclear Overhauser effect spectroscopy) 
experiments were performed in D2O at 25 °C using mixing times tm of 70, 250 and 400 
ms. All spectra were processed by NMRPipe and the volumes of crosspeaks of NOESY 
spectra were calculated using NMRView.(260,261) NOESY experiments for imino-
protons in 9:1 H2O/D2O were performed at 0 °C with a mixing time of 200 ms. DQF-
COSY (double quantum filtered correlation spectroscopy) spectra were collected without 
phosphorus decoupling. Proton TOCSY MLEV-16 (total correlated spectroscopy using 
Malcolm Levitt's composite-pulse decoupling sequence) experiments were performed 
with a mixing time of 76 ms. Phosphorus spectra and H,P-correlation HSQC 
(heteronuclear single quantum correlation) spectra (with JPH = 15 Hz) were recorded on 
Varian VNMRS (
31
P NMR 202.3 MHz and proton NMR 500 MHz). Proton chemical 
shifts were measured relative to internal DSS (4,4-dimethyl-4-silapentane-1-sulfonic 
acid), and phosphorus resonances were indirectly referenced to 85% H3PO4.(262) 
Correlation times (τc=3-3.5 ns) were determined using the H5-H6 NOESY cross-peaks of 
dC assuming isotropic motion.(263) 
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7.2.11 Structural modelling 
The starting coordinates were generated from PDB 1N4B.(241) Crystallography & 
NMR System 1.2 software with nucleic acid all-hydrogen force field was used for 
molecular modelling.(222) The number of NOE-distance (nuclear Overhauser effect), 
torsion angle and other constraints are reported in the results section in Table 7.2. A 2-
fold symmetry, noncrystallographic symmetry restraints were imposed on all heavy 
atoms. The gentle refinement was accomplished by molecular dynamics simulation (15 
ps at 2000 K with slow-cooling annealing to 0 K) including a cartesian cooling stage. The 
final ensemble of the 10 best structures were collected, and the atomic coordinates of 
average and energy minimized structures have been deposited in the Protein Data Bank 
under ID code 2LZV for XLUU7 and 2LZW for XLGG7. 
Distance restraints were derived from NOESY spectra at different mixing times by 
crosspeak volume integration, using the d
-6
 distance relationship and average crosspeak 
volume values for H5-H6 in dC and dU (d = 2.45 Å) and Me-H6 in dT (d = 2.70 Å) as 
calibration. The distance constraints were given with a 10% lower and 15% upper limits. 
Sugar puckering was determined from vicinal J-couplings. The five sugar torsion angles 
were constrained corresponding to the range of S-type conformations (C1’-exo, C2’-endo, 
C3’-exo), which were determined from the strong H1’-H2’ and very weak H2”-H3’ 
crosspeaks in the DQF-COSY spectra. The β torsion angles were constrained using the 
information from the H5'/H5"-P and H4'-P crosspeaks in the H,P-HSQC spectra. The β 
angles were found to be in the trans conformation (180 ± 30 °) as determined by the 
relative low intensity of the H5'/H5"-P crosspeaks as well as strong 
4
JH4'-P W-pathway 
couplings. The γ angles were constrained (60 ± 20 °) using the NOE H4'-H1’ crosspeak 
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linewidths (9-11 Hz). Due to the larger values of the NOE H4' crosspeak linewidths for 
U6 in XLUU7 and T7 in XLGG7 residue (~14 Hz) and absence of 
4
JH4'-P W-pathway 
coupling crosspeak (see Appendix VII), the γ angles for U6 in XLUU7 and T7 in 
XLGG7 were constrained to be out of the 60 ± 40 ° range.(264) Phosphorus chemical 
shifts spanned a very narrow region that is typically found for undistorted DNA, and the ε 
angles were constrained based on the moderate intensity of the H3’-P crosspeaks, in the 
range of B-DNA (170 ± 50
 
°). Finally, the glycosidic angles (χ) were not constrained in 
structure calculations but were fixed indirectly by intranucleotide aromatic-sugar 
distances. Global helical parameters were calculated using the CURVES+ 
program.(265,266) 
7.3 Results 
7.3.1 Substrate preparation 









dU (3b) bis-amidites were synthesized as 
shown in Scheme 7.1 starting from the mono-adduct containing nucleoside containing a 
tetra- or heptamethylene linker with a terminal alcohol which was prepared as previously 
reported by reacting the appropriate di-alcohol with 3’-O-(t-butyldimethylsilyl)-5’-O-
(4,4’-dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-2’-deoxyuridine (see CHAPTER VI). The 
protected monomers was reacted with 3’-O-(t-butyldimethylsilyl)-5’-O-(4,4’-
dimethoxytrityl)-C4-(1,2,4-triazol-1-yl)-2’-deoxyuridine to achieve the protected dimers 
1a and 1b. Desilylation of the dimers followed by phosphitylation produced the cross-
linked bis-amidites 3a and 3b, required for solid phase synthesis. 
31
P NMR signals at 
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148.35 and 148.22 ppm for 3a and 148.35 and 148.21 ppm for 3b confirmed the presence 

























2a, 2b (R =H)






















Reagents and conditions: (i) DBU, ACN. (ii) TBAF (1M in THF), THF. (iii) N,N-
diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, THF. 
7.3.2 Oligonucleotide characterization by ESI-MS and nuclease 
digestion 
Mass spectrometry analysis of XLUU4 and XLUU7 confirmed the presence of the 
cross-links and absence of other modifications as the observed and calculated masses 
were in agreement.  
The nucleoside compositions of XLUU4, XLUU7 and the control sequence U, 
were confirmed by exonuclease digestion. All elution chromatograms showed the four 
standard nucleosides while XLUU4 and XLUU7 displayed an additional peak, each 
eluting later than the standards corresponding to the cross-linked nucleosides. The single 
stranded control sequence U diplayed an additional peak that eluted between dC and dG, 
231 
 
corresponding to dU. The extracted nucleotide ratios are in correlation with the 
theoretical compositions. Moreover, the elution chromatograms of XLUU4 and XLUU7 
show no species that elutes at the same time as dU (from control oligonucleotide U) 
indicating that the cross-links were not compromised during solid-phase synthesis and 
oligonucleotide deprotection.  
7.3.3 UV thermal denaturation studies 
The effect of the cross-link in XLUU4 and XLUU7 on duplex stability was 
analyzed by thermal denaturation studies. Both modified duplexes displayed sigmoidal 
denaturation curves comparable to the control duplex as observed in Figure 7.2. The 
presence of the ICL stabilized the DNA duplex with the 4 methylene linker having a 
greater stabilizing effect than the 7 methylene linker. The melting temperatures for 
XLUU4, XLUU7 and the control (U-A pair instead of U-U cross-link) were 61, 47 and 
41 °C, respectively. These values follow the same trend as our previously prepared 
XLTT series, where XLTT4, XLTT7 and the control (T-A pair instead of the T-T cross-
link) displayed melting temperatures of 66, 50 and 41 °C, respectively.(235) 
 
Figure 7.2: Tm curves of XLUU4, XLUU7 and control DNA duplex containing U. 
Control DNA (——), XLUU4 (……) and XLUU7 (– •  • –). 
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7.3.4 CD spectroscopy 
The overall secondary structures of the control DNA, XLUU4 and XLUU7 
appeared virtually identical demonstrating that the alkylene linker had no substantial 
effect on the DNA conformation. All DNA showed characteristic B-form DNA 
signatures with positive signals centered around 275 nm, cross overs around 260 nm and 
negative signals around 250 nm, as shown in Figure 7.3.(200,201) Similar Far-UV CD 
signatures were reported by our group for XLTT4 and XLTT7.(235) 
 
Figure 7.3: Far-UV CD spectra of XLUU4, XLUU7 and control DNA duplex containing 
U. Control DNA (——), XLUU4 (……) and XLUU7 (– •  • –). 
7.3.5 Cross-link repair  
Repair of XLUU4 and XLUU7 were performed with hAGT, OGT, Ada-C and the 
chimeric hAGT/OGT protein. The positive control, XLGG7 incubated with hAGT (lanes 
2 and 13), was used as a marker since the various species produced by this reaction are 
known and aid in the identification of the products formed in our assay.
 
Sixteen hour 
reactions between AGT and ICL DNA lead to no detectable levels of fully repaired DNA 
species (bottom band) nor an AGT-DNA covalent complex (top band) representing a 
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repair intermediate (Figure 7.4). Clearly, XLUU4 and XLUU7 evaded repair by all 
AGTs tested. 
 
Figure 7.4: Repair gel of XLUU4 and XLUU7 by hAGT, OGT, Ada-C and the chimera. 
Denaturing gel of the repair of 2 pmol of DNA by 60 pmol AGT. Lane 1, Control DNA 
U; lane 2, XLGG7 + hAGT; lane 3, XLUU7; lane 4, XLUU7 + hAGT; lane 5, XLUU7 + 
OGT; lane 6, XLUU7 + Ada-C; lane 7, XLUU7 + chimera; lane 8, XLUU4; lane 9, 
XLUU4 + hAGT; lane 10, XLUU4 + OGT; lane 11, XLUU4 + Ada-C; lane 12, XLUU4 
+ chimera; lane 13, XLGG7 + hAGT. 
7.3.6 Binding studies 
EMSA were invoked to gain an understanding on how the various AGT interact 
with XLUU4 and XLUU7. All AGTs bound the ICL DNA in the low μM, while they 
showed no binding to the control DNA at these and higher concentrations (Table 7.1). 
XLUU7 was bound with slightly higher affinity than its XLUU4 equivalent by all AGTs 
representing commonality amongst AGTs. OGT and Ada-C, did not bind the ICL DNA 
as tightly as their mammalian homologue or the engineered chimera. Ada-C, hAGT and 
the chimera bound the ICL DNA with a 2:1 protein:DNA stoichiometry, while OGT 
showed a 4:1 stoichiometry under identical binding conditions (data not shown).  
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Table 7.1: Kd of AGTs binding to control and ICL DNA XLUU4 and XLUU7. 
DNA OGT (μM) Ada-C (μM) hAGT (μM) Chimera (μM) 
Control
a
 >20 >100 >20 >20 
XLUU4
b
 8.40 ± 0.18 8.73 ± 0.42 2.78 ± 0.03 4.02 ± 0.18 
XLUU7
b
 7.61 ± 0.54 8.22 ± 0.60 1.74 ± 0.22 2.33 ± 0.17 
a
 5' CGAAAUTTTCG / 3' GCTTTAAAAGC 
b
 5' CGAAAXTTTCG / 3' GCTTTXAAAGC, where X are cross-linked by a 
butylene (XLUU4) or heptylene (XLUU7) linkers. 
7.3.7 NMR Spectroscopy of ICL DNA 
The assignment of the oligonucleotide non-exchangable proton resonances in the 
NOESY spectra (Figure 7.5) was performed using the H1’(i)-H6/H8(i)-H1’(i-1) pathway 
in the standard manner employed for right-handed DNA duplexes.(267) The DQF-
COSY, TOCSY and H,P-HSQC spectra (see Appendix VII) were also used to assign the 
sugar protons and phosphorus signals. The dA H2 resonances were confirmed by 
interstrand H2(A3)-H1’(C10), H2(A4)-H1’(T9), H2(A5)-H1’(T8) NOE crosspeaks. The 
proton and phosphorous chemical shifts obtained for XLUU7 and XLGG7 (see 





dC cross-link where the cross-link was harbored in an identical DNA 
sequence apart from the cross-linked nucleotides.(36) The strong intraresidue NOE 
crosspeak observed for H6-H1’(U6) in XLUU7 corresponds to a distance of ~2.5 Å 
(Figure 7.5A). This was coupled with a relatively weak H6-H2’(U6) crosspeak and weak 
sequential H6(U6)-H1’/H2’/H2”(A5) crosspeaks indicative that U6 adopted the syn-
conformation about the glycosidic bond in XLUU7.(268) The same phenomenon was 
observed for T6 of XLTT7 (data not shown). The heptylene linker protons of both 
XLUU7 and XLGG7 displayed various crosspeaks amongst each other but produced 
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very few crosspeaks with the oligonucleotide protons except for a strong H5(U6) to the 
neighboring CH2(1) group crosspeak in XLUU7.  
 
Figure 7.5: Expanded plots of NOESY spectra of (A) XLUU7 and (B) XLGG7 
NOESY spectra were recordedat at 500 MHz at 25 °C (tm=250 ms), the assignments of 
oligonucleotide protons are shown by solid line and nucleotide name with number; I-III 





The most noteworthy difference amongst the ICL DNA analyzed stems from the 
NOE data linking the orientation of the cross-linked alkylene chain with respect to the N3 
atom of U6 in XLUU7 and the N1 atom of G6 in XLGG7. The adoption of the syn-
conformation about the glycosidic bond of U6 in XLUU7 causes the CH2(1) (methylene 
attached to O
4
) to adopt the E-configuration about the C4-O
4
 bond of the cross-linked 
nucleotides as extrapolated from the strong NOE cross-peaks between H5(U6) and 
CH2(1) protons in XLUU7 (corresponding to a distance of ~2.5 Å). On the other hand, 
the CH2(1) in XLGG7 adopts the Z-configuration about the C6-O
6
 bond as a result of the 
canonical anti-conformation adopted by G6 about the glycosidic bond as validated by the 
absence of cross-peaks between H8(G6) and CH2(1) protons in XLGG7.  
The presence of strong H1’-H2’ crosspeaks and weak H2’’-H3’ crosspeaks for all 
residues except for the terminal G11 in the DQF-COSY spectra indicates that the most 
populated conformations are of the South type, corresponding to the B-DNA form (see 
Appendix VII).(268)  
The imino-proton assignments were conducted based on NOESY spectra in H2O by 
inter-imino crosspeaks and their crosspeaks with H2(A3,A4,A5) as well as with NH2 
proton signals (Figure 7.6A). The 1D NMR spectra of the imino protons for XLUU7 at 
different temperatures are shown in Figure 7.6B. A strong inverse dependence between 
the intensity of the signal at 13.95 ppm with increasing temperature from 0 to 10 °C was 
detected, but the temperature dependence was greatly reduced for the signals of the T8 
and G2 imino protons. This could be a result of signal overlaps between the T7 and T9 
imino proton. Indeed, great fluctuations in the positions of the T7 imino protons have 
been reported for different ICL DNA within virtually identical sequences, ranging from 
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13.7-14.1 ppm.(238,241,269) The T7 imino proton in XLUU7 did not show strong or 
medium intensity NOE crosspeaks with other protons suggesting a faster exchange with 
water protons (as in case of imino proton of terminal G11, see Figure 7.6A). This was 
not observed with XLGG7 as it appeared to exist in a single conformation, where all 





Figure 7.6: NMR spectroscopy of amine and imino protons of XLUU7 and XLGG7 
(A) Selected region of 800 MHz NOESY (tm=200 ms) spectrum of XLUU7 in H2O at 0 
°C, correlations between amino and imino protons are shown. (B) 
1
H NMR spectra of 
imino-protons of XLUU7 at low temperatures, the minor form signals are indicated with 
stars. (C) 
1






7.3.8 Structure modelling and analysis 
NMR-restrained molecular dynamic calculations were performed to determine the 
structures of XLUU7 and XLGG7. The structural statistics are presented in Table 7.2. 
The superimposition of residues 1-5 of strand A and 7-11 or strand B (corresponding to 
half the ICL duplex) of 10 minimized structures of XLUU7 are shown in Figure 7.7A. 
The DNA sugars adopted the South conformation with pseudorotation angles between 
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° and 180 °. The cross-linked U6 residues in XLUU7 adopted the syn-conformation 
with a χ-glycosidic angle of 77 °. The heptylene cross-links reside in the major groove for 
both ICL duplexes. The ICL DNA melting temperature profiles, as observed by NMR, 
suggest a greater flexibility for the central nucleotides in XLUU7 with respect to 
XLGG7. This notion is supported by the larger atomic RMSD for XLUU7, as noted in 
Table 7.2, and also the broadened and lower intensity H5-H6 NOESY crosspeaks for the 
U6 residues compared to C1 and C10 residues (Figure 7.5A).  
The atomic RMSD for residues 1:5 of strand A and 7:11 of strand B for XLUU7 
and XLGG7 was calculated to be 0.65 Å (Figure 7.7B). The atomic RMSD for the 
whole duplex, omitting the cross-linked nucleotides, was 1.22 Å for all heavy atoms. 
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Table 7.2: Structural statistics for 10 final individual structures of XLUU7 and XLGG7  
Duplex XLUU7 XLGG7 
Number NOE distance restraints 131 150 
Intranucleotide 77 84 
Internucleotide 54 66 
Torsion angle restraints 87 87 
Hydrogen bond restraints 34 34 
NOE violation (>0.2 Å) 0 0 
Torsion angle violation (>5 °) 0 0 
Heavy atoms RMSD relative to average structure:   
Full duplex (Å) 0.58 0.41 
Residues 1:5 of strand A and 7:11 of strand B (Å) 0.24 0.29 
Average RMSD from covalent geometry:   
Bond lengths (Å) 0.0026 ± 0.0001 0.0026 ± 0.0001 
Angles (°) 0.380 ± 0.005 0.411 ± 0.011 




Figure 7.7: Superimposition of half of the ICL duplex by residues 1:5 of strand A and 
7:11 of strand B.  
(A) Superimposition of 10 final individual structures of XLUU7. (B) Superimposition of 
XLUU7 (in blue) and XLGG7 (in red) average minimized structures. 
Upon comparing the overal minimized structures of XLUU7 and XLGG7, as 
shown in Figure 7.8, it is obvious that the stacking interactions between the A5:T7 base 
pair and the neighboring U6 residues in XLUU7 (Figure 7.8C) are poor compared to 




nucleotides of XLUU7 where the imino-protons of the A5:T7 base pairs undergo a faster 
exchange with water, as eluded to earlier. 
 
 
Figure 7.8: Comparison of the average minimized solution structures of XLUU7 and 
XLGG7.  
The view into the major groove of (A) XLUU7 and (B) XLGG7. The stacking 
interaction between A5:T7 (in red) and cross-linked (in blue) (C) U6 and (D) G6 
residues. 
The helical and groove parameters extrapolated for XLUU7 and XLGG7 are 
shown in Figure 7.9. The minor groove is slightly larger around the G6 residues in 
XLGG7 compared to the cross-linked U6 residues in XLUU7. The major groove in 





neighboring G6 residues in XLGG7 is ~1 Å bigger than the remaining nucleotides in the 
DNA. 
A noted increase of 10-12 Å in the major groove width around the site of the cross-
links was observed when comparing the parameters of XLUU7 and XLGG7 to those of a 




dC linker within an 
identical DNA sequence (except for the cross-linked nucleotides).(241) Rather, the 
widening of the major groove as observed in XLUU7 and XLGG7 is analogous to the 




Figure 7.9: Helical parameters and groove widths of average minimized structures 
XLUU7 (filled triangles), XLGG7 (filled squares) and the previously characterized 
XLCC2 (PDB 1N4B) (open circles). The helical parameters involving the central 
nucleotides in XLUU7 could not be used in the comparison due to the syn-conformation 
of the U6-bases and were therefore omitted. 
7.4 Discussion 





dU cross-links were prepared with high yield reactions such as those used by 
Swann for O
4
-alkylated dT.(221) The solid-phase synthesis of the XLUU and XLTT ICL 
DNA generated little desired product. On average, 10 A260 (60 nmoles) of pure material 
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was obtained per 1 μmol column, representing only a 6 % yield. The basis for the low 
overall yield can be attributed in part to the method of deprotection of the 
oligonucleotide. Since O
4
 alkylated dT and dU are susceptible to nucleophilic attack at 
C4, the standard ammonia/ethanol deprotection could not be utilized.(256,257) 
Moreover, oligonucleotide deprotection in methanol and DBU lead to the O
4
 methylated 
products, removing our cross-links in the process as observed by denaturing PAGE and 
confirmed by mass spectrometry (data not shown). To circumvent this issue a mixture of 
10 % DBU in n-propanol was adopted for deprotection. It is our belief that the larger size 
of the n-propanol alkoxide, in comparison to the methanol alkoxide, prevented 
breakdown of the cross-links at the expense of recovery from the CPG during the 5 day 
incubation. 
The presence of the ICL in XLUU4 and XLUU7 increased the Tm of the duplex 
from 41 °C to 61 °C and 47 °C, respectively. This is comparable to results obtained with 
the XLTT series where the control, XLTT4 and XLTT7 had a Tm of 44 °C, 66 °C and 50 
°C, respectively.(235) These ICL DNA are not as stable as the XLGG series where 
XLGG4 and XLGG7 had Tm of 70 °C to 60 °C, respectively.(145) The reduction in 
thermal stability of the XLUU series with respect to the XLGG may be attributed to the 
greater flexibility of the duplex at the cross-link site brought upon by disturbances to the 
base stacking interactions as observed in the NMR experiments. 
Much like its XLTT counterparts, XLUU4 and XLUU7 evaded repair by all AGT 
tested. It is known that hAGT and the chimera are capable of repairing ICL DNA, 
whereas the E. coli homologues are not.(146,214,235) It has been recently documented 
that hAGT and the chimera have increased repair abilities of O
4





-alkyl dT adducts (CHAPTER VI). This inhibitory effect of the C5 
methyl on AGT mediated repair of O
4
-alkylated dT was initially believed to be the cause 
for hAGT and chimeras inability to repair XLTT ICLs. Removing the C5 methyl 
conferred the chimera with the ability to repair larger lesions at the O
4
 atom of the 
modified dU, where butyl-4-ol and heptyl-7-ol adducts were efficiently removed from dU 
by the chimera as opposed to the same lesions on dT which were left virtually untouched 
by the protein. Unfortunately, the XLUU series, lacking the C5 methyl groups, did not 
confer hAGT or the chimera with the ability to remove this ICL damage. 
All AGT recognized the cross-links in XLUU4 and XLUU7 as observed by our 
binding results. The AGTs displayed poor binding to the control DNA. Such poor 
binding of similar DNA by hAGT was previously observed by our group. This was 
ultimately attributed to the lack of a central dG in the DNA duplex.(235) Indeed, a 
similar parallel can be made with Ada-C where it binds unmodified DNA with a Kd of 2 
μm when dG is present in the central region of the duplex.(173) It appears that all AGT 
have evolved to recognize unmodified dG to aid in initial DNA binding prior to migration 




Both AGT capable of ICL damage repair (hAGT and the chimera) bound XLUU4 
and XLUU7 with the highest affinity. This higher binding affinity partially explain the 
source for hAGT and the chimeras ability to process ICLs over their E. coli counterparts. 
More interestingly, OGT bound the ICL DNA with a different stoichiometry than the 
other AGTs. Ada-C, hAGT and chimera bound the ICL DNA with a 2:1 protein:DNA 
ratio while OGT bound the DNA with a 4:1 ratio. OGT binds non-ICL DNA with a 
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similar stoichiometry as Ada-C, hAGT and the chimera, which indicates that with non-
ICL DNA OGT binds DNA in a similar fashion as the other AGTs (CHAPTER VI). The 
increase in stoichiometry observed with OGT in the presence of the ICL could be a result 
of OGTs inability to migrate across the cross-link. This would cause OGT to recognize 
the ICL DNA as 4 distinct strands of DNA as opposed to 2, validating the increase from 2 
to 4 proteins per ICL duplex. Irrespective of stoichiometry, all AGT bound the ICL 
DNAs in the low μM range, similar to the affinity reported with hAGT for XLGG4 or 
XLGG7, which are repaired by the protein.(214) Therefore ICL DNA recognition by 
AGT is not the basis for the lack of activity observed. 
An overlay of XLUU7 and XLGG7 exposes their similar overall structure. Both 
ICL DNA adopted the standard B-form fold as was expected from our and previous CD 
analysis of the DNA. XLUU7 and XLGG7 show similar bends in the DNA structure 
suggesting that preferential repair of ICL DNA by AGT is not brought upon by 
deviations of the DNA structure from its canonical form, such as is stipulated for other 
DNA binding proteins including minor groove binders.(270,271) As was previously 
modelled, the cross-link resides in the major groove for XLGG7.(145) The same pattern 
was observed for XLUU7. This entails that the location of the cross-link in XLUU7 is 
not responsible for DNA repair evasion by this potential substrate. 
Some substantial differences in structure, namely at the site of cross-link were 
observed between structures. These dissimilarities have the potential to play a role in 
substrate recognition and repair by AGT homologues. The most important finding is the 
adoption of the orientation of the cross-linked nucleotides about their glycosidic bonds. 
The modified heterocycles in XLUU7 adopted the syn-configuration about the glycosidic 
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bond, which caused the cross-link to adopt the E-configuration about the C4-O
4
 bond. 
The modified heterocycles in XLGG7 adopted the usual anti-configuration about the 
glycosidic bond, placing the linker in a Z-configuration about the C6-O
6
 bond. In view 
that hAGT has been crystallized repeatedly with mono-alkylated dG in the Z-
configuration about the C6-O
6
, it appears that the orientation of the linker may play a role 
in substrate repair by the protein.(155) Similar crystallographic data stemming from 
hAGT co-crystallized with DNA harboring a modified dC displayed the adduct in a Z-
configuration about the C4-O
4
 bond, supporting the notion that purine and pyrimidine 
orientations are conserved when present in the hAGT active site prior to repair.(151)  
XLGG7 showed a slight increase in minor groove width (~1.5 Å) relative to 
XLUU7. Since hAGT is known to bind in the minor groove of DNA, this added space 
may be required for the protein to interact correctly with the substrate to place the adduct 
in the proper orientation for repair to occur.(155) 
The greater level of flexibility observed in the core of XLUU7 could aid in evading 
repair by AGT. Unlike nucleotide excision repair based DNA damage reversal, AGT 
mediated repair is not based on the flexibilty/bendability of the DNA scaffold.(272) 
Rather, flexibility may aid in evading repair since DNA binding by hAGT is 
transient.(149,163,166,167) Due to this nature, a preorganized substrate, such as 
XLGG7, would undergo repair more efficiently than a disorganized molecule since the 
protein must be associated with the substrate long enough for the proper conformation to 
be adopted by the substrate to promote repair. 
Our solution structures shed some light on the selectivity of hAGT for different ICL 
substrates. Our findings would be greatly aided by AGT-ICL DNA crystal structures. 
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Due to the inherint complicated nature of DNA-Protein co-crystals, the preparation of 
such material do not appear readily accessible. Also, the cooperativity of AGT binding to 
DNA could be required for ICL repair. Since hAGT has only been crystallized in its 
truncate form, missing part of its C-terminal, its cooperativity has been 
abolished.(168,169) Moreover, biomolecular NMR of such complexes would be 
considerably complicated to solve considering the size of the DNA-AGT complex but 
more importantly the 2:1 stoichiometry observed for AGT binding to these ICL DNA. 
7.5 Conclusions 
The solution structures of two ICL DNA (XLUU7 and XLGG7) have been 
determined by NMR which show that the α-methylene groups of the linkers must adopt 
the proper Z-configuration about the C6-O
6
 bond in purines or C4-O
4
 bond in 
pyrimidines to enable their removal by hAGT. In the former ICL, this properly 
preorganized system allows hAGT and the substrate to interact in an efficient manner, 
placing the reactive thiolate anion of the protein in close proximity to the α-carbon of the 
adduct undergoing nucleophilic attack leading to ICL repair. This was not the case for the 
latter DNA, which adopted the E-configuration and hence evaded hAGT based repair. 
7.6 Acknowledgments 
This research was supported by grants from the Natural Sciences and Engineering 
Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI) and 
the Canada Research Chair (CRC) program. FPM and DKO are the recipients of a 
postgraduate fellowship from NSERC. The authors are grateful to Sameer Al-Abdul-
249 
 













8.1 General conclusion 
The methodology to generate ICL DNA using a combination of solution and solid 
phase synthesis proved versatile and effective during the course of this research. Using 
solution synthesis modified nucleosides containing various protecting groups were 
produced to either generate mono-adducts or cross-linked DNA in the desired motif by 
automated DNA synthesis. The methodology is versatile enabling the ICL to be 
engineered in the 1,3 motif. These 1,3 ICL motif (see CHAPTER II) were attained due to 
the added asymmetry in the ICL duplex, which was achieved by using the Alloc 
protecting group which was selectively removed prior to phosphitylation creating an 
amidite with two DMT and a TBS protective group. 
Introduction of an alkyl group at the O
6
 atom of dG was performed using the 
Mitsunobu reaction which is selective and can be performed under mild conditions.(188) 
Alkyl groups were introduced at the O
4
 atoms of dT and dU using a method described by 






The results presented in this thesis provides evidence that hAGT may very well 
play a role in ICL damage detection and removal. In vivo assays conducted in Section 
2.2.12 provide convincing evidence that overexpression of hAGT limits the cytotoxic 
effects of hepsulfam. Whether this effect is due to removal of ICLs (such as those 
generated in XLGG7), mono-adducts or reacting directly with the agent itself is still 
unclear. Indeed, highly reactive Cys containing proteins are known to react with 
alkylating agents. Such an example is the reactivity of glutathione S-transferase and 
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hepsulfam, where increased levels of glutathione S-transferase are correlated with a 
reduced toxicity by the agent.(273) Certain steps still need to be taken to address this 
concern. For example, hAGT could be expressed after cell exposure to the agent. This 
would allow time for the DNA lesions to be induced prior to hAGT repair. If similar 
correlations are observed when hAGT expression is induced post alkylation with respect 
to those reported by our group, then it would suggest that hAGT reacts with the DNA 
adducts formed by hepsulfam rather than with the agent directly. hAGT is documented to 
increase the toxicity of certain bifunctional alkylating agents, such as 1,2-
dibromoethane.(236) As eluded to in the introduction, hAGT is believed to directly react 
with 1,2-dibromoethane to create a bromoethylated hAGT, after which the alkylated 
protein interacts with DNA to form a protein-DNA covalent complex containing an 
ethylene linkage. According to the 1,2-dibromoethane mechanism, if hAGT reacts 
directly with hepsulfam we should, in theory, observe a positive correlation between 
hAGT and toxicity levels by the agent. Further in vivo studies are clearly needed to 
understand the exact role of hAGT in hepsulfam chemistry.  
Irrespective of the in vivo studies, the in vitro repair assays demonstrate hAGTs 




dG ICL in the clinically relevant 1,3 motif. The 
phenomenon occurred with butylene and heptylene cross-links, demonstrating substrate 
promiscuity by the protein. hAGT is limited to ICL that involve to the O
6
 atom of dG as 









ICL DNA, irrespective of the tether length. The mode by which hAGT can eliminate 
these ICL remains to be uncovered and needs to be studied. Moreover, the substrate 
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selectivity presented by hAGT for the XLGG ICL DNA series is not understood nor 
documented in the literature.  
Repair of the corresponding mono-adducts highlighted substantial difference 
amongst homologues. Repair of O
4
-butyl-4-ol dT and O
4
-heptyl-7-ol dT was achieved by 
OGT and to a minimal extent, by the engineered chimera, which was created by replacing 
a portion of the hAGT active site (residues 139-159) with the respective amino acids in 
OGT. hAGT, unlike the E. Coli homologues, did not repair O
4
-MedT with an appreciable 
rate. These findings follow the same correlation as observed for the ICL DNA, where 
hAGT shows limited capability to eliminate O
4
-alkyl damage. 
The poor repair of O
4
-alkyl dT damage by hAGT represent a significant 
evolutionary oversight, considering that many organisms have evolved AGT capable of 
eliminating such damage. We deemed it important to understand the basis for this 
discriminatory pattern amongst AGTs.  
The first approach involved generating covalent complexes between hAGT and O
4
-




dT containing ICL DNA were 
employed to create hAGT-DNA covalent complexes where Cys 145 of hAGT would be 
tethered to the O
4
 atom of dT by the alkylene chain due to the previously observed 
selectivity of hAGT for cross-links involving the O
6
 atom of dG. The hAGT-alkylene-
O
4
dT cross-linking reaction was not efficient where the reaction was virtually absent 
when the tether was composed of 4 methylene groups (XLGT4). The cross-linking 
reaction conducted with XLGT7 produced a considerable amount of hAGT-heptylene-
O
4
dT cross-linking.  
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The second approach, which stemmed from molecular modelling, entailed 
analyzing the effect of the C5 methyl of dT on O
4
-alkyl damage repair by AGT. This was 
achieved by comparing the rates of repair of O
4
-alkyl dU versus their O
4
-alkyl dT 
analogues by the various AGT. Removal of the C5 methyl conferred hAGT with the 
ability to eliminate O
4
-Me dT damage with a 30-fold increase in rate of repair. A similar 
trend was observed with the chimera, indicating that the C5 methyl of dT clashes 
somewhere in the hAGT active site (shown in red in Figure 8.1) in a location other than 
the altered residues found the chimera. This adverse effect of the C5 methyl on AGT 
processivity was less significant in OGT. To the best of our knowledge, these are the first 
results that provide a rational for the differential substrate repair trends documented for 
AGT homologues. The C5 methyl of dT is not the only source for the observed difference 
in rates between OGT and hAGT since its removal did not enable hAGT to repair the 






-MedT in hAGT active site 
Residues altered in chimera with respect to hAGT are shown in green, those conserved in 
white, Cys 145 in yellow and residues not altered in chimera in red. 
Having had some success in determining the cause of poor O
4
-alkyl mono-adduct 
damage repair by hAGT, efforts were subsequently focussed on determining the source 
of hAGTs ability to selectively repair XLGG and not XLTT nor XLUU. Insight into 
hAGT mediated repair of ICL DNA was provided by the solution structures of XLUU7 
and XLGG7. An overlay of the two structures (Figure 7.7B), solved by Dr. Denisov, 
highlight their virtually superimposable overall scaffold. The major differences between 
these two ICL DNA originate at the cross-link site. The modified heterocycles in XLUU7 
(and XLTT7) adopt the syn-configuration about the glycosidic bond, which places the 
cross-link in the E-configuration about the C4-O
4
 bond. The modified heterocycles in 
XLGG7 adopt the canonical anti-configuration about the glycosidic bond, placing the 
linker in a Z-configuration about the C6-O
6
 bond. This disparity between ICL DNA 
duplexes is believed to be one of the causes for the way they are processed by hAGT. 
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Based on the hAGT repair mechanism for O
6
-alkyl dG (Scheme 1.4), one of the events 
required to achieve repair of the adduct is the donation of a proton from Tyr 114 to the 





-MedG as, shown in Figure 1.19, suggests that the O
2 
atom 
of dT resides where the N3 atom of dG is situated when bound by hAGT. This indicates 
that the O
2
 atom of dT should accept the proton from Tyr 114. For XLUU7 (and 
XLTT7), the adoption of the syn orientation by the modified heterocycle rotates the O
2
 
atom of dT away from Tyr 114, inhibiting repair by hAGT. 
This syn versus anti orientation adopted by the cross-linked dT and dU may be 
translatable to the mono-adducts. Since the C5 methyl of dT is presumed to clash in the 
hAGT active site, perhaps this clash is accentuated through adoption of the syn 
orientation about the glycosidic bond by the modified dT, see Figure 8.2. This rotation 
would relieve the clash produced by the C5 methyl of dT while still placing the adduct in 
a similar location in the hAGT active site, explaining the binding trends reported. In the 
case of dU, the absence of the C5 methyl would favour the anti orientation of the 
heterocycle about the glycosidic bond with respect to dT, explaining its preferential 
repair. The purine nature of dG would not allow the protein to bind to the syn orientation 
of the nucleoside due to the added aromatic ring that would clash considerable in the 
hAGT active site. 
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Figure 8.2: Modelling of anti and syn configuration of O
4
-MedT in hAGT active site 
(A) in the classic anti orientation and (B) in the syn orientation. 
The solution structure of XLGG7 revealed that hydrogen bonding of the 
neighbouring nucleosides was unaffected by the presence of the cross-link. However 
there are disruptions to the base stacking interactions of the modified nucleotides which 
are pushed away from each other. This may account for the reduction in the Tm observed 
in the heptylene versus butylene containing ICL DNA. 
8.2 Future works 




dG ICL DNA 
ICLs formed by chlorethylating agents (Scheme 1.2) have been of interest for 
decades. Recent advances have allowed the first chemical synthesis of their ICL using 
photocaging methodology.(212) Other agents such as 1,2-dichloroethane and 1,2-
dibromoethane have the capability to make ethylene cross-links though they have yet to 




DNA.(274) It would therefore be of interest to note if ethylene cross-links bridging the 
O
6
 atoms of dG are repaired by hAGT since such a cross-link could form in DNA.  





dG cross-link containing DNA (XLGG2) could provide 
further insight into the limitation of hAGT mediated ICL repair. The synthesis of the 
cross-linked nucleosides required for the solid phase synthesis of XLGG2 is proposed in 
Scheme 8.1. A totally asymmetrical approach is explored so that the ICL can be 
incorporated into any motif within DNA. To achieve total asymmetry, the levulinyl 
protecting group is invoked in addition to the aforementioned Alloc, TBS and DMT 
groups due to its selective removal by hydrazine at the proper pH.  




dG cross-link have 
failed using the Mitsunobu reaction, where homo-dimerization of O
6
-ethyl-2-ol dG is 
believed to occur (unpublished data). For this reason a "convertible" dG approach using 
benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate will be 
investigated. This methodology has been employed multiple times by the Lakshman 



















































2. (R = TBDPS)






























6. (R = Lev)











Reagents: (i) Levulinic acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, DMAP, 
dioxane. (ii) PPh3, DIAD, 1-t-butyldiphenylsilylethanol, dioxane. iii) TBAF, THF. iv) a) 
TBS-Cl, pyridine. b) Alloc-OBT, DMAP, THF/pyridine (v) Benzotriazole-1-yl-oxy-tris-
pyrrolidino-phosphonium hexafluorophosphate, DBU, THF (vi) Compound 3, DBU, 
ACN. (vii) hydrazine, pyridine/acetic acid. viii) N,N-
diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, THF.  
8.2.2 Mimic of mechlorethamine induced ICL  
The tunnel model that is proposed which grants hAGT the ability to repair ICLs can 
be probed by introducing appendages to the ICL tether. Mimics of cross-links generated 
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by various nitrogen mustards could achieve this goal, see Figure 8.3 for the structures of 
the mimics XLGG5H and XLGG5Me. A cross-link with a central methyl appendage 
(XLGG5Me) should cause a clash in the hAGT active site if it does indeed assume a 
tunnel shape. This clash should cause the ICL to evade repair while its methyl lacking 
control (XLGG5H) should be processed by the protein. A proposed synthesis of the 
linkers is presented in Scheme 8.2. Their use during solution synthesis are as described in 
CHAPTER II without the need for modifications since both compounds 6 and 8 are 































































































Scheme 8.2: Proposed synthesis of cross-links for XLGG5H and XLGG5Me 
Reagents: (i) TBDPS-Cl, imidazole, DMF. (ii) TBDPS-Cl, imidazole, DMF. (iii) PAC-
Cl, TEA, THF. (iv) DMT-Cl, pyridine. v) PPh3, imidazole, I2, dioxane. vi) Compound 4’, 
DBU, ACN. (vii) p-Toluenesulfonic acid, DCM/methanol. (viii) Compound 4’, DBU, 
ACN. (ix) p-Toluenesulfonic acid, DCM/methanol. 
8.2.3 Improvements on XLGT cross-linking  
The short comings observed with the XLGT ICL series could be overcome by 
modifying the substrate. Eliminating one of the DNA strands from the XLGT ICL DNA 




-dT* (where dT* represents a dangling nucleoside) may 
achieve this effect, see Figure 8.4A for structure. Removal of one of the DNA strands 
from the cross-linked substrate could also serve as a substrate for OGT since it has been 




-dG* cross-links, where dG* is a dangling 
nucleoside. This would promote the formation of OGT-O
4
-alkyl dT* covalent complexes 
in addition to the hAGT-O
4
-alkyl dT* covalent complexes. The proposed synthesis of the 
amidites to be used for solution synthesis are shown in Scheme 8.3. In this scenario the 
complex formed should have only a modified dT covalently tethered in the AGT active 
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2. (R = Alloc)






















Reagents: (i) TBS-Cl, imidazole, DMF. (ii) 1,2,4-triazole, POCl3, TEA, ACN. (iii) 3’-O-
alloxycarbonyl-5’-O-dimethoxytrityl-N2-phenoxyacetyl-O6-(hydroxyalkyl)-2’-
deoxyguanosine, DBU, ACN. (iv) Pd(PPh3)4, PPh3, n-butylamine/formic acid, THF. (v) 




The negative impact of the C5 methyl of dT on O
4
 alkyl damage repair was 
predicated based on steric clashes. Other properties of the C5 methyl might come into 
play. On a purely chemical level, the C5 methyl of dT donates electron density by 
induction into the heterocyclic ring, which would increase the transition state energy of 
the anionic intermediate formed during AGT repair (Scheme 1.4). To validate our sterics 
assumption, the 5-fluoro derivative of dU could be utilized. The preparation of the O
4
-
methyl-5-fluoro-dU amidite is presented in Scheme 8.4 starting from commercially 
available 5-Fluoro-2′-deoxyuridine. The scheme shows the pathway to generate the 
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methyl adduct of 5-fluoro dU but using the appropriate alcohol in step iv) can vary the 
adduct with ease, as demonstrated in CHAPTER III and CHAPTER VI.  
If the adverse effect of the C5 methyl of dT is based solely on sterics the rates of 
repair of the 5-fluoro analogues should be virtually identical to those of O
4
-alkyl dU. If 
on the other hand electronics come into play, the electron withdrawing properties of the 
fluorine atom should cause the reaction rate of the 5-fluoro analogues to be greater than 
those of the O
4
-alkyl dU series. 
 
Scheme 8.4: Proposed synthesis of O
4
-methyl-5-fluoro-dU amidite. 
Reagents: i) DMT-Cl, pyridine. ii) TBS-Cl, imidazole, DMF. iii) 1,2,4-triazole, POCl3, 
TEA, ACN. iv) methanol, DBU, ACN. v) TBAF, THF. vi) N,N-
diisopropylaminocyanoethylphosphonamidic chloride, DIPEA, THF. 
8.3 Significance of thesis 
8.3.1 ICL DNA and derivatives for hAGT crystallography 
The formation of covalent complexes for crystallographic purposes have been 
employed for various protein systems, including hAGT. Currently, there exists no 
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structural data, from NMR or crystallography, that explains hAGTs inability to remove 
O
4
-alkyl dT damage proficiently. The correct ICL substrate with the proper nucleotide 
composition should generate hAGT-O
4
-alkyl dT covalent complexes that could be of use 
during crystallography. These complexes, once crystallized and solved, would provide 
much needed insight into hAGTs selectivity. These crystal structures would also be a 
great starting point for rational design based engineering of hAGT to enhance this 
proteins ability to remove O
4
-alkyl dT damage.  
The advantage of these ICL substrates for use in the formation of covalent 
complexes is the amount of control one can have over the nature of the complex formed. 
Indeed, the length of the ICL, which eventually becomes the covalent cross-link between 
protein and DNA, can be varied with ease during solution synthesis. Such diversity 
cannot be introduced with poly-cyclic substrates such as N1,O
6
-ethanoxanthosine 
generated by Noll due to ring strain.(155)  
Moreover, the functionality of the cross-link itself can be varied, such as 
substituting methylene groups for phenyl rings, for example. Lastly, since hAGT 
selectively repairs the O
6
-alkyl dG moiety of the cross-link, any other nucleobase, 
nucleoside, nucleotide or even molecule can be attached at the other extremity of the 
tether, see Scheme 8.5. This means that hAGT could, in theory, be crystallized with any 
molecule, as long as its tethered atom is not repaired. Being able to form these covalent 
complexes between hAGT and other molecules could grant some insight into the 






























Scheme 8.5: Repair of ICL DNA derivatives by hAGT to form covalent complexes 
8.3.2 hAGT variants in chemotherapy 
Alkylating agents used during chemotherapy are known to alkylate various atoms 
of the DNA non-specifically. The O
4
 atom of dT is no exception. For this reason an 
hAGT variant capable of eliminating O
4
-alkyl dT damage, such as the chimera presented 
in this document, could find a home in gene therapy during cancer treatments with 
chemotherapeutic agents. The formation of O
4
-alkyl dT is highly mutagenic and if left 
unrepaired in cancer cells can cause advanced cancer development. 
An hAGT variant capable of O
4
-alkyl dT damage removal would find best use 
during chemotherapeutic regimens involving bi-functional alkylators. Since the cytotoxic 
lesions they induce are ICLs that generally involve the N7 atom of dG, eliminating O
4
-
alkyl dT damage should not reduce the potency of the agent but would reduce some of 
the side effects. 
For methylating chemotherapeutic agents such as temozolamide, whose main mode 
of action is through formation of O
6
-MedG and cell apoptosis due to multiple rounds of 
futile MMR, further engineering of our chimera would show benefits. In this scenario the 
chimera displays half of the desired properties, but it can still eliminate O
6
-MedG readily. 
To achieve total inversion of substrate specificity other alteration must be made to the 
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chimera. The chimera's substrate specificity could be altered by reshaping the active site 
since O
6
-MedG is larger than O
4
-MedT. Lys 165 and Val 148 alteration appear to be 
good candidates since it would remodel the active site where the exocyclic amine of dG 
lies, shown in blue in Figure 8.5. These amino acid alteration could induce a clash 
between the AGT active site and the N
2
 atom of O
6
-MedG hindering its repair. Since O
4
-
MedT lacks this functionality it should not affect how the AGT interacts with this lesion. 
 




-MedG in hAGT active site where Lys 
165 and Val 148 surfaces are shown in blue. 
8.3.3 Uracil derived hAGT inhibitors 
The work shown in this thesis leads to the potential development of 5-fluoro-O
4
-
benzyl-uracil as a hAGT inhibitor with an added anti-cancer property. Since hAGT is 
often found at higher levels in cancer cells than in healthy cells this compound should 
target malignant tumours.(277,278,279) Based on the O
4
-alkyl dU repair trends observed 
with hAGT it can be foreseen that 5-fluoro-O
4
-benzyl-uracil should be acted upon by 
hAGT. The two products of this reaction in addition to chemotherapeutic agents should 
aid in the treatment of cancer, see Scheme 8.6. The first product of this reaction is 
alkylated hAGT, which leads to depletion of hAGT levels in the cell. These depleted 
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hAGT levels increase the potency of many chemotherapeutic agent. (reviewed in 132) 
The novelty of this compound over classic hAGT inhibitors is the formation of 5-fluoro-
uracil as the second product. 5-fluoro-uracil has been used as an anti-cancer agent for 
over 50 years due to its ability to inhibit thymidylate synthase. Thymidylate synthase, the 
protein responsible for methylating 2’-deoxyuridine monophosphate to generate 
thymidine monophosphate is required for proper DNA synthesis. Inhibition of this 
protein disturbs the general pool of nucleotides creating a biological imbalance and DNA 
damage due to replication mistakes. This compound's required bio activation by hAGT 
signifies that in tissues with low hAGT levels, such as the brain, the adverse off-target 
effects of 5-fluoro-uracil are alleviated. 
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Figure A2.1: Absorbance (A260) versus temperature profiles of non cross-linked duplex (_____) 5’-dCGATGTCATCG-3’/5’-
dCGATGACATCG-3’, cross-linked duplex XLGG4 (_ _ _ _), and cross-linked duplex XLGG7 (……..). Solutions containing a total 
strand concentration of 2.8 µM for the cross-linked (XLGG4 and XLGG7) and non-cross-linked control duplexes in 90 mM sodium 








































Figure A2.2: CD spectra of non cross-linked duplex (_____) 5’- dCGATGTCATCG-3’/5’-dCGATGACATCG3’, cross-linked duplex 
XLGG4 (_ _ _ _), and cross-linked duplex XLGG7 (……..). Solutions containing a total strand concentration of 2.8 M for the cross-
linked duplex XLGG 4,7 and 2.8 M of the non-crosslinked control duplexes in 10 mM sodium phosphate, pH 7.0, 90 mM sodium 






















































Figure A2.3: Molecular models of non cross-linked control duplex and cross-linked duplexes XLGG4 and XLGG7 that were 
geometry optimized using the AMBER forcefield. 
             
 non cross-linked control                                               XLGG4                                                            XLGG7 
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Figure A2.4: Effects of mutations on secondary structure of hAGT by CD. Scans were taken with 5 μM wild-type hAGT (_____), 
C145S (__ _ _ __), P140A (__ _ __) and V148L (__ __) between 260 and 200 nm in CD buffer (260-203 nm shown due to high 




































Figure A2.5: Time course repair of XLGG4 and XLGG7 by hAGT. (A) Denaturing gel of the repair of 2 pmol of XLGG4 by 60 
pmol hAGT as a function of time: lane 1, 2 pmol Control; lanes 2-10, 2 pmol XLGG4 + 60 pmol hAGT incubated for 0, 5, 15, 30, 60, 
120, 240, 510 and 540 min, respectively (B) Denaturing gel of the repair of 2 pmol of XLGG7 by 60 pmol hAGT as a function of 

















Figure A2.6: Graphic representation of the % abundance of each species in the time 
course repair by hAGT of (A) XLGG4 and (B) XLGG7. hAGT-DNA complex/partially 






















































Figure A2.7: EMSA Gel of C145S hAGT and the control 11-mer DNA duplex. 5 nM 









Figure A2.8: Hill plot representation of log[PD]/[D] versus log[P] for the control duplex 
(■), XLGG4 (♦) and XLGG7 (▲). 
Control = 1.41x - 1.30
XL4 = 1.75x - 1.74





















Control = 1.41x-1.30 
XLGG4 = 1.75x-1.74 
XLGG7 = 1.32x-1.30 
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Table A2.1: ESI-MS results of wild-type hAGT and variants 
Protein 
Molecular Weight (Da) 
Calculated Observed 
Wild-Type hAGT 21876.2 21875.0 
C145S 21860.1 21860.0 
P140A 21850.1 21850.5 
V148L 21890.2 21889.5 
 
Table A2.2: Effect of mutations on fluorescence emission signals of intrinsic hAGT on 
Tryptophan and Tyrosine (λex 280nm) and Tryptophan only (λex 295nm). 
Protein 
λex 280nm λex 295nm 
λem (nm) 
Fluorescence  
Intensity λem (nm) 
Fluorescence  
Intensity 
Wild-Type hAGT 346 438 350 184 
C145S 350 409 350 176 
P140A 346 440 348 169 
V148L 350 428 350 173 
 
 





Observed Wild-Type Difference 
 Wild-Type hAGT 56.5 56.5 0.0 
 C145S 50.7 56.5 -5.8 
 P140A 47.0 56.5 -9.5 





APPENDIX III: Supporting information to CHAPTER III 
O
4
-alkyl thymidine cross-linked DNA to probe recognition and 
repair by O
6
-alkylguanine DNA alkyltransferases 
Francis P. McManus, Derek K. O'Flaherty, Anne M. Noronha and 
Christopher J. Wilds* 
 
Figure A3.1: Thermodynamic data for control, XLTT4 and XLTT7 DNA ................. 299 
Figure A3.2: Tm curves of various O
4
-alkyl dT mono-adducts ...................................... 300 
Figure A3.3: CD profiles of various O
4
-alkyl dT mono-adducts ................................... 300 
Figure A3.4: Repair gel of O
4
-MedT, T4 and T7 by AGTs .......................................... 301 
Figure A3.5: Bar graph representation of repair of O
4
-MedT, T4 and T7 by AGTs .... 301 
Table A3.1: Kd and stoichiometry of hAGT binding with XLTT4, XLTT7 and control 
duplex .............................................................................................................................. 302 
Table A3.2: Kd of hAGT binding to single stranded 5' CGAAAXTTTCG ................... 302 
Table A3.3: Kd of hAGT binding to duplexes containing various O
4
-alkyl dT mono 
adducts and O
6
-MedG ..................................................................................................... 302 
299 
 
Figure A3.1: Thermodynamic data for the non-crosslinked control, XLTT4 and XLTT7 DNA 
 
Control (T-A) XLTT4 XLTT7 
Trial 0.585 uM 2.719 uM 12.57 uM 58.46 uM 0.585 uM 2.95 uM 0.585 uM 2.95 uM 
1 38.0°C 42.0°C 47.0°C 52.0°C 66.5°C 66.0°C 52.0°C 52.0°C 
2 38.0°C 43.0°C 48.0°C 52.0°C 65.0°C 67.0°C 53.5°C 51.0°C 
3 39.0°C 43.0°C 49.0°C 50.0°C 66.0°C 66.0°C 51.0°C 53.0°C 
Avg 38.3°C 42.7°C 48.0°C 51.3°C 65.8°C 66.3°C 52.2°C 52.0°C 
StdDev 0.5°C 0.5°C 0.8°C 0.9°C 0.6°C 0.5°C 1.0°C 0.8°C 
 
Control Trial 1 (▲) 
Control Trial 2 (■) 
Control Trial 3 (♦) 
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Figure A3.2: Tm curves of various O
4
-alkyl dT mono-adducts in DNA duplexes 5’ 
GGCTXGATCACCAG 3’ / 5’ CTGGTGATCCAGCC 3’ where X is dT (——), O4-
MedT (……), O4-butyl-4-ol dT for T4 (– • –) and O4-heptyl-7-ol dT for T7 (– – –). 
Solutions containing a total strand concentration of 2.8 µM for the duplexes in 90 mM 
sodium chloride, pH = 7.0, 10 mM sodium phosphate, and 1 mM EDTA buffer, were 




































Figure A3.3: CD profiles of various O
4
-alkyl dT mono-adducts in DNA duplexes 5’ 
GGCTXGATCACCAG 3’ / 5’ CTGGTGATCCAGCC 3’ where X is dT (——), O4-































WAVELENGTH (nm)  
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Figure A3.4: Repair gel of O
4
-MedT, T4 and T7 DNA by hAGT, Ada-C and OGT. 
Denaturing gel of the repair of 2 pmol of DNA by 10 pmol AGT. Lane 1, Control; lane 2, 
O
4
-MedT DNA; lane 3, O
4
-MedT DNA + hAGT; lane 4, O
4
-MedT DNA + Ada-C, lane 
5, O
4
-MedT DNA + OGT; lane 6, T4 DNA; lane 7, T4 DNA + hAGT; lane 8, T4 DNA + 
Ada-C, lane 9, T4 DNA + OGT; lane 10, T7 DNA; lane 11, T7 DNA + hAGT; lane 12, 
T7 DNA + Ada-C, lane 13, T7 DNA + OGT. 
 
Figure A3.5: Repair of O
4


























Table A3.1: Kd and stoichiometry of hAGT binding with XLTT4, XLTT7 and control 
duplex 
DNA Duplex Kd (µM) Stoichiometry  
Control (T-A) 30.57±3.00 1.94 ± 0.03 
XLTT4 2.45±0.05 1.90 ± 0.11 
XLTT7 2.58±0.67 2.09 ± 0.02 
 
Table A3.2: Kd of hAGT binding to single stranded 5' CGAAAXTTTCG 






Table A3.3: Kd of hAGT binding to duplexes containing various O
4




DNA Duplex Kd (µM) 
Control 6.90 ± 0.04 
O
4
-MedT 2.87 ± 0.19 
T4 (O
4
-butyl-4-ol dT) 3.41 ± 0.28 
T7 (O
4
-heptyl-7-ol dT) 3.68 ± 0.15 
O
6
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Figure A4.1: Electro mobility shift assay of C145S hAGT binding to XLGT4. (A) EMSA Gel of C145S hAGT and XLGT4. 0.5 nM 
























APPENDIX V: Supporting information to CHAPTER V 
Engineering of a O
6
-Alkylguanine-DNA alkyltransferase 
Chimera and Repair of O
4
-Alkyl Thymidine Adducts and O
6
-
Alkylene-2’-Deoxyguanosine Cross-Linked DNA  
Francis P. McManus and Christopher J. Wilds* 
 
Figure A5.1: 12% SDS-PAGE of purified chimera proteins ......................................... 306 
Figure A5.2: ESI-MS of purified chimera protein and variants .................................... 307 
Figure A5.3: Effects of mutations on secondary structure of chimera .......................... 309 
Figure A5.4: Effects of mutations on thermal stability of chimera ............................... 309 
Figure A5.5: Effects of mutations on tertiary structure of chimera ............................... 310 
Figure A5.6: Repair gel of O
4
-MedT, T4 and T7 by chimera and its R135G variant ... 311 
Figure A5.7: Time course repair of XLGG4 and XLGG7 by hAGT and chimera ...... 311 
Figure A5.8: Graphical representation of time course repair of XLGT4 and XLGT7 by 
hAGT and chimera .......................................................................................................... 312 
Figure A5.9: 15% SDS-PAGE of chimera mediated repair of XLGT7 ........................ 312 
Figure A5.10: Identification of chimera-DNA covalent complex by ESI-MS. ............. 313 
Figure A5.11: Repair gel of XLTT4 and XLTT7 by chimera. ..................................... 314 
Figure A5.12: Electro mobility shift assay of C145S chimera binding to XLGT7....... 315 
Table A5.1: ESI-MS results of chimera and variants..................................................... 316 
Table A5.2: Difference in Tm between the chimera, its variants and hAGT. ................. 316 
Table A5.3: Effect of mutations on chimera intrinsic fluorescence ............................... 316 
306 
 
Figure A5.1: 12% SDS-PAGE of purified chimera proteins. Loaded: lane 1, 10 μL of 
Unstained Protein Molecular Weight Marker (Fermentas); lane 2, 5 μg chimera protein; 






























Figure A5.2: ESI-MS of purified chimera protein and variants. 
(A) Chimera hOGT
mass







(B) C145S Chimera Variant 
C145S hOGT
mass
















(C) R135G Chimera Variant R135G hOGT
mass









Figure A5.3: Effects of mutations on secondary structure of chimera by far-UV CD. 
Scans were taken with 5 μM hAGT (_____), chimera (__ _ _ __), C145S chimera variant 
(__ _ __) and R135G chimera variant (__ __) between 260 and 200 nm. 
 
Figure A5.4: Effects of mutations on thermal stability of chimera. Scans were taken with 
5 μM hAGT (_____), chimera (__ _ _ __), C145S chimera variant (__ _ __) and R135G 




Figure A5.5: Effects of mutations on tertiary structure of chimera by studying the 
intrinsic fluorescence signals of 1 μM hAGT (_____), chimera (__ _ _ __), C145S 
chimera variant (__ _ __) and R135G chimera variant (__ __). (A) Monitoring of intrinsic 








Figure A5.6: Repair gel of O
4
-MedT, T4 and T7 by chimera and its R135G variant. 
Denaturing gel of the repair of 2 pmol of DNA by 10 pmol of AGT. Lane 1, O
4
-MedT + 
R135G chimera; lane 2, T4 + R135G chimera; lane 3, T7 + R135G chimera; lane 4, O
4
-
MedT + chimera; lane 5, T4 + chimera; lane 6, T7 + chimera; lane 7, Positive Control 
(dT); lane 8, O
4




R135G Chimera     Chimera               Controls 
 
Figure A5.7: Time course repair of XLGG4 (A) and XLGG7 (B) by hAGT and 
chimera. AGT-DNA complex/partially repaired product (▲); free DNA/ fully repaired 
product (■); ICL/unrepaired substrate (♦). 
(A) XLGG4 
(B) XLGG7 
Lanes:    1    2    3          4    5    6          7    8    9    10 
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Figure A5.8: Time course repair of XLGT4 (A) and XLGT7 (B) by hAGT and chimera. 
AGT-DNA complex/partially repaired product (▲); free DNA/ fully repaired product 




Figure A5.9: 15% SDS-PAGE of chimera mediated repair of XLGT7. Repair of 625 
pmol XLGT7 by 600 pmol chimera for 5 h at 37 °C. XLGT7 + chimera reaction (left); 













Figure A5.10: Identification of chimera-DNA covalent complex by ESI-MS. 
hOGT Repair of XLGT7
mass










Figure A5.11: Repair gel of XLTT4 (A) and XLTT7 (B) by chimera. 
(A) Denaturing gel of the repair of 2 pmol of DNA by 60 pmol of AGT. Lane 1, Positive 
Control; lane 2, XLTT4; lane 3, XLTT4 + chimera; lane 4, XLTT4 + C145S chimera; 











(B) Denaturing gel of the repair of 2 pmol of DNA by 60 pmol of AGT. Lane 1, Positive 
Control; lane 2, XLTT7; lane 3, XLTT7 + chimera; lane 4, XLTT7 + C145S chimera; 


















Lanes:   1   2   3   4   5   6   7 
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Figure A5.12: Electro mobility shift assay of C145S chimera binding to XLGT7. (A) 
EMSA Gel of C145S chimera and XLGT7. 5 nM XLGT7 and 1.11 - 5.55 μM C145S 
chimera increasing from lanes 1 to 7. (B) Hill plot representation of log[PD]/[D] versus 









Lanes:      1       2       3       4       5       6       7 
XLGT7 = 1.994x -1.173 
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Table A5.1: ESI-MS results of chimera and variants. 
Protein 
Molecular Weight (Da) 
Calculated Observed 
Chimera 21959.3 21958.1 
C145S variant 21943.2 21942.2 
R135G variant 21860.2 21860.0 
 
Table A5.2: Difference in Tm between the chimera, its variants and hAGT. 
Protein 
Melting Temperature (°C) 
Observed Wild-Type Difference 
hAGT 56.5 56.5 0.0 
Chimera 49.0 56.5 -7.5 
C145S Chimera 45.5 56.5 -11.0 
R135G Chimera 49.0 56.5 -7.5 
 
Table A5.3: Effect of mutations on chimera intrinsic fluorescence on tryptophan and 
tyrosine (λex 280 nm) and tryptophan only (λex 295 nm). 
Protein 
λex 280 nm λex 295 nm 
λem (nm) Fluorescence Intensity λem (nm) Fluorescence Intensity 
hAGT 350 385 353 169 
Chimera 346 413 347 169 
C145S Chimera 346 368 348 166 





APPENDIX VI: Supporting information to CHAPTER VI 
Effect of the C5 Methyl on O
6
-Alkylguanine-DNA 
Alkyltransferase Mediated Repair of O
4
-alkyl Thymidine Adducts  
Francis P. McManus and Christopher J. Wilds* 
 
Figure A6.1: Tm curves of the various O
4
-alkyl dU adducts in DNA duplexes ............. 318 
Figure A6.2: Overnight repair of O
4
-alkyl dU by AGTs ............................................... 319 
Figure A6.3: EMSA of C139S OGT binding to U ........................................................ 321 
318 
 
Figure A6.1: Tm curves of the various O
4
-alkyl dU adducts in DNA duplexes. 5’ 
GGCTXGATCACCAG 3’ / 5’ CTGGTGATCCAGCC 3’ where X is dU for U (——), 
O
4
-MedU for U-Me (……), O4-BenzyldU for U-Bn (– •  • –), O4-butyl-4-ol dU for U4 (– 
• –) and O4-heptyl-7-ol dU for U7 (– – –). Solutions containing 2 µM for the duplexes in 
90 mM sodium chloride, pH = 7.0, 10 mM sodium phosphate, and 1 mM EDTA buffer, 






Figure A6.2: Overnight repair of O
4
-alkyl dU by AGTs. (A) Denaturing gel of the repair 
of 2 pmol of DNA by 10 pmol AGT: lane 1, U (control); lane 2, U-Me; lane 3, U-Me + 
hAGT; lane 4, U-Me + C145S hAGT; lane 5, U-Me + P140V hAGT; lane 6, U-Me + 
V148L hAGT; lane 7, U-Me + OGT; lane 8, U-Me + C139S OGT; lane 9, U-Me + 
S134P OGT; lane 10, U-Me + Ada-C; lane 11, U-Me + Chimera; lane 12, U-Me + 
C145S Chimera variant; lane 13, U-Me + R135G Chimera variant. Bar graph 






















































Figure A6.3: EMSA of C139S OGT binding to U. (A) EMSA gel of C139S OGT and U. 
5 nM dsDNA and 0, 3.7, 5.1, 6.2, 7.3, 8.4, 9.5 and 10.6 μM C139S OGT (lanes 1-7, 
respectively). (B) Hill plot representation of log[PnD]/[D] versus log[P] for U (■). 
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Figure A7.1:  Spectral regions of (A) DQF-COSY and (B) H,P-HSQC spectra at 25 °C. 














Table A7.1: Proton and phosphorus chemical shifts (ppm) of XLUU7 (1) and XLGG7 
(2) duplexes at 25 °C
a
. 




















































































































































































































 Proton signals for linker - CH2(1) 3.47/3.62, CH2(2) 1.18, CH2(3) 0.86, CH2(4) 0.95 
ppm for XLUU7, and CH2(1) 3.55/3.88, CH2(2) 1.23/1.42, CH2(3) 1.09, CH2(4) 1.01 
ppm for XLGG7. 
 
